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The aims of this thesis are to develop fast, accurate and clinically applicable motion-correction
solutions in T1 mapping acquisitions in cardiac and lung imaging. In order to maximise
clinical applicability, this thesis focuses on using automated post processing solutions which
minimise the time-cost to patients, clinical staff and MRI scanner scheduling.
This has been achieved in 4 separate but related original pieces of work:
• Chapter 3: A novel method for correcting accidental respiratory motion in Modified
Look Locker Inversion Recovery (MOLLI) sequences for cardiac T1 mapping is
presented and compared to an established, alternative method. The method presented
produces synthetic images via an inversion recovery model. It is shown that both
methods successfully improve image registration, but that the method presented here
uses less post-processing time.
• Chapter 4: The method discussed in Chapter 3 is implemented and evaluated in a large
cohort of patients with pulmonary hypertension to assess the diagnostic and prognostic
value of T1 mapping in this patient cohort. Although myocardial T1 was found to be
significantly elevated in patients with pulmonary hypertension, the diagnostic and
prognostic value of myocardial T1 was found to be limited.
• Chapter 5: The method discussed in Chapter 3 was extended to free breathing lung T1
mapping, and implemented in patients with idiopathic pulmonary fibrosis (IPF) and
healthy volunteers. The method is shown to register free breathing Look-Locker lung
vi
images successfully. The results show that free breathing lung T1 can discriminate
between patients with IPF and healthy volunteers. Free breathing lung T1 is significantly
lower and more heterogeneous in patients with IPF compared to healthy volunteers.
• Chapter 6: The method discussed in Chapter 5 is extended to free breathing cardiac
MOLLI sequences, and is implemented in healthy volunteers. It is shown that the
images are successfully motion corrected in the short axis plane, though the results are
likely to be less precise due to out of plane motion. The myocardial T1 is shown to be
significantly affected by oxygen enhanced imaging, and is significantly higher during
free breathing, compared to breath hold.
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The concept of using magnetic resonance to categorise tissue properties was first used to
assess the relaxation properties of normal and cancerous tissues by Raymond Damadian in
1971, before the first magnetic resonance image [3]. Damadian measured longer T1 and T2
relaxation times in cancerous tissues using nuclear magnetic resonance. Two years after
Damadian published his work on the relaxation properties of cancerous and normal tissues,
Paul Lanterbur published the first magnetic resonance image, followed in 1977 by the first
images of a living alive subject - a clam [4]. 30 years later, Lauterbur was jointly awarded the
2003 Nobel prize in physiology or medicine with Sir Peter Mansfield, for his contributions
to the invention of magnetic resonance imaging (MRI). By this time MRI was established
for diagnostic and prognostic clinical investigations worldwide. The use of measurement
of magnetic resonance times in research continues, however nowadays usually focusing on
measurement derived from 2D or 3D images. Despite initial indications that relaxation times
may be useful in identifying and characterising diseased tissues, it has become clear that
relaxation times are non-specific and changes in relaxation times may be caused by a wide
variety of mechanisms, such that a single measurement is not able to identify or characterise
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a tissue. Nevertheless, interest in relaxation times and their use in understanding tissue
changes continues, with the caveat that multiple information sources or circumstantial data
are needed to contextualise and interpret the relaxation time changes. The use of imaging
allows parametric mapping: pixel by pixel visualisation of tissue relaxation times. This can
identify regional changes in tissues, such as the presence of fibrosis or oedema. In order to be
clinically useful, these methods need to be accurate and reproducible, a particular challenge
in areas significantly affected by motion such a cardiac and respiratory systems. The use of
breath hold and cardiac gating can compensate for motion to some degree. However, not all
patients are able to maintain the breath holds required for longer sequences - such as 17s
for cardiac T1 mapping sequences. This has lead to the development of motion-correction
algorithms to compensate for unintended motion [5] [6], and free breathing acquisitions
which side-step the restriction of breath hold all together, and increase patient comfort [7]
[8]. Patients with pulmonary hypertension may benefit greatly from motion correction in
their imaging. These patients have elevated pressure in the pulmonary arteries leading to
cardiac remodelling and reduced cardiac function. Cardiovascular MRI is now an established
imaging technique for the assessment of patients with pulmonary hypertension, allowing
direct visualisation and accurate analysis of cardiac structure (mass, size and shape of
the ventricles) and function (volume and flow of blood within the ventricles). The use of
contrast agents (such as gadolinium) allow enhancement of areas of myocardial fibrosis and
scarring via late gadolinium enhancement imaging (LGE). However, T1 mapping may allow
tissue changes in these patients to be identified without the use of contrast agents, and may
also allow diffuse myocardial changes to be detected. In addition, this patient group may
struggle to maintain the breath hold needed for a traditional cardiac or pulmonary MRI,
and therefore free breathing image acquisition would significantly improve image accuracy
and patient comfort. The aim of this work was to investigate the use of motion-corrected
T1 mapping sequences. This would establish whether T1 mapping can produce accurate,
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useful and clinically applicable measurements of cardiac and lung tissue changes. This
work investigates patients with pulmonary hypertension (cardiac) and idiopathic pulmonary
fibrosis (lung).
1.2 Objectives
The objective of this thesis is to work towards fast, accurate, clinically applicable free
breathing solutions to T1 mapping of both the cardiac and respiratory systems. This will be
achieved by addressing four specific aims:
1. To develop a method to correct unwanted respiratory motion in cardiac T1 mapping
images.
2. To robustly assess the diagnostic and prognostic utility of cardiac T1 mapping in
patients with pulmonary hypertension.
3. To develop a free breathing motion correction method for cardiac and lung T1 mapping
applications.
4. To assess the impact of free breathing on cardiac and lung T1 values.
1.3 Overview
Chapter 2 provides the necessary information to understand the work described in this
thesis. It provides an introduction to MRI theory including imaging principles and T1
relaxation principles, an introduction to T1 mapping sequences and methods, an introduction
to pulmonary hypertension - the main patient population considered in this thesis, and an
introduction to idiopathic pulmonary fibrosis.
4 Introduction
Chapters 3-6 describe four separate pieces of original research, which are linked themati-
cally by the concept of motion correction in T1 mapping and through which a novel method
for motion correction in T1 mapping is developed.
Chapter 3 describes a novel method for image registration to correct unwanted respiratory
or cardiac motion in a MOLLI (MOdified Look-Locker Inversion recovery) T1 mapping
sequence. The method is implemented and compared to an alternative motion correction
method from Xue et al [5]. The two methods are compared in a cohort of patients with
pulmonary hypertension.
Chapter 4 uses the method described in Chapter 3 and implements it in a large pulmonary
hypertension cohort to assess the utility of cardiac T1 mapping in these patients, including
the diagnostic and prognostic utility of T1.
Chapter 5 modifies the method described in Chapter 3 for free breathing lung T1 mapping.
The method is tested on a small cohort of patients with idiopathic pulmonary fibrosis and
healthy volunteers. The method is also used for oxygen enhanced lung T1 mapping during
free breathing on a subset of the healthy volunteers.
Chapter 6 modifies the method described in Chapter 5 for free breathing cardiac T1
mapping. The method is tested in a small cohort of healthy volunteers, and the feasibility of
oxygen enhanced cardiac T1 mapping during both breath hold and free breathing is tested on
a subset of the healthy volunteers. The challenges and potential for free breathing cardiac T1
mapping and the role that oxygenation plays in myocardial T1 values are discussed.
Chapter 7 summarises the work described in chapters 3-6 and discusses areas of future
work to further validate the free breathing method described, it discusses the method’s
potential potential for future clinical studies evaluating cardiac and lung changes due to
disease, without the need for breath hold.
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This chapter outlines the relevant MR (magnetic resonance) theory and background informa-
tion to aid understanding of the work described in the experimental chapters of this thesis.
Unless otherwise referenced, section 2.1 is informed by the two text books [9] and [10].
2.1 MRI theory
2.1.1 Introduction to basic magnetic resonance imaging
2.1.1.1 Spin basics
In a magnetic field, stationary particles that possess a property known as spin have angular
momentum, and an associated magnetic moments, µ . In classical mechanics this is analogous
to an object physically rotating around an axis. However, over small distances (objects on
an atomic scale), classical mechanics breaks down and other models - such as quantum
mechanics - better describe and predict particle behaviour at this scale. In quantum mechanics,
spin is understood to be an inherent property of a particle - much like mass or charge.
However, spin is quantised, only existing in increments of n2 , where n is an integer. A
classically rotating object has angular momentum with a direction - either up or down with
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respect to its axis of rotation. Similarly, in quantum mechanics, spin can be parallel to the
static magnetic field (spin up) or anti-parallel to the magnetic field (spin down). A nucleus
will have an overall magnetic moment arising from the combined effect of its nuclear spins.
The maximum projection of nuclear spin is represented by I, which in the case of a fermion
(such as a proton, neutron or electron) is equal to 12 . MRI manipulates the spin state of a
nucleus (usually a hydrogen proton) to obtain information about nuclear density and position.
As illustrated in Figure 2.1, in the presence of a static magnetic field (B0), nuclear spin can
align parallel or anti-parallel with the magnetic field. The alignment of a spin with respect to
the field alters its energy state. For a nucleus with spin quantum number I, there are a number
of discrete energy levels, due to the alignment of spins, with values given by m, where m
can take 2I + 1 values. For example, for 1H the spin quantum number is 12 and therefore
spin can be either +12 ,
−1
2 . The energy levels due to the spin alignment of a proton take the
values ±γ h̄IḂ0, where γ is the gyromagnetic ratio (the ratio of a particle’s magnetic moment
to its angular moment). The energy difference between spin states which lie parallel and
anti parallel alignment with the field is δE = γ h̄B0, this is illustrated in Figure 2.1. This
splitting of nuclear energy levels in the presence of a magnetic field is known as the Zeeman
Fig. 2.1 Schematic drawing showing the energy difference between spin = −12 (E1) and
spin = 12 (E2) energy levels, where E is energy, B is static magnetic field, γ is gyromagnetic
ratio and h̄ is the reduced Planck’s constant.
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effect. The lower-energy state is the most stable, so protons can only transition from the
lower-energy state (spin =+12 ) to the higher-energy state ( spin =−
1
2 ), if they absorb exactly
quantum δE of energy (see Figure 2.1).
The behaviour of a particle’s spin in the presence of a static magnetic field can be
understood using both quantum mechanics and a semi classical model. For the purpose of
this thesis, a semi classical model will be used where spin exists in a quantised form creating
a net magnetisation but the behaviour of particles is described using classical mechanics. For
a single nucleus in a static magnetic field, its spin due to its magnetic moment (µ) experiences
a torque (rate of change of angular momentum) given by τ = dJ/dt = µ ×B, where J is the
nuclear angular momentum. As µ = γJ and the net magnetisation of N spins is given by




Where M is the net magnetisation. This is the equation of motion for a group of non-
interacting spins in the laboratory frame.
Statistical mechanics describes the behaviour of a population of spins at a macroscopic
level and can be used to describe the behaviour of a population of spins which can transition
between Zeeman energy levels by absorbing or emitting discrete amounts of energy (equal
to the energy difference between states) in the form of photons. A spin system will have
a resonance frequency - a frequency which corresponds to the photon absorption energy
required to excite proton spins from the lower energy level (spin 12 ) to the higher energy level






Where ω0 is the Larmor frequency, ν is frequency, γ is the gyromagnetic ratio and B0 is the
externally applied static magnetic field strength.
Within a spin population, some spins will be in the lower energy level (Nα ) and some
will be in the higher energy level (Nβ ). When in equilibrium, the spin population (Nα Nβ )
can be described using statistical mechanics as a Boltzmann energy population similar to






Where K is the Boltzmann constant and T is the temperature. The thermal equilibrium
of spins in a static magnetic field will be reached at a time characterised by T1, which
is a characteristic relaxation time defined, in part, by the temperature of the system (the
Boltzmann lattice). Spins change energy level by interacting with the surrounding molecular
environment (known as the lattice). Interactions with the lattice provide mechanisms for
energy loss and gain, and the properties of the molecular environment (i.e. the probability
of interactions occurring which provide energy at the frequency required for absorption)
characterise how quickly the system can reach equilibrium. The properties of the molecular
environment therefore characterise to the overall relaxation time, T1.
In an MR experiment, the net magnetisation is perturbed by an external energy source
(known as a radio-frequency or RF pulse) and the magnetisation relaxes back to equilibrium
in time characterised by T1. The behaviour of a spin system in this environment are described
phenomenologically by a set of equations known as the Bloch equations [11].
The evolution of a macroscopic magnetisation M(t)= (Mx(t),My(t),Mz(t)) in a magnetic




















Where M0 is the equilibrium magnetisation.
Equation 2.6 refers to the z plane and is governed by relaxation time T1. Equations 2.4
and 2.5 are governed by the relaxation time T2, which describes the relaxation in the xy plane.
Both relaxation mechanisms are described in more detail in section 2.1.2.1 and 2.1.2.2.
If we consider a magnetic field which is static in the longitudinal plane, and another
applied rotating field in the transverse plane: Bx = B1cos(ωt), By = B1sin(ωt), Bz = B0 and
apply an RF pulse along the +x axis, such that Mx(0) = Mz(0) = 0 and My(0) = M0 the
equations 2.4, 2.5 and 2.6 can be solved to show:
Mx(t) = M0sin(ω0t)) · e
−t
T2 (2.7)
My(t) = M0cos(ω0t)) · e
−t
T2 (2.8)
Mz(t) = M0(1− e
−t
T1 ) (2.9)
Fig. 2.2 Schematic drawing showing a spin precessing about its axis due to the presence of
an external magnetic field.
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An example of a simple MRI experiment is the observation of free induction decay (FID).
During FID, an object is placed in a static magnetic field (B0). The static magnetic field
causes the spin to precess around its axis. Then, a 90◦ radio-frequency (RF) pulse is applied
which transiently polarises (aligns) the spins in the protons in a different plane. The net
magnetisation is rotated from the z plane into the xy plane. Once the RF pulse is removed,
the polarised dipoles gradually begin to dephase, due to small differences in the magnetic
field they experience (T2 decay). The acquired phase difference increases with magnetic field
difference and time. Over time, the acquired phase differences result in the spin isochromats
becoming incoherent, see Figure 2.3, so that the overall magnetisation decreases with a
characteristic time, T2, see Figure 2.4. The application of a 180◦ RF pulse (or a suitable
gradient) will reverse the phase angle of each spin, leading the spins to come back into phase
as the spins precession re-aligns and a second coherence occurs. This is known as a spin
echo (SE) experiment.
Fig. 2.3 Schematic drawing of the concept of dephasing and free induction decay showing a
series of waves which start in phase and gradually become incoherent, leading to a reduction
of the overall summed waveform.
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2.1.1.2 Imaging basics
The basic principle of nuclear magnetic resonance (NMR) is that a changing magnetic field
will cause magnetic induction. A wire in the presence a changing magnetic field caused by
the precession of spins in the xy plane will experience a current, due to the effect of the
varying magnetic field on the free electrons, which can be measured. In the presence of a
resonant coil (i.e. tuned to the Larmor frequency), this precession will induce a voltage in a
coil, which will be damped as the spins dephase (T2 decay).
An RF pulse perturbs the net magnetisation vector out of equilibrium (aligned with the
static magnetic field) and into the xy plane, see Figure 2.5. In a rotating frame of reference
(rotating at the same frequency of spin precession) the spin behaviour is simplified and can
be described as the magnetisation flipping from the longitudinal (z) plane into the transverse
plane (xy) when manipulated with either a 90 degree radio-frequency pulse or an appropriate
magnetic field gradient. The "RF pulse" itself is an oscillating field, B1, which is orthogonal
to B0.
Spatial information is encoded by magnetic field gradients Gx,y,z =
dBz
dx,y,z
. To obtain spatial
information, an MRI pulse sequence requires three basic components: an RF pulse with
a simultaneous slice selective gradient (in this work, depicted in the in the z axis, Gz); a
frequency encoding gradient (in this work, depicted in the x axis, Gx) and a phase encoding
gradient (in this work, depicted in the y axis, Gy). These three components combine to enable
spin spatial location to be resolved in three dimensions. The MRI signal is then received in








Where r is radial distance, s is signal, and k is frequency.
ω0(x) = γ(B0 +Gxx) (2.11)
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Fig. 2.4 Schematic drawing showing a spin echo experiment. A) Shows the RF pulse
sequence over time, B) shows the magnetisation behaviour of the spin system and C) shows
the measured signal over time in response to A). All panels share a time axis.
Fig. 2.5 Schematic drawing showing the net magnetisation of a spin, with angular frequency
ω0 about the z axis, being flipped from the z plane into the y plane by an angle of α .
To achieve frequency encoding an additional magnetic field that varies spatially is applied
to the system. For example, a linear gradient Gx in the x axis could be applied such that
the overall magnetic field experienced by a spin would be Bx = B0 +Gxx. The precession
frequency of that spin will depend on its location along the x axis.
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Which, in the rotating frame of reference which rotates at γB0 can be written as:
ω(x) = γGxx (2.12)
If an image of a certain field of view (FOV) is desired in the x direction, with a resolution








As a gradient requires a finite time to turn on and off (ramp up and down), the shape of
the magnetic field with time is trapezoidal, as depicted in pulse sequence diagrams in Figure
2.6. Frequency encoding cannot be used in both the x and y directions, as some points in
space will have overlapping frequencies. Therefore, phase encoding is used in the y plane to
determine spatial information. When a spatially varying field gradient is applied to a set of
spins, they precess at a different frequency and acquire a phase shift which depends on their
spatial location. When the gradient is turned off, they return to precessing at their original
frequency but the phase shift remains. This allows a location-dependant phase shift to be
applied to the spins in the y-plane prior to the image acquisition window.
The phase encoding gradient must be repeated for each step in frequency ∆ky where the
time between repetitions is known as TR. Therefore for number of phase encoding steps Ny,
with image resolution ∆y = FOVNy there is a total time cost of:
tacquisition = NyTR (2.14)
For this reason, increased spatial resolution in the phase encoded direction results in a
longer acquisition time, whereas the spatial resolution in the frequency encoding direction
can be increased by simply decreasing the gradient amplitude.
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The slice selection gradient, Gz, is applied to obtain information from a specific image
plane (or slice). Gz is applied at the same time as the RF pulse such that only spins in the
selected spatial plane are perturbed. The RF pulse has bandwidth (range of frequencies it
excites) BW = 2πδω which are centred around ω0. The simultaneous field gradient Gz is









Where ∆z is slice thickness.
When combined, as in Figure 2.6, a 2D spatially resolved image can be obtained. Figure





f (t)eiωt dt (2.16)
However, if TR is smaller than T1, the longitudinal relaxation (z plane) does not fully
recover at the end of acquisition. Over time, the residual longitudinal relaxation will reach a
steady state as the transverse magnetisation, which can be fed back into the spin system and
when the system is re-excited. Similarly, if TR is smaller than T2 there will also be residual
magnetisation in the transverse magnetisation (xy) plane. This can either be eliminated with
a spoiling gradient, or preserved for the next iteration of the sequence.
If the transverse magnetisation is spoiled (removed), it is known as a SPGR (spoiled
gradient) sequence, whereas if it is recovered it is known as a SSFP (steady state free preces-
sion) sequence. An example of a SSFP sequence is a balanced steady state free precession
sequence - bSSFP - where all three axes (transverse and longitudinal magnetisation) are in a
steady state, as shown in Figure 2.7.
An alternative to a gradient echo sequence is a spin echo sequence, which uses a second
180◦ RF inversion pulse (rather than a gradient) to reverse the individual phase angles of the
spins, creating a second coherence in the transverse plane, as shown in Figure 2.8.
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Fig. 2.6 Schematic drawing showing a pulse sequence timing diagram, with an RF pulse
and simultaneous slice selection gradient on the z axis, a frequency encoding gradient on
the x axis, and a phase encoding gradient on the y axis (depicted as a number of gradient
amplitudes on top of one another).
Fig. 2.7 Schematic drawing showing a pulse sequence timing diagram for a bSSFP sequence.
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In general, for T1 weighted imaging gradient echo sequences (which are usually acquired
with a large flip angle (α) and a short echo time (T E) result in much faster image acquisition.
This is particularly important in breath-held chest imaging such as cardiac and lung imaging,
where acquisition time is restricted to that of a single breath hold. T1 weighted gradient echo
images also result in high SNR (signal to noise ratio) and image resolution. T1 weighted
imaging results in good contrast between tissue, fluid and fat, with fluid such as blood
appearing darker than tissue and fat due to its short T1 (the reasons for this will be discussed
further in section 2.1.3). For imaging the lungs or the myocardium, this can be particularly
useful because the signal from the blood in the heart and lungs is low and signal from tissue
is high.
2.1.2 T1 relaxation principles
The relaxation times T1 and T2 have already been described in reference to the Bloch
equations: eq (2.7), eq (2.8) and eq (2.9). Particular molecular environments and lattice
temperatures have characteristic relaxation times. The times represent how efficiently a set
of spins reach their equilibrium population states. For the longitudinal relaxation time, T1,
the relaxation mechanisms arise from interactions with the surrounding environment (the
lattice), see section 2.1.2.1. For the transverse relaxation, T2, interactions with other spins
drive the relaxation mechanisms, see section 2.1.2.2.
2.1.2.1 Longitudinal relaxation - T1
Protons (spin 12) can absorb or emit energy, resulting in transfer between the lower energy
state (+12 )and the higher energy state (−
1
2 ). Protons absorb or emit energy at the frequency
that corresponds to the energy difference between energy levels, as mentioned in section
2.1.1. The speed of this process depends on the molecular interactions that can occur at
this frequency (i.e. interactions that result in the emission or absorption of energy that
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corresponds to this frequency). The more mechanisms, and the more energy available to the
system, the faster the system will reach equilibrium.
For the proton, T1 relaxation primarily occurs due to intra-molecular dipole-dipole
interactions, which occur at the energies required for longitudinal relaxation, see Figure 2.1.
δE = h̄γB0 (2.17)
The energy required for transitions depends on B0; at higher magnetic fields, more energy
is needed for a transition to take place. Therefore, the resultant relaxation time (T1) is
dependent on the energy is available to the system (i.e. the spins’ local environment) and the
energy required to transition (i.e. the Zeeman energy which is determined by the magnetic
field strength).
Each individual spin fluctuates over time, but overall there is a small net alignment with
the magnetic field. This is known as spontaneous magnetisation. This magnetisation is
described by
Mz(t) = Mequilibirum(1− e
− tT1 ) (2.18)
Where TR is the time between RF pulses, and T1 is the longitudinal relaxation time T1 [9].
In an MRI experiment where spins are manipulated out of their equilibrium energy states
using RF pulses or gradients, T1 will also characterise the time it takes for the system to
return back to its equilibrium position, losing energy to the surrounding environment (or
"lattice") in the process. During this process longitudinal magnetisation can be described by:





The primary mechanism for longitudinal relaxation, intra-molecular dipole-dipole inter-
actions, occur due to the magnetic dipoles (i.e. the spins) creating small local changes to the
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magnetic field. These local magnetic field changes create small localised energy changes,
and these energy fluctuations can cause protons to transition between spin states [1]. Two
spins in the presence of one another have four possible alignment combinations, with four
different associated energies, see Figure 2.9, and moving between these states allows energy
emission/absorption in the frequencies associated with longitudinal relaxation. Transfers
between the energy states are shown in Figure 2.9. Each of the energy levels has an associated
transition rate, i.e. the probability of these interactions occurring has an associated rate of
transfer. These interactions are the dominant mechanism for spin-lattice relaxation.
The strength of the interaction between two dipoles depends upon the type of spins
(electrons have a larger gyromagnetic ratio than protons and therefore a proton-electron
interaction is stronger than a proton-proton interaction), the distance between the spins (with
interactions stronger between closer spins), the angle between the spin vectors, and other
properties such as the relative motion of the spins. The thermal motion of molecules leads to
fluctuations of the field experienced at the site of the nuclear spin. As a molecule tumbles
in its environment, the strength and direction of the local field experienced changes. The
magnetic field experienced by nuclei can be described as a combination of an approximately
static magnetic field in the z direction (Bo) and a fluctuating transverse field due to the
thermal motion of molecules leading to fluctuating interactions between spins (Bx(t)) which
changes with time.
For each spin, Bx(t) (the local magnetic field each spin experiences in the transverse
plane) is different and fluctuates with time. Bx(t) is assumed to have a mean of 0, but
B2x(t) > 0. The mean magnitude value of the field is assumed to be the same for all spins.
The fluctuations of Bx(t) can be described using an autocorrelation function, G. At some
point in time, t + τ , the field’s behaviour is independent of its behaviour at a previous point
in time t, and so the system "loses it’s memory". This occurs when τ is much greater than
the size of the fluctuations in G.
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Fig. 2.8 Schematic drawing showing a pulse sequence timing diagram for a spin echo
sequence.
Fig. 2.9 Schematic drawing showing the four energy levels between two dipoles. W0 indicates
a zero-quantum transition, W1 indicates a single-quantum transition and W2 indicates a
double-quantum transition.
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Although not based in theory, qualitatively G may be assumed to be equal to:
G=< Bx(t)Bx(t + τ) ≯= 0 (2.20)
Correlation time (τc), is a constant that characterises the loss of correlation in the system
- rapid fluctuations have a small τc and slow fluctuations have a large τc. The dependence of
T1 and T2 on τc is shown in Figure 2.10. Relaxation is most efficient when the tumbling rate,
1
τc
, occurs approximately at the Larmor frequency (ω0) (i.e. ω0 ∼ 1τc ). This can be seen at the
minimum of the T1 dependence line on Figure 2.10 [1]. Therefore, although at low fields
dipole-dipole interactions are the dominant relaxation mechanism, as B0 increases chemical
shift ansiotropy (CSA) plays an increasingly important role in longitudinal relaxation for
spin 12 nuclei. CSA interactions occur at a higher frequency and are the result of electrons
in the molecules causing submolecular magnetic field fluctuations. Electrons within the
molecule itself create fields due to their movement through the magnetic field. As field
strength increases, the relative importance CSA to dipole-dipole coupling to longitudinal
relaxation mechanisms changes, with CSA interactions contributing more to longitudinal
relaxation as field strength increases.
2.1.2.2 Transverse relaxation - T2
T2 relaxation describes the dephasing of spins over time due to interactions with other spins.
Local field inhomogeneities occur due to two processes: 1) inhomogeneities in the main
magnetic field, and 2) inhomogeneities caused by nearby spins own magnetic moments. Each
spin has an associated magnetic moment, which causes a local perturbation of the magnetic
field. Therefore, the location of other spins effects the magnetic field experienced by a given
spin, causing spin precession to occur at slightly different frequencies, due to experiencing
slightly different magnetic fields.
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Two protons experiencing a slightly different field, ±δB0 will precess at slightly different
frequencies:
ω1 = γ(B0 +δB0) (2.21)
ω2 = γ(B0 −δB0) (2.22)
The two different frequencies result in the two protons acquiring a phase difference in the
rotating frame:
δθ = θ1 −θ2 = ω1t −ω2t = tγ(B0 +δB0 −B0 +δB0) = 2δB0γt (2.23)
The acquired phase difference therefore increases with magnetic field difference and time.
Over time, the acquired phases differences result in the spins becoming incoherent so that
the overall magnetisation decreases, as described in section 2.1.1.1.
2.1.3 Longitudinal relaxation times in the body
T1 relaxation time of a spin depends upon how it interacts with its surroundings, as discussed
in section 2.1.2.1 and the dominant mechanism for this is magnetic dipole-dipole interactions.
The rate at which relaxation occurs depends on the rate of interactions between the proton
(the spin) and its local environment (the lattice) as well as the static magnetic field strength
B0. As discussed in section 2.1.2.1, this rate can be described by using a time scale, τc,
which corresponds to the average time between interactions with the environment. The
random motion of surrounding particles produces random fluctuations in the magnetic field
experienced by a spin. Generally, solids have long τc, as the protons move slowly, and liquids
have shorter τc values as the protons are move quickly, although this is not always the case.
For example lipids have a very short T1, due to the large size of unbound lipid molecules.
Different tissues will be differently affected by an increase in static magnetic strength, in
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general protons in solids have less freedom of movement (are "bound") and therefore at
higher field strengths the fraction of molecules able to tumble at the resonance frequency
decreases, resulting in reduced energy transfer and thus increase in relaxation time. Liquids
and gases, in general, are less affected by a change in field strength as they are more mobile
and so a higher proportion of protons within the gas or liquid are able to interact at higher
frequencies.
This behaviour can be understood as a proton interacting with a heat reservoir (where the
heat reservoir describes the thermal motion of atoms and the energy available due to those








Where N− and N+ are the number of spins with spin −12 and
1
2 respectively. K is the
Boltzmann constant, and T is temperature in Kelvin. The thermal equilibrium population is
therefore defined by the reservoir (lattice) temperature (how much energy is available to the
system) and the static magnetic field, B0. The static magnetic field defines the energy levels
between spin states, see equation (2.17) and Figure 2.9, and therefore the probability of a
transition between energy levels occurring.
However, few tissues within the body are a solid (bound protons) or liquid (freely moving
protons). Rather, most can be described as "structured" (somewhere in between). Therefore,
their behaviour falls on a continuum between predictions for a solid or liquid object. There
are exceptions to this - blood and cerebrospinal fluid are MRI relevant liquids. In general
though, most tissues contain a range of proton binding levels, which are exchanged between
environments.
In a water or fluid environment, such as blood, the presence macromolecules (e.g. pro-
teins) shorten T1 by providing additional relaxation pathways for water molecules, for
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Zhang et al [13] 6 Look-Locker 1.5T 50% 31±6 sagittal sinus 1480 ± 61
Zhang et al [13] 6 Look-Locker 3T 50% 31±6 sagittal sinus 1480 ± 61
Zhang et al [13] 6 Look-Locker 1.5T 50% 31±6 sagittal sinus 1649 ± 68
Zhang et al [13] 6 Look-Locker 3T 50% 31±6 sagittal sinus 2087 ± 131
Reiter et al [14] 40 MOLLI* 1.5T 50% 24±3 left ventricle 1586 ± 103
example, through proton exchange between water molecules and macromolecules. Blood
contains several macromolecules, such as albumin in the blood plasma, and haemoglobin
in red blood cells, and increases in the blood macromolecule content will shorten blood T1
[2]. Paramagnetic substances can also affect T1. Examples include macromolecules such
as deoxyhaemoglobin in the blood. Therefore blood T1 will vary with oxygenation and
the hematocrit (the ratio of the volume of red blood cells to the total volume of blood).
Hematocrit also varies with age and sex [12] with women typically having lower hematocrit
levels and a higher blood T1 [13] [14]. Typical blood T1 values are shown in Table 2.1.
The measured T1 will always occur due to a combination of processes, and usually the
multiple, complex anatomical mechanisms responsible for changes to tissue T1 cannot be
understood through an MRI examination or image alone. However, in general, changes to
tissue composition due to disease alter the atomic environment, which may lead to T1 changes.
For example, the existence of oedema (an abnormal build up of fluid) results in an increased
T1, as does fibrosis - a thickening and scarring of connective tissue in the body. Similarly, the
presence of fat in a tissue will cause a decrease in T1. Combining T1 measurement with other
data, either MRI (such as T2) or other medical information (such as tissue samples), can help
determine how T1 changes relate to pathology and what T1 changes indicate in the context of
certain patient groups or pathologies.
When calculating T1 from a region of interest drawn on a T1 map, or set of images, it is
necessary to avoid tissue boundaries in order to avoid partial volume effects and measure the
28 Theory
T1 of a single tissue. Including pixels corresponding to more than one tissue into a regional













Where N is the number of protons corresponding to a given T1, and Ntot is the total number
of protons. Which, if interpreted as a the T1 for a single tissue which lead to inaccuracies in
calculating T1.
2.1.4 Effect of oxygenation on T1
Molecular oxygen contains two unpaired electrons (i.e. two electrons which do not occupy
an orbit with a paired electron of opposite spin). Each oxygen molecule therefore has a
magnetic moment of 2.8 Bohr Magnetons [15]. This makes oxygen paramagnetic; it has a
permanent magnetic moment in a magnetic field. Paramagnetic ions provide a mechanism
for dipole-dipole coupling, as the gyromagnetic ratio of the electrons is much larger than that
of another proton, so it can interact with a proton’s spin over longer distances. The presence
of oxygen in an object will increase relaxation rate, in terms of both T1 (by providing a
dipole-dipole relaxation mechanism) and T2 (by perturbing the local magnetic field and
causing additional precession dephasing).
Oxygen is both present in the body naturally, due to respiration of air (21% O2), and
can be used at higher inhaled concentrations as an additional contrast agent. In the body,
molecular oxygen can effect blood T1 via two methods: 1) by attaching to the paramagnetic
deoxyhaemoglobin, reducing the amount of deoxyhaemoglobin present and thus increasing T1
relaxation time and 2) by dissolving in the plasma, thus decreasing T1 by promoting relaxation
in nearby protons [16]. Lung T1 measurements when using 100% oxygen as a contrast agent
demonstrate a decrease in T1 due to the presence of oxygen dissolved in the blood plasma
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[17]. Ex− vivo and in− vivo blood measurements show that blood T1 is dependent on both
haematocrit levels and oxygenation state. Blood with oxygenation levels between 5% and
95% demonstrate a decrease in T1 as blood becomes less oxygenated, and deoxyhaemoglobin
increases. This effect is stronger with higher levels of haematocrit. However, at high levels
of oxygenation (>95%) T1 decreases with increased oxygenation due to the presence of
dissolved oxygen in the blood plasma [2], see Figure 2.11. Deoxygenated venous blood is
typically 60−70% oxygenated, whereas oxygenated arterial blood is typically 95−100%.
The T1 of deoxygenated right ventricular and oxygenated left ventricular blood at 1.5T are
1535±76ms and 1515±76ms respectively [18].
Oxygen enhanced T1 maps have been performed to visualise and calculate the transfer of
oxygen to the lung, by using 100% inhaled oxygen. The T1 shortening can be measured with
T1 weighted MRI sequences providing information on oxygen absorption by blood and tissue.
This is considered to indirectly measure pulmonary function. As oxygen passively diffuses
from the alveoli to the blood capillaries in the lung (due to the partial pressure gradient that
exists between them) the dissolved oxygen lowers overall lung T1, demonstrating regions that
have been ventilated and subsequently perfused [19]. The wash-in and wash-out of O2 over
time can be visualised using rapidly acquired lung T1 maps. By not waiting for magnetisation
to fully recover before subsequent inversions, T1 maps can be acquired quickly enough to
visualised the uptake (and wash out) of oxygen in the lung via T1 mapping. Oxygen was
found to have a wash-in time of 52.20±15.53s and a wash-out time of 43.90±10.47s in
healthy volunteers [17].
2.2 T1 mapping methods and MR sequences
A T1 map is an image where each pixel represents the T1 value of the corresponding real-space
image. It shows pixel-by-pixel T1 differences in a single slice of the object or anatomy being
imaged, allowing regional variations in T1 to be visualised. Measuring an objects T1 can
30 Theory
Fig. 2.10 Variation of T1 and T2 with τc according to the simplified theory where all interac-
tions are assumed to have the same τc. Note: Reprinted with permission from [1].
Fig. 2.11 a) Longitudinal relaxation rate (R1) in bovine blood at haematocrit 0.41 as a function
of deoxygenation (1-Y) at 4.7T. Open circles show hyperoxygenated blood (Y>0.95). b)
hyperoxygenated blood as a function of partial pressure of oxygen at 4.7T. Note: Reprinted
with permission from Magnetic Resonance in Medicine [2].
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be achieved in several ways, including: saturation recovery sequences, inversion recovery
sequences and signal ratio sequences. To implement a saturation recovery sequence, a spin
echo experiment is repeated with a variable recovery time (TR) or flip angle (α). This varies
the amount of magnetisation in the longitudinal plane. The intensity change of the images
depends on T1. A spoiling mechanism must be used to eliminate remnant transverse (xy)
magnetisation prior to each RF pulse. For a low TR and variable flip angle sequence, a small







Where S0 is the initial magnetisation and E is: E = exp(−TRT1 ). The maximum signal (which








To which the solution for maximum magnetisation is:
cos(α) = E (2.28)
Therefore, the an angle which maximises transverse magnetisation is given by:
α = cos−2(E) (2.29)
This is known as the Ernst angle [20].
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An inversion recovery sequence uses a 180◦ RF pulse to invert magnetisation prior to
magnetisation being flipped into the transverse plane. The initial magnetisation is −M0. This




The equation (2.30) is only true if it is assumed that there is a perfectly inverted set of
spins. In reality, spin inversion is imperfect in practice due to the pulse profile being finite,






Where S0, A and T1 are parameters to be fit [10].
This creates a 3 parameter fitting technique. However, if the images are magnitude
images, the signal polarity of the images is not known. Signal polarity can be restored by a
multi-fitting approach, where the signal is inverted for each TI, per pixel, and fit to Equation
2.31. This creates pixel sets with different signal polarity, the first with all positive pixel
values, the second with the first pixel signal inverted, the third with the first two pixels signal
inverted, and so on. By choosing the set of pixels which minimises the residual between a
fitted value and the data, polarity can be restored to the images, on a pixel by pixel basis.






Which may result in quicker computation but at the expense of a poor estimation of signal
at the zero crossing point, see Figures 2.12 and 2.13. In addition, a magnitude fitting has
been found to be more sensitive to initial conditions than a multi-fitting approach [21],
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Fig. 2.12 Examples of fitting to a 3 parameter inversion recovery equation from a MOdified
Look-Locker Inversion recovery sequence (MOLLI) acquisition, where signal polarity has
been restored via a multi-fitting approach.
Fig. 2.13 Examples of fitting to a magnitude fit to the inversion recovery equation from a
MOdified Look-Locker Inversion recovery sequence (MOLLI) acquisition.
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An alternative method to saturation and inversion recovery techniques is to use the ratio











Where ST 1 is the signal from the T1 weighted image and SPD is the signal from the proton
density weighted image. This method automatically eliminates T2 weighting and does not






2.2.1 Cardiac T1 mapping
The MOdified Look-Locker Inversion Recovery sequence (MOLLI) adapted the inversion
recovery Look-Locker sequence [22] for cardiac imaging. The sequence is gated to cardiac
motion and combines acquisitions from three inversion recovery sweeps in order to sample
the beginning of the inversion recovery curve more thoroughly. The original Look-Locker
sequence uses a correction factor based on using a spoiled gradient echo readout (SPGR). A
spoiled readout eliminates any transverse magnetisation, ensuring there is no magnetisation
in the transverse plane, such that a steady state of transverse magnetisation cannot develop.




Where T1 is given by
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However, MOLLI uses single-shot steady-state free-precession (SSFP) readout. Instead
of eliminating transverse magnetisation, an SSFP readout allows the system to reach a
steady-state in the transverse plane (i.e. an equilibrium of non-zero transverse magnetisation
develops). This makes the above correction inapplicable and gives the sequence a slight
T2 weighting. The correction in equation (2.36) is technically invalid, and leads to an
underestimation in resultant T1 due to longitudinal magnetisation recovering faster than
it would with an SPGR readout. Nonetheless, the correction factor has been found to be
reasonably affective at low read-out excitation flip angles [21].
The MOLLI sequence consists of three inversion recovery sweeps, see Figure 2.14. The
original version of the sequence has 11 image acquisitions in 17 heartbeats [23]. The signal
intensity from each MOLLI image is plotted against the time of data acquisition, showing a
signal recovery curve. From this, curve fitting can determine the value of T1 as the signal
recovers according to equation 2.35.
Fig. 2.14 Schematic drawing of a MOLLI sequence and subsequent inversion recovery curve.
Studies comparing MOLLI T1 values in phantoms have shown that T1 values are less
accurate but more reproducible when compared to saturation recovery based techniques
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[24] with phantom spin-echo acquisitions used as reference T1 data. Magnetisation transfer
comprises a significant component of MOLLI underestimation, as the RF inversion pulse
does not fully invert the bound pool of spins (spins that are bound to molecules, but which
are continually exchanging with free spins). This leads to an accelerated impression of
inversion recovery. Saturation recovery techniques, such as SASHA [25] acquire cardiac
gated saturation recovery images which do saturate the bound pool and are not effected by
magnetisation transfer. However, in inversion recovery images the effect of the un-inverted
bound pool is largely due to physiological parameters rather than acquisition parameters and
is found to be reproducible. This results in an inaccurate but reproducible T1 measurement.
SASHA has been found both through simulations and phantom experiments to be less precise
and less reproducible than MOLLI [21].
The precision of T1 measurement when using a MOLLI sequence also depends on the
method of curve-fitting employed to determine T1 from the acquired images. Resultant T1
accuracy depends on how signal-polarity is determined (restored) from magnitude images.
Signal polarity can be determined from magnitude images using curve-fitting to equation
(2.35). Though time consuming a final fitting process to equation (2.35) results in a more
precise fitting than a fit to magnitude data, as shown in Figures 2.12 and 2.13.
Phantom studies show that the MOLLI sequence is heart-rate dependent as the time
interval between inversions and SSFP readout is determined by heart rate. Heart rate
dependence can be reduced by acquiring just 7-8 images over 11 heartbeats, using two
inversions (5-3), or (4-3). In this there is a trade-off between increasing heart-rate dependence
versus acquiring less data with shorter sequences which may effect curve-fitting precision.
An alternative method is to reverse the order of sampling, so that 5 images are acquired in
the first inversion, followed by 3 images after the subsequent inversions (5-3-3), reducing
average time between inversions and therefore heart rate dependence without acquiring less
images [26, 27]. However, an in vivo study on 20 healthy volunteers and a separate study
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of 60 healthy volunteers showed no measurable T1 heart rate dependence within the group
[28, 29], which may indicate heart rate dependence contributes less to variability than normal
physiological variation.
The shMOLLI sequence was designed to overcome the heart rate dependence of MOLLI.
The shMOLLI sequence uses three inversions, but acquires 5 images after the first inversion,
followed by 1 image after the subsequent inversions (5-1-1) as well as using conditional
fitting [30]. In phantom and in-vivo based experiments (10 patients and 8 controls) shMOLLI
showed greater underestimation of T1 compared to MOLLI and less precise measurement.
However, the shMOLLI acquisition still resulted in more precise T1 measurements than
SASHA acquisition [24]. In a larger, in-vivo experiment characterising normal T1 variation
(342 subjects) shMOLLI T1 was found to be heart-rate independent – once corrected for age
and sex. However, the use of conditional fitting results in less precise measurement if T1 due
to the discarding of data, with no corresponding gain in accuracy [21].
Overall, despite alternative sequences being developed, such as saturation recovery
(SASHA) and combined saturation and inversion recovery based techniques (SAPPHIRE
[31] ) MOLLI sequences remain widely used for their advantages in reproducibility and
precision. Many of the accuracy-based disadvantages are reproducible and do not necessarily
effect the clinical usefulness of the sequence, especially when centre-specific normal T1
values are well established and understood. Examples of normal myocardial T1 values are
presented in Table 2.2.
2.2.2 Lung T1 mapping
The gold-standard MRI technique for measuring T1 is a cardiac-gated inversion recovery
sequence with a spin echo readout, however long scan times are required for this sequence.
Faster sequences have been developed using faster readout and with a larger number of
images acquired enabling more robust curve fitting. Acquiring 16 low flip angle (α) gradient
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Dabir et al [32] 102 MOLLI 3-3-5 1.5T 41 52 entire myocardium 950 ± 21
Bulluck et al [33] 101 MOLLI 5-3-3 1.5T 51 46 inferior septum 1013 ± 27
Reiter et al [14] 40 shMOLLI
5-1-1
1.5T 50 46 mean myocardium 984 ± 28
Dabir et al [32] 102 MOLLI 3-3-5 3T 41 52 entire myocardium 1052 ± 23
Rosmini et al [34] 94 shMOLLI
5-1-1
3T 50 52 mid septum 957±30
Rosmini et al [34] 94 MOLLI 3-3-5 3T 50 52 mid septum 1028±38
Roy et al [35] 75 MOLLI 3-3-5 3T 56 54 entire myocardium 1122 ± 57
Roy et al [35] 75 MOLLI 3-3-5 3T 56 54 mid septum 1162 ± 81
echo images with short effective echo times after an inversion pulse was proposed [22], see
Figure 2.15 for a pulse sequence diagram. This creates a set of images using breath hold to
suppress respiratory motion. These images can be processed in much the same way as cardiac
T1 mapping images, using equations (2.35) and (2.36) but in this instance the correction
factor remains valid as the sequence uses a SPGR readout.
A modified version of the approach by Jakob et al., [36] uses an ultra-short TE (UTE) of
750µs and an asymmetric readout to compensate for the short T ∗2 of the lung parenchyma.
This sequence was implemented in the lung in volunteers and resulted in a breath hold of less
than 5 seconds. However this method used an image resolution of 64x128, due to acquisition
time limitations. There is a limit on the resolution of the images, as multiple images at short
T Is need to be acquired in order to sample the beginning of the inversion recovery curve well
and ensure an accurate curve fitting. Therefore, increasing spatial resolution of the images
increases the time between subsequent image acquisitions which may lead to inaccurate T1,
especially for tissues with a short T1, see Figure 2.16.
A free breathing UTE sequence has been developed which is sensitive to both T1 and
T ∗2 changes from which two parameter maps can be calculated from one sequence. The
technicalities of the motion correction of this sequence is described in the next section of
this thesis. The sequence uses TE of 70µs [7] and is based on a Look-Locker sequence, but
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is segmented into blocks. Each block contains an inversion pulse, a set of radial k-space
projections and a delay time to allow the magnetisation to fully relax between segmentations.
A 3D, UTE saturation recovery sequence which maps both T1 and T2 named ITSR-DUTE
(interleaved saturation recovery with dual echo ultra short echo time) has also been published
[37]. In this method T1 is calculated from two images, one with and one without a saturation
pulse:
T1 =−TS/(ln(1−βS(TS)/S0))/η) (2.37)
Where TS is the saturation delay time, S0 is the signal from the image without a saturation
pulse. η is the saturation efficiency. During Bloch simulations of the excitation profile of the
saturation pulse used in the ITSR-DUTE sequence, the saturation efficiency was measured to
be η ≈ 1 for lung and muscle tissue [37]. β is a correction term, for which the derivation is
shown in [37]. A 3D stack acquisitions (acquired with a radial k-space acquisition scheme)
result in two sets of images: one which follows a saturation pulse and one which does not.
There is a minimum delay of 4 seconds between each acquisition to allow the saturated signal
to recover.
Lung T1 mapping is often used with oxygen enhancement to demonstrate regions of
poor ventilation and/or perfusion as well as any native T1 changes due to disease processes
[19] [38]. A meta-analysis of published data of MR measurements of the human lung at
1.5T found the average, healthy T1 of the lung to be distributed around 1200±150ms with a
reduction of around 10% upon inhalation of 100% oxygen [39]. Oxygen enhancement T1
mapping has been described in more detail in section 2.1.4.
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Fig. 2.15 Diagram of a Look-Locker inversion recovery acquisition. A 180 degree inversion
pulse is followed by 16 low flip angle (α) gradient echo image acquisitions.
Fig. 2.16 Diagram of a Look-Locker inversion recovery curve to demonstrate the increased
sampling at the beginning of the recovery curve when a shorter acquisition time is used.
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2.3 T1 mapping and motion correction
2.3.1 Image registration background
Image registration is the process of spatially aligning images. In medical imaging, it can be
necessary to spatially align images: when the subject has moved; when combining images
that occur at different times; when images are acquired with different modalities; or when
images originate from different patients. There are a wide variety of image registration
techniques that have been developed to solve these varied problems. A registration algorithm
itself has four basic components which are shown Figure 2.17. Two images will usually
be used - a reference (fixed) image and a target (moving) image and the moving image is
spatially aligned to the fixed image.
Fig. 2.17 Diagram showing the basic registration algorithm.
The transformation applied to an image can take one of four forms: rigid, affine, projective
or curved/deformable. The different transformations have different degrees of freedom
available to them. Rigid transformations have rotational and translational degrees of freedom;
affine transformations have rotational, translational, skew and scaling degrees of freedom;
projective transforms allow straight lines to be transformed to straight lines, and curves to be
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transformed to curves; deformable transformations can be considered free-form and allow
straight lines to be mapped to curves, see Figure 2.18 for examples [40].
Fig. 2.18 Diagram showing the four basic transformation descriptions.
A similarity measure will calculate the likeness of two images using a criteria based
on either feature matching (e.g. matching landmarks of segmentations) or pixel properties
(e.g. cross correlation coefficient). The similarity measured used will evaluate how well the
images align during the optimisation process, and the registration algorithm will iterate until
the similarity measure meets a specified criteria (e.g. is minimised).
For inversion recovery images with respiratory motion, image registration may be able to
correct both accidental and free breathing respiratory motion without extending scan-time or
requiring additional equipment during the MRI scan (such as bellows or optical tracking) to
monitor motion or for a radiographer to segment an image or identify landmarks. Alternative
methods of dealing with motion in inversion recovery images are discussed in Section 2.3.2
and 2.3.3, and usually require greatly extended scan times for patients or manual input
from the radiographer analysing the data. In contrast, image registration may offer a fully
automated method of motion correction without any extension in scan time.
In the cases discussed in this thesis, the images are from the same modality (monomodal),
patient (intrasubject) and image slice. This thesis will only consider 2D imaging problems,
as a single 2D slice is the most common situation in cardiac and lung T1 mapping as 3D
imaging increases scan time. There are a wide variety of choices theoretically available when
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2D registering inversion recovery images, see Figure 2.19 [41] [40]. However, to create
fast, efficient and clinically-applicable image registration, an intrinsic, automated method
is preferable. Moreover, in the case of inversion recovery images, some images will have
poor contrast due to signal-nulling and tissue contrast changing with T I, making it difficult
to segment or landmark the images. Pixel-property based methods are most suited to an
automated work-flow and are theoretically the most flexible similarity measure as they are
not specific to a certain anatomic region (or even anatomy at all), however they generally
have a larger computational cost [41].
Fig. 2.19 Diagram showing the key registration choices available in approaching a
monomodal intrasubject registration problem.
A common pixel-property based similarity measure is the sum of square differences
(SSD), which uses the pixel intensity differences between the fixed image, f, and target image,
m, as a measure of image similarity. This can be written as:
SSD = ∑(f−mT(a))2 (2.38)
Where parameter a is a set of vectors which define the deformation between f and m. Thus
a is optimised via minimising SSD. A common alternative to the sum of square differences
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is mutual information, as it does not rely on image intensity, instead looking at similarities
in the histogram distribution of signal between the fixed and target image. However mutual
information can be very computationally costly.
In the work described in this thesis, a pre-existing image registration toolkit called ShIRT
was used [42] [43]. The ShIRT toolkit is written in C and for this work ran from Matlab. The
image space is described using a finite mesh (grid) which is then warped by the mapping
functions u(x, t) and v(x, t) to result in the moved (registered) image. The transformation is
described by the mapping between the registered and unregistered images, such that if the
co-ordinates of a region on the fixed image are x,y and the co-ordinates of the same region on
the target image are x′,y′, the mapping is described by functions u(x,y) and v(x,y) such that:
x′ = u(x,y)+ x,y′ = v(x,y)+ y (2.39)
ShIRT uses a diffeomorphic transformation, which is applicable to this work as the
cardiac and respiratory system may exhibit large non-rigid motion. The deformation is non
linear uses one-to-one (the image cannot fold back on itself) and continuous (an object cannot
be bisected or torn) mapping. The smoothness of the deformation can be controlled via a
user-defined input.
Image similarity is measured using the sum of square differences with an additional
modification which reduces the methods sensitivity to variations in signal intensity. This is
described in [43] as the following cost function:
Q = ∑(f−mT(a))2 +λa′L′La (2.40)
Where the second term is a weighting function which acts as a smoothing constraint, L is
the discrete second derivative (Laplacian) and the coefficient λ corresponds to the degree of
smoothing. Therefore λ controls the relative importance of the first term (sum of squares) and
the second term (smoothing constraint). λ is halved iteratively from its starting value until
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mutual information between the images decreases. This works to balance image registration
and image smoothness. The starting value of λ is chosen based on empirical findings to
minimise TTT+λLLT where T is a function of m(a) which is derived in the work of Barber
and Hose [42].
The node spacing (the space between the grid nodes on the mesh) starts at one quarter of
the image size and is similarly iteratively optimised until there is no improvement in mutual
information between images. The minimum node spacing (the distance between nodes on
the grid that describes the image transformation) can be chosen by the user. A smaller node
spacing will warp finer details but at an increased computational (and therefore time) cost.
The transformation applied to pixels between nodes is interpolated. The mapping solution is
therefore found iteratively until (a) falls below 0.1 pixels.
Although the ShIRT toolkit is robust to intensity differences between the fixed and
target image due to the additional smoothing term in the cost function in Equation 2.40,
the dramatically changing contrast as well as signal intensity across images in an inversion
recovery series cannot be overcome using ShIRT alone. Existing registration methods which
have been developed to overcome this additional problem in T1 mapping (of drastic contrast
changes and signal inversion), as well as non-registration based motion correction alternatives,
are described in the following sections 2.3.2 and 2.3.3.
2.3.1.1 Evaluation of image motion using Dice Similarity Coefficient
Dice Similarity Coefficient measures how well two segmented areas overlap (DSC) and





Where M and N are two segmented areas. An example of the process of segmenting cardiac
images and calculating DSC is shown in Figure 2.20.
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For each segmentation ‘M’, ‘N’ corresponded to the segmentation for the first image,
such that the DSC value corresponds to how well each image is registered to the first image.
If image registration has been applied to the image set, DSC is calculated as a metric of
how well each image corresponds to the first registered image (not the unregistered first
image). Although DSC is a global metric which does not provide precise information on
spatial alignment, it is a robust and well established method which gives a basic indication
of image alignment. An example of DSC calculated before and after image registration are
shown in Figure 2.21.
2.3.2 Cardiac T1 mapping and motion correction
Cardiac T1 mapping relies upon pixel-by-pixel calculations across a set of images acquired
at different times, see Figure 2.14, therefore image sets must be spatially aligned. Spa-
tial misalignment leads to the same pixels in different images corresponding to different
anatomical space, which results in erroneous T1 calculations. The problem of motion-induced
artefact or misalignment can be overcome in several ways: restricting motion (e.g. breath
hold or sedation); reducing sensitivity to motion (e.g. using sequence acquisitions with less
vulnerability to motion artefact); detecting motion and acquiring data in line with it (e.g.
gating or triggering); detecting motion and correcting for it (e.g. using an external sensor
or image data itself to navigate image acquisition); minimising the time in which motion
can occur (e.g. using shorter sequences); or correcting motion post-acquisition using image
registration.
In cardiac T1 mapping, image alignment is usually achieved by combining breath hold
and cardiac gating. Cardiac gating synchronises image acquisition with cardiac motion,
and breath hold suppresses respiratory motion. The original MOLLI sequence requires 17
heartbeats, which with a 60bpm heart rate results in a 17 second breath hold. For some patient
groups this may be a struggle: 40% - 48.3% of some patient cohorts have been reported to
2.3 T1 mapping and motion correction 47
Fig. 2.20 An example of the process of segmenting cardiac images and calculating DSC.
Pink segment corresponds to ’M’, green segment corresponds to ’N’.
Fig. 2.21 An example of the process of segmenting cardiac images and comparing DSC
before and after image registration. The pink segments correspond to the fixed image (image
1) and the green segments to target images (image 5).
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display motion [5, 45]. Cardiac gating difficulties or irregular heart beats can also result in
cardiac motion regardless of respiration.
Studies using MOLLI sequences have responded to cardiac motion in different ways,
including:
• Discarding images which show motion [46],
• Manually segmenting or correcting each image [28, 47, 48],
• Automated image registration [5, 45],
• Shortening image acquisition time [30].
The shMOLLI sequence reduces problems with breath-holding in patients (as well
as reducing heart rate dependence) by shortening the sequence. However, the shortened
sequence acquires less data which results in a loss of precision in the resultant T1 measurement
[24].
Several different image registration algorithms to correct motion MOLLI images have
also been suggested. These algorithms have been developed specifically for cardiac T1
mapping images, which pose additional challenges for image registration due to the contrast
differences between images. Areas such as the blood pool and myocardium may have no
relative contrast in some images and considerable contrast in others. Traditional image
registration techniques which use signal intensity to align images are therefore unsuccessful.
Similarly, though images adjacent in T I (the time between image acquisition and the most
recent inversion pulse) have similar contrast, attempts to register each image to the previous
or next image are also unsuccessful as the image contrast differences still are too severe. The
existing motion-correction methods include:
• Creating synthetic images using an iterative energy minimisation algorithm. This
method creates an initial T1 map estimate to calculate synthetic images. The synthetic
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images are iteratively improved to produce a spatially aligned set of images with
similar contrast to the acquired images. Acquired images are then co-registered to their
corresponding synthetic images, creating an aligned set of acquired images [5].
• Acquiring phase-sensitive images and using an estimated background phase removal
to remove contrast changes between inversion recovery images. This method allows a
more simplistic registration process by removing phase-based signal intensity changes
[45].
• A group-wise image registration method based on principle component analysis which
registers all of the images as a group [6].
An alternative approach to respiratory motion is to remove the breath hold and acquire
images during free breathing. This improves patient comfort and allows for the possibility of
acquiring 3D data in cases where breath-hold length would otherwise be prohibitive. Cardiac
free-breathing methods usually involve selectively acquiring data or selectively discarding
data such that you only acquire or use data within the same respiratory phase. Navigator
images known as NAV-echos are commonly used in cardiac MR imaging to automatically
determine the state of respiration of the patient and then choose whether to acquire the
following image based upon a pre-determined respiratory window. NAV-echos can be either
spin echo or gradient echo RF pulses which acquire a fast image (known as a "scout image")
across the right hemi-diaphragm. A common scout image is a rapid, cylindrical, 1D image
through the liver known as a pencil beam. The signal from the scout image is reconstructed
prior to acquisition of the following image. Over time the reconstructed pencil beam images
form a respiratory curve with peaks and troughs corresponding to expiration and inspiration.
Therefore, the diaphragm position in the reconstructed 1D data can be used to determine
respiratory state. If the scout image occurs within the pre-defined respiratory window,
the following image is acquired, otherwise it is not. The linear relationship between the
diaphragm motion and the resultant cardiac motion means that the motion tracked at the
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diaphragm can indirectly select aligned cardiac images (in the superior-inferior plane) [49].
However, due to the large amount of discarded data, free breathing navigated acquisitions
can result in long scan times.
One example of this has been demonstrated in a cardiac T1 mapping sequence, which
used NAV respiratory gating (using a rapid 1D image acquisition to track the position of
the diaphragm) for central k-space, and both NAV respiratory gating and prospective slice
tracking to acquire outer k-space. This method produces 3D T1 maps, with a 9 minute scan
time for five component 2D images [8]. A similar method using a 1D NAV respiratory gating
and the SASHA image acquisition sequence resulted in a 5-10 minute scan time [50]. In
contrast, a 2D breath hold MOLLI sequence allows a scan time of around 17 seconds for the
patient per slice.
2.3.3 Lung T1 mapping and motion correction
Fig. 2.22 Example of a lung T1 map from a healthy volunteer, with three images averaged
prior to T1 map calculation, acquired matrix size 128 x 128.
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Lung T1 maps are usually acquired during breath hold. Due to the low proton-density
in the lung resulting in a poor signal to noise ratio (SNR), which may be improved with
image averaging, see Figure 2.22. In healthy subjects, expiration breath hold produces a
significantly higher T1 than those acquired in inspiration [51]. It is known that in expiration
breath hold pulmonary perfusion significantly increases to over 200% of inspiration breath
hold levels, which would substantially increase the relative contribution of blood to mean
lung T1 values [52].
Lung inversion recovery images require breath hold which patients may struggle to
maintain. As with MOLLI images, contrast varies significantly throughout an image series.
In particular, the liver, stomach, body fat and blood vessels vary in T1 posing a challenge
to lower lung registration. Like cardiac T1 mapping, navigated free-breathing acquisitions
can be used to remove the restrictions of breath hold. Free breathing datasets increase
patient comfort and allow for longer sequences. An external navigator may be used to
track respiratory motion. A data acquisition window is defined, and images are acquired
within a certain respiratory range, such that they are aligned without the need for breath
hold. However, this means only a fraction of the acquisition time results in useful imaging,
leading to a much longer scan times with around 10 minutes for a 3D acquisition [37]. In
addition, external respiratory triggering devices may provide poor gating resolution and if a
large acquisition window is chosen there will still be some mis-registration in the images.
As well as external navigators, MR data itself can provide the information for respiratory
monitoring and triggering. This can lead to more accurate respiratory triggering, although
scan times are still much longer than a breath hold sequence. One example of this is navigator
echoes (NAV-echoes) where respiration is tracked by acquiring a "pencil" imaging band at
the diaphragm and automated software detects signal peaks and troughs due to respiration.
The imaging sequence also uses a radial readout which reduces motion corruption in free
breathing images. Images are acquired following several inversions occur and are interleaved
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after acquisition according to T I. However, this method requires around 2 minutes for a
single 2D slice [7].
2.4 Clinical applications of T1 mapping applications
2.4.1 Introduction to pulmonary hypertension
Fig. 2.23 Pulmonary hypertension subcategories.
Pulmonary hypertension a condition where blood pressure is increased in the pulmonary
artery with a threshold for diagnosis of mean pulmonary artery pressure (mPAP) ≥25mmHg
as measured by right heart catheter (RHC) [53]. RHC is an invasive procedure where a
catheter is inserted into the pulmonary artery via a vein, commonly in the neck or groin,
to allow measurement of blood pressures within the pulmonary artery. The RHC allows
multiple quantitative measures, described in Table 2.3.
Pulmonary hypertension is a complex heterogeneous condition, with 5 diagnostic sub-
categories and a variety of causes, see Figure 2.23 [54]. Pulmonary arterial hypertension
(group 1, see Figure 2.23 ), is the result the small pulmonary artery branches stiffening or
thickening which restricts blood flow through the arteries. The restricted flow in the arteries
then results in a build up of pressure in the main pulmonary artery. The prolonged elevated
pressure in the right ventricle (RV) in patients with pulmonary hypertension leads to the RV
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adapting by thickening (RV hypertrophy) and dilating see Figure 2.24. There may be no
known cause of the stiffening and/or thickening of the pulmonary artery branches (known
as idiopathic pulmonary arterial hypertension - IPAH), however, it is more common for
pulmonary hypertension to be the result of an associated cardiac or respiratory disease.
Pulmonary hypertension occurs in around 2.6% of the population and is more predominant
in older individuals, with 59% of the PH population being female [55]. Diagnosis often
occurs late with patients waiting up to two years after first experiencing symptoms to be
diagnosed [56]. The median survival of patients with pulmonary hypertension without
treatment is 2.8 years [57], although survival of patients with pulmonary hypertension
depends on the form of the condition. For patients with pulmonary hypertension caused by
another medical condition, treatment is primarily for the underlying medical condition which
causes pulmonary hypertension. Patients with pulmonary arterial hypertension (group 1) or
CTEPH (group 4) may receive treatment targeted at managing the condition specifically.
Table 2.3 Typical cardiac parameters obtained in a right heart catheterisation examination.
Parameter description Calculation Units
PCWP pulmonary capillary wedge pressure - mmHg
sPAP systolic pulmonary artery pressure - mmHg
dPAP diastolic pulmonary artery pressure - mmHg
mRAP mean right arterial pressure - mmHg
svO2 mixed venous oxygen saturation - %
saO2 mixed arterial oxygen saturation - %
CO cardiac output estimated based on
thermodilution
L/min
CI cardiac index CO/BSA L/min/m2
mPAP mean pulmonary arterial pressure dPAP + (sPAP - dPAP)/3 mmHg
PVR pulmonary vascular resistance (mPAP - PCWP)/CO dyn/s/cm3
PVRI pulmonary vascular resistance index (mPAP - PCWP)/CO dyn/s/cm5
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Fig. 2.24 Schematic drawing of the effects of pulmonary hypertension on the cardiovascular
system.
Table 2.4 Typical cardiac parameters obtained in a cardiac exam for patients with suspected
pulmonary hypertension measured from a cardiac cine MR image (bSSFP). BSA: body
surface area.
Parameter Description Calculation Units
RVEDVI Right ventricular end diastolic
volume index
RVEDV/BSA ml/m2
RVESVI Right ventricular end systolic
volume index
RVESV/BSA ml/m2
RVSVI Right ventricular end stroke
volume index
RVESV/RVEDV ml/m2
RVEF Right ventricular ejection
fraction
RVESV/RVEDV %
LVEDVI Left ventricular end diastolic
volume index
LVEDV/BSA ml/m2
LVESVI Left ventricular end systolic
volume index
LVESV/BSA ml/m2
LVSVI Left ventricular end stroke
volume index
LVESV/LVEDV ml/m2
LVEF Left ventricular ejection
fraction
LVESV/LVEDV %
RV mass index Right ventricular mass index Estimated from myocardial slice volumes
assuming density of 1.05 / BSA
g/m2
LV mass index Left ventricular mass index Estimated from myocardial slice volumes
assuming density of 1.05g/cm2 / BSA
%
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2.4.2 Introduction to imaging modalities used in patients with pulmonary
hypertension
Although pulmonary hypertension is diagnosed and characterised by elevated mPAP and
pulmonary vascular resistance (PVR), it is failure of the RV to function that causes mortality
in this condition. Therefore, visualising and measuring the structure, function and changes in
the RV via imaging plays a key role in diagnosing and managing pulmonary hypertension.
Imaging can aid in the identification of the cause of pulmonary hypertension which will
guide treatment options and prognosis.
Transthoracic 2D Doppler echocardiography is a cheap and efficient way to estimate
systolic pulmonary arterial pressure. However, for a more detailed assessment of RV volume,
mass and function MRI or CT can be used [57–62]. MRI can provide both structural
and functional information of the cardiac system without exposing the patient to ionising
radiation. Analysis of a cardiac short axis cine MRI can provide volumetric, functional and
mass metrics which describe cardiac adaptations and functionality see Table 2.4. In addition,
cardiac flow measurements provide information on cardiac function and stiffness. The use of
contrast agents (such as gadolinium) allow pulmonary perfusion to be visualised, as well as
enhancement of areas of fibrosis and scarring via late gadolinium enhancement imaging in
the myocardium (LGE).
Fig. 2.25 Schematic drawing of two examples of interventricular septal angle measure-
ments - the angle made between the interventricular insertion points and the centre of the
interventricular septum.
To obtain ventricular volumetric measures the endocardial and epicardial surfaces on
a short axis cine image are manually traced. Measurements are typically divided by body
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surface area (BSA) resulting in a volume index, see Table 2.4 [63]. High pressures in
the RV may result in the interventricular septum bowing or deviating due to the pressure
difference between the right and left ventricles. This can be characterised by a measurement
of interventricular septal angle, see Figure 2.25 [64].
Cardiac MRI allows non-invasive investigation of the cardiac system and how it is
adapting and changing due to the elevated pulmonary artery and right ventricular pressures.
Multiple parameters can be calculated from a cardiac MRI scan, many of which have diag-
nostic and prognostic utility. VMI, septal eccentricity and pulmonary arterial velocity have
been found to be of diagnostic value in pulmonary hypertension [56] and prognostic mark-
ers include RVEDVI, RVESVI, LVEDVI, RVEF, RVSVI and pulmonary arterial coupling
[58, 60, 62, 65], see Table 2.4.
2.4.3 T1 mapping applications in patients with pulmonary hyperten-
sion
Fig. 2.26 Example images of LGE patterns in patients with pulmonary hypertension. A)
LGE is shown in the RV insertion points extending into the interventricular septum. B) LGE
is shown in the RV insertion points only. Arrows indicate regions of enhancement.
Cardiovascular magnetic resonance has become an established imaging technique in the
evaluation of patients with pulmonary hypertension, as it allows direct visualisation and
accurate analysis of the cardiac structure and function. MRI can also be used to assess
myocardial tissue changes during disease. In late gadolinium enhanced (LGE) imaging,
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gadolinium accumulated in the extrocellular space in the myocardium is visualised using
T1 weighted imaging, due to the paramagnetic properties of the gadolinium contrast agent.
In patients with pulmonary hypertension, LGE tends to present in the RV insertion points
and septum in a distinctive pattern [66, 67], see Figure 2.26. The gadolinium contrast agent
cannot pass through intact cell membranes, and therefore accumulates in the extra cellular
space and damaged cells. An increase of gadolinium enhancement in the myocardium
therefore indicates pathology. In addition, gadolinium enhanced imaging may be used to
calculate Extracellular Volume Fraction (ECV) measurement, where the ratio of gadolinium
uptake in the blood pool and myocardium is used as a measure of myocardial interstitial
volume (i.e. extracellular volume) due to the accumulation of gadolinium in the interstitial
area but not the myocyctes, see Figure 2.27. Native T1 will also change to reflect a change
in interstitial volume, as the component of overall T1 which originates from the interstitial
volume T1 will increase accordingly.
Fig. 2.27 Diagram showing how gadolinium uptake in the myocardium is increased when ex-
tra cellular volume is increased, (A) shows a healthy myocardium and (B) shows myocardium
with increased extra cellular volume.
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The specific mechanism responsible for accumulation of gadolinium (and associated na-
tive T1 changes) in the myocardium in pulmonary hypertension is unclear. The myocardium
is comprised of myocytes (long tubular cells which form muscle and lie in striated bands),
blood vessels and blood (which is supplied by the coronary circulation), nerves and extracel-
lular space (molecules which exist outside of the cells, including structural proteins such as
collagen). Interstitial thickening is known as fibrosis and causes a stiffening of the cardiac
muscle and may lead to functional deterioration [68]. This is known as replacement fibrosis,
if the fibrosis replaces myocytes after damage to the myocytes occurs. If fibrosis occurs due
to myocardial stress or inflammation, it is known as reactive fibrosis and is diffuse rather
than localised [68].
Studies into tissue composition in pulmonary hypertension have shown that 2 patients with
PAH show fibrosis at the RV insertion points [69]. However, a different study found a patient
with IPAH and LGE present during MRI who did not have replacement fibrosis on autopsy,
but the patient did have increased collagen and fat between fibre bundles [70]. Histological
analysis of two porcine models of pulmonary hypertension showed the RV insertion points
were found to have increased interstitial collagen associated with fibre disarray compared to
controls [71]. Fibre disarray occurs where cardiac myocytes lie irregularly, rather than parallel
which increases extracellular space, see Figure 2.28. Overall, it seems that while increased
extracellular space and associated collagen is present in pulmonary hypertension, the presence
Fig. 2.28 Diagram showing how myocyte disarray results in increased extra cellular volume.
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of replacement fibrosis does not seem to be. This may indicate that the myocardial changes
present in pulmonary hypertension occur due to strain or inflammation, i.e. diffuse fibrosis,
rather than replacement fibrosis due to cell damage.
It has been shown that RV dysfunction and remodelling is associated with worse prognosis
in the presence of septal myocardial changes visualized by LGE [66, 72], however it has
also been shown that myocardial changes visualised by LGE do not provide additive value
over existing markers of prognosis in pulmonary hypertension [61, 66]. The prognostic
significance of LGE in pulmonary hypertension therefore remains unclear.
An increase in extra cellular volume is expected to change native T1 due to the tissue
comprising a different ratio of cellular to extracellular space. In addition, native T1 is also
expected to change due to any changes in the composition of the extra cellular space, for
example an increase of lipid molecules or collagen. T1 mapping may provide a contrast-free
alternative to visualising and quantifying myocardial changes in pulmonary hypertension
without the side effects and risks associated with gadolinium. Porcine models and CTEPH
patients show that native T1 is significantly higher in subjects with LGE compared to those
without LGE, and in addition, in pulmonary hypertension models and CTEPH patients
without LGE native T1 is significantly higher than control models - indicating that native T1
may be a more sensitive marker to tissue changes [71, 73].
Elevated T1 in the RV insertion points has been identified in porcine models [71] as well
as patients with pulmonary hypertension [73] [74] [75] at both 1.5T and 3T, with one study
finding elevated T1 across the entire myocardium [75], see Table 2.5. Although these studies
show promise, the number of patients considered are between 18-70 patients and do not
evaluate diagnostic or prognostic significance. Therefore, it remains unclear whether the
visualisation of myocardial changes via T1 mapping is clinically beneficial for pulmonary
hypertension patients.
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Table 2.5 Scope of the current literature on native T1 mapping in patients with pulmonary
hypertension.
Subjects Sequence N Field
strength
(T)





MOLLI 3-5 38 3 porcine model of chronic PH insertion points elevated
Spruijt [74] patients MOLLI 3-3-5 70 1.5 mixed IPAH, PAH-SSc and
CTEPH
insertion points elevated
Roller et al [73] patients MOLLI 3-3-5 24 1.5 CTEPH septal and insertion points el-
evated
Reiter [75] patients MOLLI 5-1-1 35 3 groups 1 3 4 and 5 septal, lateral, global and in-
sertion points elevated
Wang et al [76] patients MOLLI 3-5-5 19 1.5 PAH insertion points elevated
2.4.4 Introduction to idiopathic pulmonary fibrosis (IPF)
Idiopathic pulmonary fibrosis (IPF) is a condition where the lung contains heterogeneous
regions of fibrosis, inflammation and cysts known as honeycombing. Patients with IPF often
have traction bronchiectasis - a widening of the airways leading to a build up of excess mucus
which increases the likelihood of infection. The condition normally presents in patients
in their 60-70s with men being almost twice as likely to develop IPF as women [77]. The
cause of IPF is unknown, however it is overrepresented in patients who have worked with
woodwork, metalwork, agriculture or who have been regularly exposed to cigarette smoke
and therefore it may be that long term exposure to dust particles plays a role in causing
or aggravating this condition [78]. Around 32%−50% of patients with advanced IPF also
develop pulmonary hypertension. IPF is fatal and prognosis is poor with a median survival
of 2-3 years [79].
The symptoms of IPF are unspecific, with patients experiencing the following: breath-
lessness; a dry cough; tiredness; aching; clubbing of fingers and toes. Due to the unspecific
nature of symptoms diagnosis often occurs late in these patients. The prevalence of IPF in
the UK has increased in recent years to 15-25 people per 100,000 of the UK population
[80]. Assessment of the condition can include X-ray or CT imaging, lung function tests
and biopsy [81], however predicting prognosis remains difficult in patients with IPF. Some
patients with IPF experience exacerbations and/or a rapid deterioration of disease and others
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a much slower disease progression with few symptoms many years after diagnosis. However
differentiating those patients from one another is challenging [81].
The presence of fibrosis in the lung causes the lung to lose elasticity in the affected
areas. This results in a decrease of lung volume, as the lung cannot stretch to accommodate
large volumes of air. For this reason IPF is termed a restrictive lung disease and the clinical
gold standard for assessment is the Forced Vital Capacity (FVC). In addition, the presence
of fibrosis in the lung thickens the tissue between the airspace and blood, which inhibits
oxygen exchange within the effected regions of tissue. This is assessed clinically with the
carbon monoxide gas transfer test (DLCo). Both loss of lung elasticity and increase in lung
fibrosis limit lung function, and there is currently no way to reverse the fibrosis present in the
lung. The fibrosis is often distributed in the periphery and base of the lung, and can only be
visualised using imaging methods such as CT and UTE MR imaging see Figure 2.29.
The clinical gold standard methods currently available to assess patients with IPF lack
sensitivity. Pulmonary function tests (PFTs) provide easy to perform measurement of lung
volume and function, but are unable to visualise tissue changes or regional variation within
the lung. FVC has been shown to be an indication of mortality [82] however its longer
term value is limited and can only predict short-term mortality, not future exacerbations
[83]. Furthermore, a reduction in airway elasticity associated with emphysema may also
Fig. 2.29 Two coronal UTE images from patients with IPF demonstrating heterogeneous
honeycombing in the lung.
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occur within patients with IPF. This reduction in airway elasticity may appear as an increase
in lung volume and obscure the severity of disease. X-ray allows some visualisation of
fibrosis but with limited sensitivity to honeycombing (where cystic regions within the lung
are small and widespread) and traction bronchiectasis (widened airways). CT imaging allows
greater sensitivity to these features, however both X-ray and CT imaging expose the patient to
ionising radiation. Therefore, there remains an urgent need for novel markers to help visualise
the effect and progression of the condition, monitor treatment and to assess prognosis.
2.4.5 Lung T1 mapping in patients with IPF
IPF is a condition characterised by changes to the lung tissue which limit the volume, oxygen
exchange and function of the lung. Therefore, MRI methods which could characterise the
tissue changes within the lung and evaluate lung function and oxygen exchange may be able
to assist in diagnosing and characterising the condition without the use of invasive biopsy or
ionising radiation.
T1 mapping is used to assess tissue changes, including fibrosis, within the myocardium,
and therefore may be able to assess pulmonary tissue changes too. T1 mapping is also
sensitive to oxygenation changes within the lung [39] and maybe be able to visualise regions
of poor oxygenation in the lungs of patients with IPF. Due to the heterogeneous nature of
tissue and oxygen exchange within the lung, it is possible that T1 mapping may be able
to demonstrate regional changes in tissue and oxygenation due to IPF in patients with the
condition.
To date, two studies have performed lung T1 mapping in patients with IPF [84] [85] which
have found significant differences in lung T1 compared to healthy volunteers, and significant
correlations with measures of lung function such as lung capacity and lung residual volume.
Fibrotic regions of lung in patients with IPF were found to have significantly different T1
when compared to non-fibrotic lung regions within the same patients when CT was used to
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locate fibrotic areas [85]. These studies provide promising indications that lung T1 mapping
could be of use in the assessment and characterisation of IPF, however both studies had
small patient numbers (7 IPF patients [85] and 10 IPF patients [84]). Before possible clinical
benefits of lung T1 mapping in patients with IPF can be explored, it is necessary to:
• Characterise the changes in lung T1 in patients with IPF in larger numbers.
• Understand cause of changes in lung T1 and the extent to which they arise from tissue,
perfusion and oxygenation changes.
In addition, as patients with IPF experience breathlessness, the breath holds associated
with conventional lung T1 mapping may be a challenge for this patient cohort and development
of free breathing techniques for lung T1 mapping would improve patient comfort and clinical
applicability [7]. Therefore assessing the practicality of a free breathing T1 mapping sequence
would be of particular benefit for this patient group.

Chapter 3
Image Registration method for Cardiac
T1 Mapping
This chapter describes a novel method for image registration to correct unwanted respiratory
or cardiac motion in a MOLLI T1 mapping sequence. The method is implemented and
compared to an alternative motion correction method from Xue et al [5]. The two methods
are compared in a cohort of patients with suspected pulmonary hypertension 1.
3.1 Background
T1 mapping and extracellular volume imaging (ECV) are emerging tools for assessing the
myocardium in multiple cardiac pathologies [86] and can detect myocardial changes such
as fibrosis, inflammation or oedema. Both native T1 and ECV imaging methods require
the acquisition of accurate T1 maps, which traditionally combine cardiac gating and breath
hold to eliminate cardiac and respiratory motion. However, this also limits the number of
1The contents of Chapters 3 has been written in the form of a manuscript which is intended to be submitted
for publication in the near future by: Saunders, L., Stewart, N.J., Kiely, D.G, Graves., M.J, Swift., A.J. Wild.,
J.M.
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longitudinal recovery images which can be acquired to one image per cardiac cycle, and
limits time duration to that of a comfortable breath hold.
As seen in equation (2.25), if a pixel contains two tissues, the overall T1 will be a weighted
combination of the individual T1s of the two tissues. This is particularly important in cardiac
T1 mapping where the typical myocardial thickness in a short axis plane is 5.3±0.9mm and
6.3±1.1mm for women and men respectively [87]. This results in pixels around the edges of
the myocardium corresponding to a mixture of signal from the myocardium and blood pool,
see Figure 3.1. In order to visualise the myocardium, good spatial resolution is therefore
required. However, as spatial resolution increases, so does the inversion time interval (T I)
and the resultant scan time. The spatial resolution of the acquired images will determine
the extent to which the myocardium is affected by partial volume, see Figure 3.1. With
decreased spatial resolution, a higher proportion of pixels which make up the myocardium
correspond to a mixed signal. When drawing a region of interest on the myocardium,
including these pixels results in an artificially elevated T1 due to the inclusion of signal from
the blood pool, resulting ultimately in a less precise T1 measurement and potentially poorer
reproducibility as mean T1 will depend on the extent to which signal from the blood pool
is included in regions of interest. Awareness of the issue of partial volume effects in T1
mapping has led to suggestions of standardising methods of drawing regions of interest when
assessing myocardial T1 measurements, to minimise inclusion of the blood pool and increase
reproducibility in T1 measurements [88]. For this reason, unless otherwise specified, regions
of interest are drawn conservatively and centrally, to avoid the blood-myocardium boundary
throughout the work in this thesis.
Although T1 mapping is becoming established as a tool for understanding myocardial
changes in multiple pathologies, to utilise the full potential of T1 mapping and ECV the
methods used need to be reproducible, accurate and precise. This can be particularly
challenging in patients who exhibit respiratory motion which leads to inaccuracies, or
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Fig. 3.1 Schematic diagram to show how with decreased spatial resolution, partial volume
effects increase as a higher proportion of pixels in an image correspond to signal which
corresponds to more than one tissue.
demonstrate heterogeneous myocardial T1 where it can be difficult to determine where the
myocardial boundaries lie.
Patients with pulmonary disease can struggle to maintain breath hold, leading to motion
in acquired images and inaccuracy in resultant T1 maps. Previous studies have reported 40%
[45] and 48.3%[5] of patients National Heart, Lung and Blood Institute (Maryland, USA)
displaying some motion in acquired images when using a MOLLI 3-5 protocol. The matter of
respiratory motion has resulted in both the development of sequences with a shortened acqui-
sition time and image registration based motion correction solutions. Shortened sequences,
such as shMOLLI which uses a 5-1-1 sequence with conditional fitting, are intended to reduce
respiratory motion by acquiring the majority of the images at the beginning of acquisition
when breath-hold is more likely to be maintained, as well as reducing overall breath-hold
time. However, as shMOLLI collects less data than the original 3-3-5 sequence, this is at the
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expense of SNR. Motion correction solutions aim to eliminate unintended respiratory motion
after acquisition using image registration techniques designed to overcome the intensity and
contrast differences in inversion (or saturation) recovery images. However, it has not been
established the extent to which these solutions overcome the problem of motion in cardiac T1
mapping, and whether both are required to optimally reduce motion.
Motion correction has been demonstrated with a variety of approaches: using pair-wise
image registration to synthetic images [5]; using phase-sensitive motion correction [45] and
using a group-wise algorithm to solve a combined motion problem [6]. These three methods
are summarised in Table 3.1 and described below.
3.1.1 Synthetic Images
Using synthetic images to register MOLLI images was suggested by Xue et al. [5] using
synthetic images created via iterative energy minimisation. The method creates a set of
spatially aligned images with similar signal contrast and intensity to the acquired images
using an energy minimisation algorithm. The method defines energy as a function of the
acquired MOLLI images (I(x,y, t)), the inversion recovery images calculated from the initial
T1 parameter fitting (S(x,y, t)), the synthetic images (M(x,y,)) and a weighting parameter
(ω(x,y)) to preserve edge sharpness based on a pixel’s correlation coefficient, such that:
E(M, I,S,ω)=
∫
[((I(x,y, t)−M(x,y, t))2+α ·ω(x,y)·(M2x +M2y )+β ·(|S(x,y, t)|−M(x,y, t))2]dxdydt
(3.1)
Were Mx and My are the first order partial derivatives of M with respect to x and y, and
α and β are constants. The partial differential equation in equation 3.1 can be discretized,
leading to a direct solution. I(x,y, t), S(x,y, t) and M(x,y, t) are reformatted as a 1 dimension
vectors, Ĩ, S̃ and M̃ :
Ĩ = [I(1,1,1), I(2,1,1)...i(Nx,1,1)...I(Nx,Ny,1)...I(Nx,Ny,N)] (3.2)
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Such that the energy function can be rewritten:




(M̃ ·Dd) ·ωd · (M̃ ·Dd)+β (s̃M) · s̃M)′ (3.3)
Where the four-neighbourhood of every pixel, D1 to D4 are first order derivative operators
which form a sparse matrix of size NxNyNZ for four neighbouring pixels. Minimising equation
3.3 leads to a linear equation:




Dd ·ω(x,y)d ·D′d] = Ĩ+β · S̃ (3.4)
Where Ind is the identity matrix.
Solving the minimisation problem given in equation 3.4 produces a set of synthetic
images, which are then used to register the acquired images and produce a T1 map. The
registered images and T1 map are then re-input into the energy minimisation problem,
creating an iterative process where the synthetic images, registration and resultant T1 map are
improved upon. An initial registration step is undertaken prior to the energy minimisation
process between the first and last images in the sequence. Image registration is performed
using a fast variational non-rigid image registration framework which is an extension of the
classical optical flow method, using cross correlation as the similarity measure and estimating
the deformation field as a solution to a calculus of variation problem. The choice of the
coefficients α , β and number of iterations was not specified by Xue et al., [5].
Phase-sensitive inversion recovery registration removes the contrast inversion which
occurs in MOLLI images due to different T1s in the myocardium and blood pool. However,
misregistration in acquired images will lead to phase estimation errors, and this is overcome
with a pre-registration step between the last image of the first inversion and the last image
of the sequence (i.e. in a 3-3-5 sequence, between the third and last acquired images),
the deformation field from this registration is then applied to all other images of the first
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Xue et al [5] 2012 MOLLI 3-5 synthetic images via iterative energy minimisation
Xue et al [45] 2013 MOLLI 3-5 phase-sensitive inversion recovery registration
Tao et al [6] 2017 MOLLI 3-3-5 group-wise registration
inversion. This method uses the same image registration framework as the method using
synthetic images via energy minimisation. This method assumes that the MOLLI image
with the longest T I has fully recovered magnetisation, and therefore uses the phase of this
image to restore signal polarity for the MOLLI series. In addition, the use of phase-sensitive
reconstruction results in eliminating the need to undergo multiple fitting to restore signal
polarity, which results in a high computational cost. Phase-sensitive motion correction has
been found to achieve similar accuracy to registration to synthetic images, but to be more
computationally efficient.
Both synthetic image registration and phase-sensitive registration are pair-wise methods.
An alternative is group-wise motion correction. Group wise motion correction optimises
a transformation for two sets of T1 mapping images pre and post contrast in a unified
registration strategy with 22 frames. The method measures the alignment of all frames
together, the more aligned the images are, the more that the signal time course of each pixel
across images 1...N is similar.
Both phase-sensitive inversion recovery and group-wise registration techniques were
compared to the iterative synthetic image based registration method in the publications of Xue
et al., [5] and Tao et a., [6]. Both methods were found to be of similar registration robustness
and quality to the synthetic-image registration method, but faster in terms of post-processing.
Phase-sensitive inversion recovery was found to be 3.2x faster than their implementation of
the iterative synthetic image based method [45], and group-wise registration was found to be
3.1x faster than their implementation of the iterative synthetic image based method.
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To summarise, three methods of registration have been described in the literature, which
compare equally well in terms of registration quality. All three methods are implemented on
a single MOLLI sequence. All three methods are shown to correct accidental patient motion,
but have not been applied to free breathing, as the authors state the methods either may not
be capable of dealing with large through plane motion [5] [45], or, in the case of group-wise
registration which was only trialled in patients who were reasonably good at breath holding,
that more work is warranted in patients with "larger motion" [6]. Shorter sequences may also
help reduce the amount of motion acquired. It is not clear whether sequences with shorter
acquisition time such as shMOLLI eliminate the need for motion correction, and whether
they improve overall registration when combined with motion correction.
3.2 Objectives
The objectives of this chapter are to
• Establish whether shortened sequences successfully eliminate the need for motion
correction,
• Present a novel motion correction method and evaluate its success against an imple-
mentation of the published synthetic image based motion correction method of Xue et
al [5].
3.2.1 Quantifying the need for image registration in cardiac T1 map-
ping
It has been established that significant levels of motion are present in MOLLI 3-3-5 se-
quences when applied to a patient population, and that a clinically relevant solution to
motion-correction is required to produce accurate T1 maps. The shortened MOLLI sequence
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shMOLLI minimises breath-hold whilst maintaining three inversions, acquiring 7 images
across three inversions in a 5-1-1 manner across 9 heart beats [30], see Figure 3.2. However,
it has not been established whether this completely eliminates motion in patient populations
with respiratory disease or breath hold difficulty. It is therefore of interest to establish the
extent to which motion is significantly reduced or removed using a shorter sequence in a
pulmonary patient population and which images are most significantly affected.
Fig. 3.2 Schematic diagram of MOLLI 3-3-5 and shMOLLI 5-1-1 acquisition schemes, and
how those images are later interleaved into one signal recovery curve. Colours are added
to show which inversion each acquisition follows, with green images following the first
acquisition, blue the second and orange the third.
3.2.2 Quantifying the efficacy of registration
Additionally, it is of interest to develop an accurate, robust, fast and automated method for
creating synthetic images. A novel method has been developed, which will be compared
to an established iterative energy minimisation method for motion correction [5] and post-
processing speed to validate the accuracy and robustness of both methods.
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3.3 Methods
3.3.1 Registration algorithm and implementation
The use of synthetic images which are spatially aligned with similar contrast to the acquired
MOLLI images was proposed by Xue et al., as a method of overcoming the contrast dif-
ferences between acquired MOLLI images [5]. Acquired images can be registered to a
corresponding synthetic image, consequentially aligning the acquired images to the aligned
synthetic image spatial frame. In this chapter, synthetic images were created by two methods,
A and B for each subject. Method A is based on the work of Xue et al., [5]. Method B
was developed in-house to provide a faster and more robust solution to synthetic image cre-
ation. All image-processing was performed using custom functions written on Matlab 2016b.
Images underwent signal polarity restoration by a multi-fitting approach. Subsequently, T1
maps were produced by pixel-wise fitting of the signal [23]. All images were automatically
centrally cropped. Matlab-based non-rigid registration toolkit ShIRT [42] was integrated into
the custom Matlab pixel-wise T1 mapping algorithm for both the initial and final registrations.
All computation was performed on a 64 bit Windows 10 workstation with 16GB RAM and 4
X Intel® Core™ 3.6GHz processors.
The left ventricle on each image was segmented and image registration was quantified
using the Dice similarity coefficient (DSC) as discussed in section 2.3.1.
3.3.1.1 Synthetic image creation Method A
Method A used an energy minimisation algorithm based on the direct implementation of
the algorithm outlined in the work of Xue et al. [5], see Figure 3.3, which corrects motion
and calculated T1 maps as one combined process. This method iteratively solves an energy
minimisation problem using partial differential equations to produce synthetic images by
solving the equation .
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Fig. 3.3 Diagram demonstrating image registration using method A.
The implementation in this chapter discretised the energy minimisation problem using
vector solutions to find M̃.
Acquired images are then co-registered to the synthetic images, followed by the produc-
tion of estimated T1 maps. The estimated T1 maps are then used in the energy minimisation
process during the next iteration, using the equation (3.1). This implementation was written
in Matlab and all common features (e.g. multi-fitting to correct signal polarity) between this
implementation and method B used identical functions in order to create a fair comparison.
The registration algoirthm was optimised using 5 randomly chosen sets of patient data, 3 pre
contrast and 2 post contrast. Coefficients α and β were both varied between 0.5 and 2 in 0.1
increments while the other had a value of 1. Number of iterations, N, was varied between 5
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and 100 iteration. DSC was used as a similarity measure, and mean DSC across the group
was found to be optimal at α=1 and β=1.2. Number of iterations was chosen to be 10, after
which it was found that improvement in registration plateaued whilst time-cost increased.
Coefficients α and β were undefined in the original paper.
3.3.1.2 Synthetic image creation - Method B
Method B produces synthetic images via an inversion recovery signal model, see Figure 3.4.
The relevant code and accompanying flow charts can be found in appendix A.1. This is an
empirically derived method developed to efficiently produce synthetic images for registration
of inversion recovery images. The method fits to a 1-parameter model to allow robust
estimation of synthetic images based on three pre-registered input images, eliminating the
need for time-costly iterations. The three input images are chosen via an algorithm described
below. The images may undergo initial registration, depending on which images are chosen
(see appendix A.1.3). The images are then input into an inversion recovery equation model
which has been simplified such that it has a single free parameter. This enables a robust
curve fitting based upon three spatially aligned images, from which a set of spatially aligned
synthetic images can be produced. The algorithm proceeds as follows, see Figure 3.4:
1. Input images for the synthetic model are selected: the first image, the last image, and
the image with the lowest overall signal from tissue (see appendix A.1.1).
2. Initial registrations: the input images are registered to an image acquired in the first 5
seconds (based on the assumption patients typically hold their breath during the first 5
seconds of imaging) if the images have similar contrast (determined by whether they
occur at similar T I) (see appendix A.1.2).
3. The three input images are then fit to a simplified inversion recovery model of: S(t) =
S(l)−2S(l)e
−t
T1 . Where S(l) is the last image (image with the longest T I) of the three
input images (see appendix A.1.5).
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4. The T1 map calculated by the model is then used to create a set of synthetic images
corresponding to each time point in the inversion recovery series (see appendix A.1.7).
The inversion recovery model makes two assumptions:
i. Spins are perfectly inverted,
ii. The last time point represents the fully recovered signal intensity.
These simplifications create a single-parameter fitting model. The inversion recovery equation
(2.35), had three free parameters: the fully recovered signal S0, the coefficient A which
takes into account imperfect spin inversion, and T1∗. This can be used to create an equation
with one free parameter (T1), from which a T1 for each pixel can be produced from fitting
pixel information from the three input images. The estimated T1 is then used to produce
spatially aligned synthetic images for all time points on a pixel by pixel basis. The simplified
inversion recovery signal model allows a robust set of synthetic images to be produced.
The predominant reason for this is the inclusion of an image which occurs in the middle of
the inversion recovery curve (the second input image) as it provides information on curve
steepness. This additional information allows a robust set of synthetic images to be produced
without iterative processing.
3.3.1.3 Key differences between the methods
Key differences between this implementation of method A and method B are that method B is
iterative and using an energy minimisation process to refine the synthetic images. In contrast,
method A creates a robust set of synthetic images in the first instance, avoiding the need for
time costly iterations. This is achieved by fitting to a simplified inversion recovery model
and using an additional image input into the synthetic image creation to provide information
on curve steepness. These differences are highlighted in Figure 3.5.
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Fig. 3.4 Diagram demonstrating image registration using method B. Method B has been
written to work for any MOLLI or shMOLLI sequence (including post contrast sequences).
S(l) is the last image input into the synthetic image model.
Fig. 3.5 Flow charts showing the basic components of method A and method B side by side.
Key differences in the two methods are highlighted in orange.
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3.3.2 Registration
Pair-wise registration is performed between each unregistered magnitude acquired image and
its corresponding magnitude synthetic image. Registration was performed using pre-existing
ShIRT Matlab registration toolkit [42]. For method B, signal polarity is restored to the
registered images, after which T1 mapping is performed. ShIRT was integrated into the
custom Matlab pixel-wise T1 mapping algorithm for both the in initial and final registrations.
A finer minimum node spacing of 1 pixel was used for the final registrations, whereas a
larger node spacing of 4 pixels was used for the initial registrations. Image registration was
performed without a mask, to fully automate the procedure. Further details of ShIRT are
given in section 2.3.1. All computation was performed on a 64 bit Windows 10 workstation
wiht 16GB RAM and 4 X Intel CoreT M 3.6GHz processors.
3.3.3 Assessing image alignment
The left ventricle on each image was segmented and image registration was quantified using
the Dice similarity coefficient, described in section 2.3.1. The left ventricular myocardium
was segmented for every subject in all images.The DSC was calculated for each subject
pre-registration and after applying the corresponding registration maps. Each set of unreg-
istered images were also viewed as a video for qualitative visual inspection of respiratory
motion. Each image set was rated as either containing motion or not containing motion by a
radiographer with 10 years’ experience blind to DSC or other data. Motion was considered
to be present if any noticeable movement of the left ventricular myocardium was observed
across the time series of images.
3.3.4 Clinical data
MOLLI image registration techniques were implemented on MRI scans from two cohorts of
consecutive patients who underwent a MOLLI sequence as part of their clinical assessment
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at a tertiary pulmonary hypertension referral centre between 01.10.2015-30.11.2015 (n=41)
and 22.11.2017-13.12.2017 (n=17) [6]. Approval for analysis of imaging data was granted
by the local research ethics committee and consent was waived for this retrospective study.
3.3.5 Image acquisition
A whole body, 1.5 T GE HDx scanner (GE Healthcare, Waukesha, WI) and 8-channel cardiac
coil were used during MOLLI image acquisition. Patients were positioned supine with ECG
gating. Of the first cohort, all 41 patients underwent a 3-3-5 MOLLI sequence pre contrast at
a resolution of 128x128 and 14 of those patients also underwent a 3-3-5 MOLLI sequence
post contrast at a resolution of 128x128. Of the second cohort, 17 underwent a 3-3-5 MOLLI
imaging at resolution 192x192, 16/17 underwent 2 sets of 3-3-5 MOLLI images at resolution
128x128 and 256x256 in the short axis slice and 1 set of 5-1-1 shMOLLI images at resolution
192x192. 15/17 of the second cohort also underwent one 3-3-5 MOLLI image 192x192 in the
long axis slice. All images were acquired during inspiration breath hold. In total there were
136 sets of MOLLI images. Imaging parameters were: 35 degree flip angle, parallel imaging
factor 2, TE: 0.92, TR: 2.82, FOV 400mm2, slice thickness 10mm. The image acquisition
time for a heart rate of 60bpm at resolution 192x192 for the MOLLI sequence was 17s, and
for shMOLLI was 9s.
3.3.6 Statistics
Statistical analysis was performed and presented using SPSS 21 (SPSS, Chicago, IL). Data is
presented as mean ± standard deviation. Unregistered DSC and qualitative motion scoring
was compared between the shortened MOLLI 5-1-1 sequence and all pre-contrast short axis
MOLLI sequences to establish whether the sequence sufficiently supresses motion in this
patient population.
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DSC values before and after registration, as well as between both registration methods,
was compared using a paired t-test and the mean DSC value for all the images in the
dataset, unless otherwise stated. Mean values were plotted using a box plot diagram. The
performance of method A and method B were compared in terms of registration success
using a Bland-Altman diagram.
Registration computation timings were compared in 3 pre-contrast and 2 post-contrast ran-
domly selected datasets. T1 maps were produced pre-registration, as well as post-registration
for both registration methods. T1 measurement was evaluated in T1 maps which underwent
registration using both method A and method B, by applying a LV mask to the T1 map and
evaluating mean T1 in the entire LV. Statistical differences between T1 mean were measured
using a paired t-test. A value of P<0.05 was considered statistically significant. The effect
of pixel size and sequence choice on resultant T1 was determined using an ANOVA with
post-hoc Bonferroni test or an independent t-test (depending on number of variables) for
both global myocardial T1 values and standard deviation of T1 values within the whole
myocardium.
3.3.7 T1 analysis
A global mean T1 measure were calculated using the segmented left ventricle that the images
are registered to. This was compared between the two methods to evaluate whether they




Table 3.2 Presence of motion in patient population. Motion score is a binary score of whether
the diaphragm moves (yes=1, no=0) due to respiration during the acquired images.
Sequence Phase x Contrast Imaging Number of Motion Unregistered
type Frequency (Y/N) plane datasets score DSC
3-3-5 128x128 N SA 56 28/56 0.71±0.09
3-3-5 128x128 Y SA 16 3/16 0.76±0.06
3-3-5 192x192 N SA 16 7/16 0.77±0.09
3-3-5 256x256 N SA 17 9/17 0.73±0.14
5-1-1 192x192 N SA 16 3/16 0.80±0.07
3-3-5 192x192 N LA 15 10/15 0.69±0.12
All data sets 136 60/136 0.74±0.10
An example of a motion corrected dataset is shown in Figure 3.6. Motion was found after
inspection in 44% of patient datasets. See Table 3.2. Pre-contrast short axis MOLLI 3-5-5
image datasets (n=89) had significantly more motion than shMOLLI 5-1-1 datasets (n=16)
when measured by DSC (p<0.001) and observer motion scoring (p<0.001). However, motion
was still observed in 19% of shMOLLI sequences. Examples of a motion corrupted T1 map
and subsequent motion corrected T1 map are shown in Figure 3.7.
82 Image Registration method for Cardiac T1 Mapping
Fig. 3.6 An example of an image data set registered using method B. Vertical red lines
correspond to the edges of the RV free wall and LV free wall in the first image of the
sequence. In the original images, it can be seen that the LV free wall is to the left of this line
in some images and to the right of this line in others - which would result in both blood and
myocardium pixels being combined into the T1 estimate for the LV free wall. The registered
images show the LV free wall being consistently to the left of this line.
Figure 3.8 confirms the assumption that overall image alignment deteriorates with increase
in time after the breath hold, with overall poorest alignment seen in image 10, and best seen
in the 2nd and 3rd images acquired. Figure 3.9 shows overall improved unregistered image
alignment compared to MOLLI images in Figure 3.8. Figure 3.10 shows two datasets, one
where respiratory motion was not observed and one where respiratory motion was observed.
The time course of a lower LV myocardial pixel is shown over time, demonstrating how when
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Fig. 3.7 T1 map created without image registration and with image registration. Blue arrows
show the LV free wall is unresolved in the unregistered image and resolved in the registered
image. Black arrows show areas of elevated myocardial T1 in the unregistered image that
may be misinterpreted as tissue T1 changes. Green arrow shows some pixels are still resulting
in erroneous T1 even though the overall T1 accuracy is improved.
motion is present pixel signal does not follow the expected signal recovery time course due to
motion misaligning the pixels. This misalignment will lead to inaccurate resultant T1. When
compared with native MOLLI sequences of the same image resolution, using a shMOLLI
sequence was not shown to significantly decrease motion in acquired images (p=0.292). Of
all 16 shMOLLI images, 3 datasets still showed motion which requires registration (19%).
3.4.2 Registration accuracy
DSC was significantly improved in images after registration to synthetic images created
via method A (p<0.001) and method B (p<0.001). An example of images registered using
method B that resulted in DSC improvement is shown in Figure 3.6. Overall there was no
significant difference between the two registration techniques (p=0.611), see Figure 3.13.
Both methods significantly improved image registration pre and post contrast. All sequences
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Fig. 3.8 A box plot to show mean DSC for all datasets analysed across all MOLLI images
per time frame, compared to time frame 1. A horizontal guide line is plotted at y=0.79, the
highest mean DSC. Images are show in the order of acquisition, and labelled in order of T I.
except shMOLLI demonstrated an improvement in mean DSC, however not all sequence
groups showed significance between pre and post registration mean DSC, see Table 3.3.
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Fig. 3.9 A box plot to show mean DSC across all shMOLLI images per time frame, compared
to time frame 1. A horizontal guide line is plotted at x=0.81, the highest mean DSC. Images
are shown in the order of acquisition, and labelled in order of TI.
Fig. 3.11 Mean DSC averaged over all inversion times over all datasets without registration,
with registration using synthetic images produced by method A, and with registration using
synthetic images produced by method B. DSC is average DSC for each image set, for all
images in this study. P values are given for the difference between registered and unregistered
DSC values (method A: p<0.001; method B: p<0.001).
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Fig. 3.10 Examples of pixel signal changes over time in the lower myocardium of a patient
without motion (B) and with motion (D).
Image sets where respiratory motion was not observed nonetheless had significantly
higher DSC post-registration, see Figure 3.12. For the three patients with shMOLLI scans
which were identified as containing respiratory motion, the mean DSC for each data set is
0.61 to 0.75, 0.82 to 0.83 and 0.82 to 0.87.
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Fig. 3.12 Mean DSC without registration, with registration using synthetic images produced
by method A, and with registration using synthetic images produced by method B. DSC is
the mean DSC for each image set, for all images in this study. Images are split into those
with observed respiratory motion and those without. P values are given for the difference
between registered and unregistered DSC values.
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128x128; No Contrast; Short
Axis; N=56
0.71±0.09 0.80±0.06 p<0.001** 0.80±0.05 p<0.001**
Sequence:3-5-5; Matrix:
128x128; Contrast; Short Axis;
N=16
0.71±0.09 0.71±0.09 p=0.037* 0.80±0.05 p=0.003**
Sequence:3-5-5; Matrix:
192x192; No Contrast; Short
Axis; N=16
0.77±0.10 0.77±0.08 p=0.166 0.82±0.06 p=0.007**
Sequence:3-5-5; Matrix:
256x256; No Contrast; Short
Axis; N=16
0.72±0.14 0.78±0.08 p=0.307 0.82±0.06 p=0.052
Sequence:5-1-1; Matrix:
192x192; No Contrast; Short
Axis; N=16
0.80±0.07 0.80±0.07 p=0.898 0.80±0.06 p=0.896
Sequence:3-5-5; Matrix:
192x192; No Contrast; Long
Axis; N=15
0.69±0.13 0.72±0.12 p=0.058 0.72±0.03 p=0.333
All cases combined, N=136 0.73±0.10 0.77±0.07 p<0.001** 0.78±0.08 p<0.001**
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Fig. 3.13 Bland Altman plot comparing DSC measurement following registration, using
method A and method B. Positive y-values correspond to method B resulting in a higher
DSC, whereas negative y-values correspond to method A resulting in a higher DSC.
3.4.3 Breakdown of computational timings
A breakdown of computational timings for post-processing is given in Table 3.4. The most
time costly process in both methods was restoring signal polarity via multi-fitting. Overall,
method B was 6 times faster than method A, primarily because it does not iterate over
time-costly curve fitting for signal polarity restoration.
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Table 3.4 Breakdown of computational post-processing timings.
Method A (minutes) Method B (minutes)
Intial registration step(s) <0.1 <0.1
Initial curve fitting 8.1 N/A
Signal polarity restoration 34.4
Creation of synthetic images 0.03 2.25
Final registration 0.42 0.42
Signal polarity restoration 2 32.4 26.3
T1 map creation 7.14 4.21
Number of iterations 10 N
Total time 405 67.5
3.4.4 Accuracy of resultant T1
A paired t-test showed no significant differences between T1 measured by method A when
compared to T1 measured by method B (p=0.735). Intra class correlation coefficient for abso-
lute agreement was calculated using Cronbach’s Alpha which was 0.981 p<0.001 between the
two methods. Mean LV T1 calculated from T1 maps created using method A was 890±27ms,
and mean LV T1 calculated from T1 maps created using method B was 900±27ms. There was
no significant difference in global T1 or pixel-wise T1 standard deviation in the myocardium
with a change in matrix size (matrix sizes: 128, 129 and 256 considered using MOLLI
3-3-5 sequences) (T1: p=0.173l; SD: p=0.104). There was no significant difference between
mean T1 in the short or long axis in this cohort (p=0.982), although the long axis showed a
significantly higher standard deviation of T1 values (p=0.003). There was not a significant




A time frame consideration of mean DSC for each inversion recovery time point showed
that misalignment between images increases with time after the beginning of the acquisition,
see Figure 3.8, which is consistent with the assumption that misalignment due to release
of breath-hold later into the image acquisition is responsible for the majority of motion
in images. Both registration methods A and B show significant improvement in overall
DSC when compared to unregistered images. The two methods did not result in an overall
significant difference in DSC. Figure 3.13 shows a mean difference of −0.020 in DSC. The
two farthest outliers with a registration difference of −0.27 and 0.27 show cases where one
method was more successful than the other during image registration. In the case of the
outlier with a lower DSC when registered using method B compared to method A, the patient
is breathing from the beginning of the exam and therefore the assumption that breath is held
in the first 5s of imaging did not hold, resulting in corrupted synthetic images and a poor
image registration. In the case where method B was more successful than method A there is
not a clear reason why one method performed a more successful image registration than the
other. In both cases there was a large amount of fat surrounding the myocardium, which due
to its low T1 has a large contrast difference in images with a low TI , further work would be
warranted to establish if this is a contributing factor for inconsistent image registration and
how it could be resolved.
A breakdown of the registration results for different T1 mapping sequences is given in
Table 3.3. Post-contrast data DSC was significantly improved using both methods. Neither
method resulted in significantly higher DSC in the long-axis orientation, however both
data sets were small (n=15) and greater numbers would be required to fully establish the
significance of results in this orientation.
Using a shMOLLI sequence was shown to significantly decrease motion in acquired
images. There was not an overall statistical difference between unregistered and registered
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DSC for shMOLLI scans, however, in the three image sets that did have motion, the mean
DSC for the image set increased after registration. This demonstrates that the use of a
shMOLLI scan can reduce the amount of respiratory induced motion present in images,
however motion remains present in around 19% of cases and in these cases image alignment
does improve the registration. Both registration methods improved image registration even
when respiratory motion was not observed. This may be due to a combination of factors,
including motion due to poor cardiac gating and diaphragm drift. This indicates that even in
patients where respiration is not observed, motion correction may still be of benefit, and does
not show detrimental warping of images.
Both registration methods resulted in significantly higher resultant T1 in the LV my-
ocardium. This confirms that unregistered images do lead to inaccurate resultant T1 and
emphasises the need for correcting motion prior to T1 mapping to prevent erroneous T1
measurement. Both registration methods led to resultant T1s which were not significantly
different from one another, however method B required only 15% of the post-processing time
of method A. The most time costly part of both registration processes was the restoration of
signal polarity, as it requires several curve fitting processes for each pixel. As method B elim-
inates the need for iterations over this time-costly process the method is intrinsically faster.
The curve fitting process used a Matlab 2016b curve fitting function. During restoration of
signal polarity, 128x128 pixels were fit multiple times in each data set, resulting in 20-30
minute of computing time. If this process was implemented using parallel processing and an
alternative programming language and fitting process, this could be significantly reduced. As
both methods were implemented on the same processors with identical code for common
processes other implementations of these methods which may be more computationally
efficient are expected to maintain similar relative processing speeds.
The need to restore signal polarity could also be overcome by using phase sensitive image
reconstruction and registration [45], which estimates background phase from the MOLLI
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image with the longest TI. This method still requires initial motion correction to remove error
in the phase sensitive images, nonetheless it remains an alternative option for fast, accurate
image registration in inversion recovery imaging. There was no significant difference found
in measured T1 or the pixel wise standard deviation of T1 values in the myocardium with
changes in matrix size, or with whether a MOLLI or shMOLLI sequence was used. There
was a higher standard deviation of T1 values in the long axis orientation, but no change in
measured mean T1 values for the LV myocardium.
One of the limitations of this study is that not all patients underwent all of the sequences
analysed. Larger patient numbers would be required to fully investigate the robustness of
the registration methods in the long axis and in shMOLLI sequences with motion present.
Nonetheless the overall data shows that both methods are successful at improving image
registration, in various MOLLI permutations including post-contrast, short axis and shMOLLI
sequences.
3.6 Conclusion
This work demonstrates the necessity for image registration in patient populations who
struggle to maintain breath hold, even when using a shortened sequence, and shows that
when motion occurs in a sequence with reduced acquisition time it can be successfully
corrected using this method. A model-based method of image registration for inversion
recovery images is described, which produces robust image registration without the need
for time-costly iterations and is successful in correcting motion in pre contrast MOLLI and
shMOLLI images as well as post-contrast MOLLI images. This work demonstrates that
shortened T1 mapping sequences can reduce image motion due to respiration in patients
considerably, however image registration may still be needed to correct respiratory motion
in some cases. The method described produces robust image registration without the need
for time-costly iterations which is 6 times faster than the iterative synthetic image creation
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method described by Xue et al., [5] and is successful in correcting motion in pre contrast
MOLLI and shMOLLI images as well as post-contrast MOLLI images.
Chapter 4
Application of motion corrected T1
mapping to patients with pulmonary
hypertension
This chapter implements the method described in Chapter 3 in a large pulmonary hypertension
cohort to assess the utility of cardiac T1 mapping in these patients, including the diagnostic
and prognostic utility of T1. 1
4.1 Introduction
Chapter 3 showed how patients who undergo MRI assessment at a pulmonary hypertension
referral centre were unable to maintain breath hold in 44% of MOLLI sequences and 19%
of shMOLLI sequences. In order to assess myocardial T1 accurately in these patients, post-
1The contents of Chapter 4 have been published in the Journal of Cardiovascular Magnetic Resonance: L
Saunders, C Johns, N Stewart, C Oram, D Capener, V Puntmann, C Elliot, D Kiely, M Graves, J Wild and A
Swift. "Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1
mapping in patients with pulmonary hypertension", 2018, vol. 20, no.78.
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processing registration was required. In this chapter2, the method that was developed and
evaluated in chapter 3 was used to register all images in a cohort of patients with suspected
pulmonary hypertension and age and sex matched healthy volunteers. The aim of this study
was to accurately assess myocardial changes in these patients with pulmonary hypertension,
and whether changes to myocardial T1 visualised by T1 mapping have diagnostic or prognostic
significance in these patients.
4.1.1 Motivation for quantification of myocardial changes in pulmonary
hypertension
Myocardial tissue changes have been visualised in patients with pulmonary hypertension
using T1 mapping, T2 mapping and late gadolinium enhanced MRI. Native myocardial
changes measured using native T1 mapping have been shown to have clinical applications
across a range of cardiac diseases [89, 90]. It has been shown that in patients with pulmonary
hypertension, RV insertion point T1 is elevated. Several studies also found elevated T1 in the
interventricular septum and, in one case, the LV free wall [73–75].
Patients with pulmonary hypertension have been shown to have worse prognosis in the
presence of myocardial changes visualized by late gadolinium enhancement (LGE) at the RV
insertion point [59] and in the septal myocardium [61], although the independent prognostic
significance of the myocardial changes in pulmonary hypertension remains unclear [66].
Elevated T1 at the insertion point occurs in a similar location and shape to LGE, and both
patients and animal models with pulmonary hypertension exhibiting LGE have been found
to have higher T1 in this region than those without. Native T1 mapping has been found to be
a more reproducible marker in healthy volunteers than post contrast T1 with good long-term
stability of native myocardial T1 [91]. The co-occurrence of LGE and elevated T1 implies that
2Laura C. Saunders, Chris S. Johns, Neil J. Stewart, Charlotte J. E. Oram, David A. Capener, Valentina O.
Puntmann, Charlie A. Elliot, Robin C. Condliffe, David G. Kiely, Martin J. Graves, Jim M. Wild, Andy J. Swift,
"Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in
patients with pulmonary hypertension", Journal of Cardiovascular Magnetic Resonance, vol. 20, no. 1, Page 1
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they may have common mechanistic causes. However, studies in both patients and animal
models have reported higher native T1 in the RV insertion points than in controls, despite no
LGE being seen in this region, which indicates that native T1 may be a more sensitive marker
than the presence of LGE [66, 73]. Therefore, T1 mapping may provide a contrast-free,
robust and sensitive marker to myocardial tissue changes in pulmonary hypertension, and
there is reason to suspect that, like LGE, T1 changes may have prognostic relevance.
Pulmonary hypertension is a heterogeneous condition with 5 diagnostic subcategories:
pulmonary arterial hypertension; pulmonary hypertension due to left heart disease (PH
LHD) pulmonary hypertension due to lung disease and/or hypoxia; chronic thromboembolic
pulmonary hypertension (CTEPH) and pulmonary hypertension with unclear or multifactorial
causes. To date T1 mapping studies have used relatively small populations, with only
one report wherein diagnostic subcategories of pulmonary hypertension were considered
separately [74] and therefore it is unclear whether myocardial T1 changes in patients with
pulmonary hypertension are homogeneous across patient subtypes.
RV remodelling and failure occur as a result of prolonged elevations of RV afterload.
Elevated mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR)
are characteristic features of the condition, however it is the failure of the RV that is the key
determinate of adverse outcome [57–61, 92]. Early markers of adverse cardiac remodelling
may be able to guide treatment strategies, predicting therapy response and failure. It is
unclear whether elevated myocardial T1 is associated with prognostic features in pulmonary
hypertension, and whether it can provide additive information to patient outcome.
4.2 Objectives
To accurately acquire native T1 maps in patients with pulmonary hypertension, using image
registration methods developed in Chapter 3 to provide more accurate T1 maps produced
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from aligned images, and to determine whether elevation of T1 exists in the LV myocardial
tissue in patients with pulmonary hypertension:
• varies according to pulmonary hypertension subtype,
• is related to adverse outcome independent of RV size and function,




Approval for analysis of imaging data was granted by the local research ethics committee
and consent was waived for this retrospective database study. Patients were consecutive with
suspected pulmonary hypertension who underwent MRI including a MOLLI cardiac MRI
sequence as part of their clinical assessment at a tertiary pulmonary hypertension referral
centre between 01.01.2015 and 31.12.2015. Exclusion criteria were applied to all subjects
according to standard criteria for undergoing MRI. A total of 490 patients were identified.
369 patients had a diagnosis of pulmonary hypertension without left heart disease as specified
below, 39 patients were identified with pulmonary hypertension associated with left heart
disease, and 82 did not have a diagnosis of pulmonary hypertension – mean pulmonary
arterial pressure (mPAP) < 25mmHg – and were used as a control group, see Figure 4.1.
25 healthy volunteers with no current cardiac or respiratory symptoms and no history of
cardiac disorders were also recruited as an additional control group. Patients with a mean
pulmonary arterial pressure ≥ 25mmHg and pulmonary capillary wedge pressure (PCWP) >
15mmHg were considered to have a diagnosis of pulmonary hypertension due to left heart
disease, and patients with a mean pulmonary arterial pressure < 25mmHg were considered to
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Fig. 4.1 Patients were grouped for statistical analysis as indicated. Patients with pulmonary
hypertension were compared to two control groups: patients without pulmonary hyperten-
sion and healthy volunteers. Patients with left heart disease (LHD), pulmonary arterial
hypertension (PAH), pulmonary hypertension due to lung disease and/or hypoxia (PH-lung),
chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary hypertension
with unclear or multifactorial causes (PH-misc) were compared using ANOVA. Patients with
idiopathic pulmonary arterial hypertension (IPAH), connective tissue disease (CTD), chronic
heart disease (CHD) and other types of PAH were compared using ANOVA. Patients with
PAH were assessed for independent prognostic value of T1.
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have a diagnosis of no pulmonary hypertension. Subtypes of pulmonary hypertension were
defined as previously described [93]. The patients with pulmonary hypertension included the
following sub-group diagnoses: Group 1 pulmonary arterial hypertension; Idiopathic PAH
(IPAH), n=83; PAH heritable, n=5; PAH associated with connective tissue disease (PAH-
CTD), n=89; PAH associated with congenital heart disease (CHD), n=31; PAH associated
with portal hypertension, n=9; PAH drug/toxin induced, n=3; PAH other, n=3. Group 2 left
heart disease (LHD), n=39 (note these patients were considered separately – see Figure 1).
Group 3 PH associated with lung disease, n=41. Group 4, chronic thromboembolic pulmonary
hypertension CTEPH n=92; group 5, sarcoidosis, n=10; patients without diagnosis: 3. All
patients with PAH (n=223) were treated with PAH therapy with 22±28 months of treatment
prior to MRI. 49% of patients with PAH were undergoing therapy with combined oral
therapy (phosphodiesterase 5 inhibitor and endothelin receptor antagonist), 27% were taking
an oral monotherapy (phosphodiesterase 5 inhibitor or endothelin receptor antagonist or
calcium channel blocker), and 24% were taking prostanoid therapy. A summary of all subject
characteristics is shown in Table 4.1.
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Table 4.1 Demographic data for patients with pulmonary hypertension (PH) patients with
pulmonary hypertension due to left heart disease (PH LHD) and patients without PH. Abbre-






















Sex (%) 66. 67.1 0.856 50.9 0.966
Heart Rate (bpm) 72.17±14.4 69.81±3.8 p=1.000 67.9±10.3 p=0.002**4
RVEDV Index
(ml/m2)
87.2±34.1 81.9±31.7 p=0.978 68.0±20.4 p<0.001**
RVESV Index
(ml/m2)
51.7±29.0 45.4±23.1 p=0.479 31.1±11.6 p<0.001**
RVSV Index (%) 35.6±14.2 36.5±12.1 p=1.000 36.9±12.9
RVEF (%) 43.1±13.6 46.8±11.2 p=0.295 54.4±10.0 <0.001**
LVEDV Index
(ml/m2)
58.5±16.1 68.9±21.2 p=0.001** 66.6±16.1 p<0.001**
LVESV Index ml/m2) 19.2±8.2 26.1±16.6 P<0.001** 21.3±8.2 p=0.037*
LVSV Index (%) 39.2±11.9 42.8±13.4 p=0.060 45.3±10.8 p<0.001**
LVEF (%) 67.3±9.7 63.8±14.5 p=0.128 68.3±7.6
Systolic septal angle
(o)
165.5±23.9 145.9±15.5 p=0.061 150.5±108.4 p=0.016*
Diastolic septal angle
(o)
143.34±11.0 138.3±10.3 p=0.014** 134.9±7.9 p<0.001**
RV mass index (g/m2) 21.9±12.5 14.4±5.5 p<0.001** 11.9±5.8 <p0.001**
LV mass index (g/m2) 48.0±12.3 57.2±21.1 P<0.001** 47.7±10.7
VMI average 0.47±0.27 0.28±0.13 p<0.001** 0.26±0.18 <0.001**
RV insertion point T1
(ms)
1065±86 1074±103 p=1.000 1017±69 <0.001** 943±
52
p<0.001**
Septal T1 (ms) 975±67 986±073 p=1.000 976±75 p=0.606 940±
56
p=0.011*
LV free wall T1 (ms) 965±68 982±81 p=0.818 961±66 p=0.694 913±
55
p<0.001**
LV blood T1 (ms) 1473±121 1515±147 1505±127 p=0.031* 1471±
88
p=0.930
RV blood T1 (ms) 1483±128 1546±164 1525±125 p=0.007** 1482±
102
p=0.972







N 237 39 37
mRAP (mm Hg) 10.31±5.50 14.95±5.46 p<0.001** 6.55±3.35 <0.001**
mPAP(mm Hg) 44.36±13.49 40.23±11.96 p=0.471 19.4±2.7 <0.001**
PCWP (mm Hg) 11.85±3.87 23.68±6.89 p<0.001** 10.9±3.8
PVR (dyne/s/cm3) 611±402 379±81 p=0.004** 183±97 <0.001**
CI (I/min/m2) 2.66±0.79 0.764±0.163 p=1.000 2.78±0.64
SvO2 (%) 64.81±8.69 62.41±7.90 p=0.648 70.4±5.0 <0.001**
SaO2 (%) 93.63±4.03 94.4±3.57 p=1.000 96.3±2.9 <0.001**
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4.3.2 MRI acquisition
Cardiac MRI was performed on a whole body 1.5T GE HDx scanner (GE Healthcare,
Waukesha, WI), using an 8-channel cardiac coil. Subjects were scanned in the supine
position with ECG gating. Short axis cine images were acquired using a multi-slice balanced
steady state free precession (bSSFP) sequence with: temporal phases per cardiac cycle: 20;
field of view: 480mm; matrix: 256x256; bandwidth: 125KHz/pixel; TR: 3.7ms; TE: 1.6ms.
T1 mapping was performed using a 2D 3-3-5 MOdified Look-Locker Inversion recovery
(MOLLI) sequence in a single short axis slice [93]. A balanced steady state free precession
(bSSFP) acquisition was executed at each inversion time point with the following sequence
parameters: Flip angle: 35◦; image dimensions: 128x128; TR: 3.20ms; TE: 1.41ms; parallel
imaging using sensitivity encoding with acceleration factor 2; FOV: 400mm; slice thickness:
5.1mm.
4.3.3 Right heart catheterisation
All patients underwent right heart catheterisation performed using a balloon-tipped 7.5 Fr
thermodilution catheter (Becton-Dickinson, Franklin Lakes, NJ), typically via the internal
jugular vein using a Swan-Ganz catheter. Pulmonary vascular resistance index (PVRI)
was defined as (mPAP-PCWP)/CI, where CI is cardiac index, measured by thermodilution
technique. Patients with right heart catheterisation within 30 days of their cardiac MRI
were included in analysis of associations between right heart catheterisation metrics and
myocardial T1.
4.3.4 T1 image registration
As has been established in Chapter 3, patients with pulmonary hypertension struggle to main-
tain breath hold throughout a MOLLI sequence resulting in the need to correct respiratory
motion. Therefore all images underwent the image registration process described in Chapter
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3, creating synthetic images using method B, which was integrated into the Matlab pixel-wise
T1 mapping algorithm previously described.
4.3.5 Image analysis
Cardiac cine MRI analysis was performed prospectively on a GE Advantage Workstation 4.1
by a radiographer with 10 years’ experience, who was blinded to the patient’s clinical data.
Right and left endocardial and epicardial surfaces were manually traced on the short axis
cine images to obtain the volumetric indices; RV end diastolic volume (RVEDV), RV end
systolic volume (RVESV), LV end diastolic volume (LVEDV) and LV end systolic volume
(LVESV). From the end diastolic and end systolic volumes, RV ejection fraction (RVEF) and
LV ejection fraction (LVEF) were calculated. The interventricular septum was included in
the LV mass. RV mass was estimated from the sum total of the myocardial slice volumes and
an assumed myocardial density of 1.05g/cm3. Ventricular mass index was calculated as VMI
= RV mass / LV mass. Cardiac MR volume and mass measurements were indexed for body
surface area where appropriate. Interventricular septal angle was measured by determining
the angle between the mid-point of the interventricular septum and the RV insertion points at
RV end systole [94]. Analysis of T1 maps was performed by a Cardiothoracic Radiologist
with 7 years cardiac MRI experience, blinded to the patient’s demographic and clinical data.
Regions of interest were drawn on the interventricular septum, RV insertion points and LV
free wall, see Figure 4.2. Additional regions of interest were placed in the RV and LV blood
pools, avoiding trabeculations. A measure of ∆T1RS was used to assess elevation of T1 in the
RV insertion points, normalised to septal T1:
∆T1RS = T1(RV insertion point)−T1(interventricular septum) (4.1)
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Regions of interest were compared across pulmonary hypertension subtypes (see flowchart
in Figure 4.1). All T1 maps were analysed by both the same observer, and a second observer,
who was a trained cardiac MRI researcher with 2 years of experience analysing T1 mapping
images blinded to previous results and patient data for assessment of both inter-observer and
intra-observer reproducibility.
Fig. 4.2 Examples of where regions of interest would be drawn on A) a healthy volunteer
and B) a patient, in the interventricular septum, interventricular insertion points and left
ventricular free wall.
4.3.6 Follow up
Patients with PAH were followed up with a census date of 30.01.2018 with a mean follow-up
period of 29±8 months and a median follow-up period of 30 months from MRI to death or
census.
4.3.7 Statistical analysis
Statistical analysis was performed and presented using SPSS 21 (SPSS, Chicago, IL). Data
is presented as mean ± standard deviation. Group comparisons were made using two-tailed
ANOVA; post-hoc Bonferroni was used for multiple group corrections. Pearson’s correlation
coefficient was used to assess the strength of correlations. Receiver operating characteristic
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(ROC) analysis was employed to assess the diagnostic accuracy of T1 metrics with area under
the curve. Inter-observer variability was assessed using the intraclass correlation coefficient
(ICC); absolute values and 95% confidence intervals.
The interval from MRI until death or 01.10.2016 was regarded as the follow-up period. To
control for the spatial heterogeneity of aetiology and therapy differences between the different
subtypes of pulmonary hypertension, we elected to study the prognostic value of T1 metrics
in PAH alone. This controls for differences in outcome caused by factors such as severe lung
disease in respiratory patients and chronic thromboembolic disease in patients undergoing
pulmonary endarterectomy. Log-log plots were produced for T1 metrics to assess proportional
hazards, with variables dichotomised by median values, and prognostic value was assessed
using univariate Cox proportional hazards regression analysis. Variable scaling (Z score)
was performed to allow direct comparison of hazard ratios of all continuous variables by
subtracting the mean from individual values and dividing by the standard deviation of the
variable. Multivariate analysis with a forward stepwise approach was performed for T1
metrics and measures of RV size and function that were significant at univariate Cox analysis
(p<0.2). Highly correlated variables (r>0.8) that were significant at univariate Cox analysis
were identified and the variables with the higher univariate hazard ratio were added to
the model. Kaplan-Meier plots were constructed to illustrate the prognostic value of MRI
volumetric measurements using median threshold values. Groups were compared using
the log-rank (Mantel-Cox) test. Unless otherwise stated, a value of p<0.05 was considered
statistically significant.
4.4 Results
All image sets underwent image registration and T1 maps were created, see Figure 4.3.
Characteristics of the study populations are given in table 4.1. Patients with pulmonary
hypertension were not significantly different in age or sex than patients without pulmonary
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hypertension or healthy volunteers. Figure 4.3 illustrates the classification of the patients
included in the study.
In patients with pulmonary hypertension, T1 was significantly elevated at the RV insertion
points when compared to healthy subjects and patients without pulmonary hypertension
(patients with pulmonary hypertension, T1 = 1065±86ms; healthy subjects, T1 = 943±52ms,
p<0.001; patients without pulmonary hypertension T1 =1017±69ms, p<0.001). Patients
with pulmonary hypertension also had elevated T1 in the LV free wall and septum when
compared to healthy subjects but not patients without pulmonary hypertension, (patients
with pulmonary hypertension: LV free wall T1 = 975±67ms, septal T1 = 965±68ms; patients
without pulmonary hypertension: LV free wall T1 = 961±66ms, septal T1 = 976±75ms;
healthy subjects LV free wall T1 = 913±55ms, p<0.001, septal T1 = 940±56ms, p=0.011).
See Table 4.1 and Figures 4.3 and 4.4.
Patients with pulmonary hypertension who were undergoing treatment did not have
significantly different T1 to those who were untreated (septal: p=0.182; RV insertion point:
p=0.977; LV free wall: p=0.46). The standard deviation of T1s within the RV insertion points
was significantly higher in patients with pulmonary hypertension (SD = 62.2ms) compared
to healthy subjects (SD = 36.5ms). The standard deviation of T1s within the LV free wall and
septum were not significantly different in healthy subjects when compared to patients (septal:
54.4ms, LV free wall: 42.9ms) with pulmonary hypertension (septal: 54.6ms, LV free wall:
44.6ms).
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Fig. 4.3 Representative T1 maps in cardiac short axis geometry of A) a healthy volunteer,
B) a patient without pulmonary hypertension, C) a patient with IPAH and D) a patient with
LHD.
Comparisons were made between pulmonary hypertension subgroups and there were no
significant differences between groups. Within PAH, LV free wall T1 was significantly higher
(p=0.046) in patients with CTD than patients with CHD. There were no other significant
differences between groups, see Figure 4.5.
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Fig. 4.4 Box plot of the mean T1 for septal, RV insertion point and LV free wall regions. P
values are given for ANOVA comparisons between patients with pulmonary hypertension and
control groups above each respective control group. Circles represents outliers, * represents
far outliers.
Fig. 4.5 Box plot of mean T1 for septal, RV insertion point and LV free wall regions for
pulmonary hypertension patient subtypes. Circles represent outliers, * represents far outliers.
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4.4.1 Evaluation of T1 as a diagnostic tool in pulmonary hypertension
The T1 at the RV insertion points was the most statistically significant measurement for
discriminating between volunteers and patients with pulmonary hypertension, followed by
∆T1RS. However, no T1 region was successful in discriminating between patients without
pulmonary hypertension and patients with pulmonary hypertension, the most successful
being ∆T1RS, see Table 4.3, see Figure 4.6.
Fig. 4.6 ROC curve for RV insertion point T1 for discriminating patients with pulmonary
hypertension from A) volunteers and B) patients without pulmonary hypertension.
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Table 4.2 ROC curve analysis for distinguishing patients without pulmonary hypertension









RV mass index 0.807 0.760 0.855
Systolic septal angle 0.850 0.809 0.892
Septal T1 0.502 0.587 0.720
RV insertion point T1 0.654 0.587 0.720
∆T1RS 0.675 0.612 0.738
LV free wall T1 0.512 0.442 0.582
4.4.2 Relationship between T1 and other MRI measures of cardiac struc-
ture and function
Across the population of pulmonary hypertension patients scanned, the RV insertion point
T1 had the strongest relationship with RV function. The mean insertion point T1 correlated
significantly with RVEDV index, RVESV index and RVEF. Additionally, the RV insertion
point T1 showed significant correlations with RV mass index, the ventricular mass index
(VMI) and the systolic and diastolic septal angle, see Table 4.4. Septal T1 and LV free wall T1
did not correlate with any markers of RV function or LV function. However, diastolic septal
angle and septal T1 showed a positive correlation. A multivariate forward linear regression
was calculated to predict RV insertion point T1 based on all significant MRI correlators. A
significant regression equation was found (p<0.001), with an R2 of 0.124. RVESVI and
systolic septal angle were significant predictors of RV insertion point T1 in patients with
pulmonary hypertension. In patients with LHD the RV insertion point T1, septal T1 and LV
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free wall T1 all showed significant correlations with cine MRI metrics of RV function. ∆T1RS
correlated significantly with diastolic and systolic septal angle in patients with LHD.
Table 4.3 Linear regression analysis for RV insertion point T1. Cardiac metrics from MRI are
described in Table 2.4.
Unstandardised coefficients Standardised
coefficients
B Std. Error Beta t p-value
Constant 0.845 0.073 11.609 <0.001
RVESVI 0.000623 0.000247 0.209 2.524 0.008
RVEF -0.000213 0.0005 -0.034 -0.425 0.921
VMI 0.001 0.001 0.119 1.483 0.837
Septal angle
systolic
0.001 0.0001 0.178 2.918 0.004
Relative area
change
-0.001 0.001 -0.066 -0.755 0.655
4.4.3 Relationship between T1 and right heart catheter data
228/369 patients with pulmonary hypertension also had right heart catheter within 1 month
of MRI scanning, with a mean of 0±1 days and a range of 15 days. The mean RV insertion
point T1 correlated significantly with the functional parameters mPAP, mRAP, and CI but
not PVR, see Table 4.4. There was also a significant correlation with mixed venous oxygen
saturation (SvO2). LV free wall T1 correlated significantly with CI and SvO2, whilst septal
T1 did not correlate with any of the RHC parameters. 29/82 patients with LHD also had right
heart catheter within 1 month of MRI scan, all of whom had MRI and right heart catheter on
the same day. Patients with LHD also showed significant correlations between RV insertion
point T1 and mPAP, mRAP, and SVO2. Patients with LHD showed significant correlations
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with septal T1 and mPAP as well as SvO2. There were no correlations between LV free wall
and right heart catheter parameters.
Table 4.4 Correlations between MRI and RHC parameters in septal, RV insertion point and
LV free. * indicates p<0.05, ** indicates p<0.025. Abbreviations described in Tables 2.3 and
2.4.
Septal T1 RV insertion point T1 LV free wall T1
n=369
Age (years) r= -0.074 p=0.159 r=0.007, p=1.000 r=-0.086, p=0.168
BSA m2 r=0.015, p=0.771 r=0.041, p=0.444 r=-0.006, p=0.915
Heart rate (bpm) r=0.011, p=0.836 r=-0.073, p=0.168 r=-0.086, p=0.103
RVEDVI (ml/m2) r=0.066, p=0.213 r=0.265**, p<0.001** r=0.076, p=0.151
RVESVI (ml/m2) r=0.027, p=0.615 r=0.290, p<0.001** r=0.088, p=0.097
RVSVI % r=0.103, p=0.050 r=0.003, p=0.958 r=0.044, p=0.406
RVEF % r=0.003, p=0.951 r=-0.238, p<0.001** r=-0.080, p=0.129
LVEDVI (ml/m2) r=-0.035, p=0.505 r=-0.060, p=0.257 r=-0.018, p=0.734
LVESVI (ml/m2) r=0.005, p=0.924 r=0.011, p=0.841 r=-0.051, p=0.335
LVSVI % r=0.051, p=0.335 r=-0.088, p=0.096 r=0.011, p=0.841
LVEF % r=0.028, p=0.598 r=-0.066, p=0.217 r=0.050, p=0.347
Systolic septal angle (o) r=0.096, p=0.069 r=0.238, p<0.001** r=0.017, p=0.742
Diastolic septal angle
(o)
r=0.157, p=0.003** r=0.253, p<0.001** r=0.017, p=0.742
n=228
mRAP (mmHg) r=0.074, p=0.256 r=0.160, p=0.011** r=0.253, p<0.001**
mPAP (mmHg) r=0.076, p=0.248 r=0.165, p=0.011** r=0.025, p=0.706
PCWP (mmHg) r=-0.002, p=0.9828 r=-0.053, p=0.434 r=-0.032, r=0.634
PVR (dyne/s/cm3) r=0.039, p=0.567 r=0.099, p=0.145 r=0.096, p=0.160
CI (I/min/m2) r=-0.003, p=0.964 r=-0.079, p=0.234 r=-0.166.p=0.012**
SvO2 (%) r=-0.004, p=0.956 r=-0.152, p=0.022** r=-0.168, p=0.011***
SaO2 (%) r=0.119, p=0.070 r=-0.081, p=0.222 r=-0.065, p=0.322
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4.4.4 Evaluation of T1 as a prognostic tool in pulmonary hypertension
59 patients with pulmonary hypertension died during the follow up period of 29 months (stan-
dard deviation: 8 months), of which 43 had pulmonary arterial hypertension. Comparison
of scaled hazard ratios showed ∆TRS to be the strongest T1 region for prediction of patient
survival. See Figure 4.7. A log-rank test comparing survival in patients with pulmonary
arterial hypertension with an T1 < median T1, and T1 ≥ median T1 for each region showed
that LV free wall T1 was the strongest dichotomised predictor of patient survival, though
not statistically significant (p=0.066), see Figure 4.8. Univariate Cox regression analysis
of patients with PAH showed that, septal, LV free wall and RV insertion point T1 were
not associated with mortality (septal: p=0.522; LV free wall: p=0.258; RV insertion point:
p=0.688), see Table 4.5. At multivariate analysis RVESVI, age diastolic septal angle were
significant predictors of mortality.
Fig. 4.7 Forest Plot of hazard ratios for patient demographics and MRI derived metrics. See
tables 2.3 and 2.4 for descriptions of MRI derived metrics.
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Fig. 4.8 Kaplan Meier for patient survival dichotomised by left ventricular free wall T1 above
and below median value, p=0.066.
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Table 4.5 Prognostic data for patients with pulmonary arterial hypertension. Abbreviations



















Age 1.938 1.342-2.798 <0.001** † 1.279 1.396-2.248 <0.001**
Sex 0.765 0.573-1.021 0.077
RVEDVI 1.642 1.330-2.027 <0.001** ‡
RVEDVI 1.804 1.453-2.240 <0.001** † 1.772 1.279-2.544 <0.001**
RVEF 0.506 0.372-0.690 <0.001** † - - -
Systolic
septal angle
1.454 1.093-1.934 0.011** ‡
Diastolic
septal angle
1.485 1.099-2.008 0.011** † 1.556 1.108-2.186 <0.001**
RV mass
index
1.341 1.091-1.649 0.018** † - - -







∆T1RS 1.205 0.888-1.634 0.237
4.4.5 Blood T1 in pulmonary hypertension
Blood T1 in the LV was not significantly different between healthy subjects, patients without
PH, patients with PH or patients with PH-LHD when considered together in an ANOVA.
RV blood was found to differ significantly between patients with pulmonary hypertension
and patients without pulmonary hypertension, p=0.049. T1 of RV blood was significantly
higher than T1 of the LV blood in patients with pulmonary hypertension (p=0.012) and
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patients without pulmonary hypertension (p<0.001), this may be due a faster relaxation of
spins in the LV blood pool due to paramagnetic dissolved oxygen in the highly oxygenated
blood. Within patients with pulmonary hypertension, the most significant correlations
(p<0.001) were between RV blood and: heart rate (r=-0.192), LVEDVI (r=-0.230), LVSVI
(r=0.237) and ventricular mass index (r=-0.204). For the LV blood, the most significant
correlations (p<0.001) were with heart rate (r=-0.205) and LVEDVI (r=0.196). For patients
with pulmonary hypertension and right heart catheter data, the most significant correlations
(p<0.001) were between RV blood and mPAP (r=-0.243) and SaO2(r=0.238).
4.4.6 Inter-observer and intra-observer reproducibility
T1 values in the septum, RV insertion point and LV free wall were tested for absolute
agreement with a random two-way model. The intraclass correlation coefficients for the
interventricular septum, RV insertion points and LV free wall T1 values respectively were:
0.841, 0.823 and 0.792 respectively. The interclass correlation coefficients for the septum,
RV insertion point and LV free wall T1 values respectively were: 0.844, 0.742 and 0.618
respectively. Intraclass reproducibility was found to be excellent in all regions in healthy
volunteers, intraclass correlation coefficients for the interventricular septum, RV insertion
points and LV free wall T1 values were: 0.898, 0.934 and 0.852 respectively. The interclass
correlation coefficients for the septum, RV insertion point and LV free wall T1 values were:
0.972, 0.942 and 0.824 respectively.
4.5 Discussion
Accurate, registered T1 maps were produced for all subjects of this study, see examples in
Figure 4.3. Despite the clinical heterogeneity found in subtypes of pulmonary hypertension
in the patients in this study, there were no significant differences found in myocardial
4.5 Discussion 117
T1 between the subtypes of this population. In particular, patients with LHD who were
considered separately (due to a different aetiology and cardiac phenotype) were found to
have no significant differences from patients with other forms of pulmonary hypertension,
this may be because the causal mechanism of T1 differences in pulmonary hypertension is
present to some extent in all pulmonary hypertension subtypes. However, this may also be
due to multiple casual mechanisms causing elevated T1 in pulmonary hypertension due to the
heterogeneity of the disease.
Patients with CTD have been previously found to have elevated T1 compared to controls
[95]. However, we did not find that patients with CTD had significantly different T1 in any
region than patients with IPAH. This indicates that any tissue changes caused by the presence
of cardiac connective tissue were not detectable in this study, likely having a less significant
effect than those of pulmonary hypertension itself, or patients with connective tissue disease
did not have significant LV disease.
Two control groups were used to evaluate changes in the myocardium in patients with
pulmonary hypertension: age matched healthy volunteers and patients without pulmonary
hypertension. Patients without pulmonary hypertension had significantly higher RV insertion
point T1 when compared to healthy volunteers. Though both RV insertion point T1 and
∆T1RS were successful at differentiating healthy volunteers from patients with pulmonary
hypertension, they were not successful at differentiating control patients from patients with
pulmonary hypertension. ∆T1RS was not significantly different between control groups
which suggests regional elevation of the insertion point T1 is characteristic of pulmonary
hypertension rather than elevation of the whole myocardial T1.
In patients with pulmonary hypertension and LHD, increase in mPAP and mRAP corre-
lated with elevated T1 in the RV insertion points, but not the LV free wall, indicating that T1
in these regions is associated with elevated pulmonary pressure. It is a limitation of this study
that concurrent right heart catheter and cardiac MRI data was not present for all subjects.
118 Application of motion corrected T1 mapping to patients with pulmonary hypertension
Patients without pulmonary hypertension had mPAP above normal and were in the borderline
pulmonary hypertension diagnostic category, see Table 4.1 which may explain why this
patient group has higher T1 in the TV insertion points than healthy volunteers.
Although patients with pulmonary hypertension and higher RV insertion point native T1
were less likely to survive than patients with pulmonary hypertension and lower RV insertion
point T1, RV insertion point T1 was not an independent significant predictor of mortality in
patients with pulmonary arterial hypertension. This conclusion is constrained by the fact that
the follow up period was relatively short 85% of patients were still alive). Therefore, census
at a later point may be required to provide more definitive evidence of whether RV insertion
point T1 has independent prognostic value.
Although LGE and elevated native T1 has been observed in the interventricular septum
in pulmonary hypertension [73–75] the same finding was not observed in this study. This
may be because regions of interest were placed in the middle of the interventricular septum,
whereas LGE imaging shows myocardial changes extending from the insertion points and
therefore weakest enhancement at the central region of the septum. Further work to evaluate
regions of interest at the inferior and superior portions of the interventricular septum may
clarify this. Thus, the relationship between T1 and late gadolinium enhancement in the RV
insertion points were not evaluated here and further work may be warranted to evaluate this
thoroughly in patients with pulmonary hypertension.
Significant differences in blood T1 between patients with pulmonary hypertension and
healthy volunteers were not found. Within patients with pulmonary hypertension significant
correlations between blood (RV and LV) T1 and parameters of left and RV function and heart
rate. In addition, increased oxygen saturation of haemoglobin (SaO2) correlated significantly
(p<0.001) with increased T1 of RV blood. This may be because deoxygenated haemoglobin
is paramagnetic, therefore as the proportion of deoxygenated haemoglobin decreases with
increased oxygen saturation, blood T1 would be expected to increase due to the oxygenation.
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As patients with pulmonary hypertension were found to have significantly lower SaO2 than
patients without pulmonary hypertension, any oxygenation effects in blood perfused within
the myocardium would obscure T1 changes which result from tissue changes. It has been
suggested that normalising myocardium T1 using blood T1 results in reduced myocardial
T1 variability and sex differences [96] and our results may indicate this may be a technique
relevant to patients with pulmonary hypertension.
Inter-observer and intra-observer reproducibility data was found to be in line with that
previously observed in patient T1 mapping studies [88]. The RV insertion points were found
to be less reproducible than the interventricular septum. This may be due to higher T1
heterogeneity in this region leading to greater T1 variation when region of interest placement
differs. T1 values tended to be less reproducible in patients with PH than volunteers, which is
consistent with other studies findings [70].
It may be that relatively poor breath-holding of the patient cohort contributes a greater
degree of motion artefact resulting in weaker inter and intra-observer reproducibility. It has
been shown previously that native T1 mapping has good scan-scan variability over 3.6±0.5
years with a coefficient of variation of 1.4%, therefore it would be of interest in future work
to establish the scan-scan repeatability in patients with pulmonary hypertension, and whether
native myocardial T1 elevation changes with time in patients with pulmonary hypertension
and whether this has prognostic significance.
4.5.1 Causes of elevated myocardial T1 in patients with pulmonary hy-
pertension
The lack of specificity of RV insertion point T1 indicates that pathophysiological processes
responsible for the elevated RV insertion point T1 are not solely confined to patients with
pulmonary hypertension. The RV insertion points were the myocardial regions with the
highest T1 and they correlated significantly with loss of RV function and RV remodelling.
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Systolic septal angle and RVESVI were independent predictors of RV insertion point T1,
however these variables only predicted 12.4% of the variance seen in RV insertion point T1
in patients with pulmonary hypertension. This may indicate that mechanisms which are not
explicable solely through cardiac volume, mass and pressure changes are responsible for the
tissue changes represented by T1.
Animal models of pulmonary hypertension with increased native T1 and LGE present in
the RV insertion points have been shown to have increased interstitial collagen associated
with fibre disarray, and increased connective tissue density [71]. It has been shown in two
patients with PAH that fibrosis was present in the RV insertion point and it has been suggested
that this is the mechanism driving LGE in PAH [69]. However, those patients also had an
increase in interstitial space and a small increase of fat. A cardiac MRI case study of one
patient with IPAH showed myocardial disarray with increased collagen and fat between fibre
bundles in the myocardium (plexiform fibrosis). That study suggests that the cause of LGE
is not pathological, and instead arises from an exaggeration of the myocardial disarray and
plexiform fibrosis where fibres from the right and left ventricle cross. It is suggested this
exaggeration of myocardial disarray may arise from a combination of RV hypertrophy and
increased shear forces upon the interventricular septum [70]. Septal angle is a measure of
deviation of the LV septum due to the high pressure in the RV, which correlated strongly
with RV insertion point T1 in patients with pulmonary hypertension and was found to be an
independent linear predictor of RV insertion point T1. Even in patients with LHD, who do
not exhibit divergence of the LV septum to the same degree as other patients with pulmonary
hypertension, ∆T1RS correlated significantly with septal angle. However, in patients with
LHD, the correlation between RV insertion point T1 and septal angle itself was not significant
(systolic: r=0.247, p=0.140; diastolic: r=0.319, p=0.054), likely due to the considerably
lower patient numbers in the LHD subgroup. The T1 value of the LV free wall, which would
not experience stress/strain due to elevated ventricular pressure, was found not to show a
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correlation between T1 and septal angle and was not elevated in patients with pulmonary
hypertension compared to patients without pulmonary hypertension. Therefore, our data
suggests that the regional elevated native T1 in the insertion points is significantly related to
the displacement of the interventricular septum in pulmonary hypertension. This supports
the suggestions from histological studies that changes in myocardial T1 and the presence of
LGE may be due to exaggerated fibre disarray in the RV insertion points of the myocardium
due to stress on the septum and RV insertion points in pulmonary hypertension.
4.6 Conclusions
The motion correction method developed in Chapter 3 has been shown to be effectively
applied to large volumes of MOLLI data from patients with pulmonary hypertension in what
we believe to be the largest study of T1 mapping in this disease to date. The RV insertion
point have been shown to be the region where T1 changes are most significantly related
to cardiac function in pulmonary hypertension. Myocardial T1 did not differ significantly
between pulmonary hypertension subtypes including LHD. The T1 in the RV insertion
point was significantly associated with RV volume and function in the patients scanned.
Interventricular septal angle independently predicted RV insertion point T1 in patients with
pulmonary hypertension suggesting that regional elevation in the RV insertion point may be
linked to increased stress on the interventricular septal wall. T1 in patients with pulmonary
hypertension was not found to be prognostic independent of RV size and function. Overall,
T1 mapping does not appear to predict the subtype of pulmonary hypertension, or provide




Modification of registration technique
for free breathing lung T1 mapping
The MRI signal from the lungs is generally weak due to a low proton density in the healthy
lung, which has a tissue density of around 0.1g/cm3 [97]. However, lung density varies with
inflation state, with an increase in lung density to 140-180% of that of inspiration during
expiration [98] [99]. This leads to a reduction in MRI signal in the lungs due to tissue density
which varies with respiratory state to 10-20% of that of a typical tissue. In addition, there is
a low T ∗2 (0.74±0.1ms during free breathing at 3T and 2.11±0.27ms during free breathing
at 1.5T [100]) due to the large magnetic susceptibility differences in the lung (∆χ = 8ppm).
While most tissues in the body are diamagnetic, air has a very low magnetic susceptibility and
dissolved oxygen and deoxyhaemoglobin in the blood are paramagnetic. Therefore, the lung
experiences local magnetic field gradients due to these susceptibility differences, leading to
increased T ∗2 relaxation [101]. There are various methods of overcoming these difficulties
in lung imaging, which usually combine a short TE with a short acquisition time in either
a spin echo or gradient echo imaging sequence [97]. More recently, ultra-short gradient
echo sequences (UTE) with a TE≤100µs have been developed. Due to the echo time of
these sequences being much less than the T ∗2 of the lung, visualisation of the lung tissue is
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greatly enhanced. However, to determine functional information, such as lung perfusion
or ventilation, additional techniques need to be employed. Pulmonary perfusion maps can
be generated with injected Gadolinium paramagnetic contrast agents and a T1 weighted,
low resolution, short TR, time resolved, 3D spoiled gradient echo sequence, resulting in
quantification of key lung perfusion parameters such as mean transit time and regional blood
volume. The paramagnetic properties of oxygen can also be exploited as a lung contrast
agent by breathing higher oxygen concentrations. Using oxygen enhancement with a T1
weighted sequence [102], or a T1 mapping sequence such as those described in Chapter 2.2,
the signal and/or T1 change due to the increased oxygen dissolved in the tissue and blood
gives an inherent ventilation and perfusion weighting.
When using a T1 mapping sequence, such as a Look-Locker sequence, UTE inversion
recovery sequence or UTE saturation recovery sequence (see Chapter 2.2.2), the change in T1
due to breathing 100% oxygen can be directly quantified. Difference maps between oxygen
enhanced T1 maps and T1 maps acquired following breathing air allows the combined effect
of ventilation of oxygen to the lung, and its diffusion into the blood, to be visualised and
quantified. However, while it may be conceptually desirable to quantify lung ventilation and
diffusion during respiration (as it removes the potential effects of the breathing manoeuvre),
in clinical practice most lung imaging methods require breath hold to suppress respiratory
motion. Free breathing methods have been developed using external navigators or navigator
echoes to identify images which are within the same respiratory window [7] [37], however
these require much longer imaging times and result in a lot of unused scanner time due to
images being discarded or due to waiting for the respiratory window of choice. For example,
a 2D free breathing UTE sequence requires around 2 minutes per slice [7] or a 3D free
breathing interleaved saturation recovery UTE sequence requires around 10 minutes [37].
T1 mapping sequences may be able to provide information on tissue changes within the
lung. In patients with dilated cardiomyopathy, an increase of collagen content due to diffuse
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myocardial fibrosis is associated with an increase in native T1 [103] and it may be that the
presence of fibrosis in the lung results in a measurable change in the T1 of the lung tissue.
However, within the myocardium, it has been shown that sex differences in myocardial
T1 can be normalised using the blood pool as a reference, which may indicate that the sex
differences seen in the myocardium are due to the blood content of the myocardium and it’s
associated sex differences (as discussed in Chapter 2.1.3.). Around half of the healthy lung
mass is comprised of blood [104], therefore, like in the myocardium, the resultant lung T1
measurement will be a combination of blood and tissue T1. Therefore, we may expect that
differences in sex, oxygenation and hemotocrit in patients will result in changes to lung T1 as
well as underlying tissue changes. Blood T1 is typically longer than tissue T1 (see Chapter
2.1.3). Fibrosis within the lung may increase the proportion of the lung comprised of tissue,
therefore decreasing the net lung T1. In patients who show heterogeneous tissue changes,
regional tissue changes may be able to be visualised by T1 mapping, which may allow regions
of affected tissue to be identified from their change in T1.
5.1 Idiopathic pulmonary fibrosis and T1 mapping
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung condition where lung
fibrosis occurs in heterogeneous regions of the lung. The condition effects a patients ability
to breath-hold considerably, and breathlessness is a common symptom. The cause of the
condition is unknown and patients with IPF have a median survival time of 2-3 years [79].
The condition has a poor outcome with a high incidence of pulmonary hypertension as the
condition progresses, with 32-50% of patients in advanced stages of IPF presenting with
pulmonary hypertension [105]. Assessment of the condition can include lung function tests,
CT and lung biopsy. However, it remains challenging to assess disease severity and quantify
disease progression in this patient group, particularly as the disease is variable and prognosis
is difficult to assess [85]. If lung MRI is able to visualise disease processes (such as fibrosis
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or poor lung oxygenation) it may be that lung MRI methods allow monitoring of patients
undergoing therapy initiation or clinical deterioration.
The presence of fibrosis in the lung causes the lung to lose elasticity and increase
septal thickness, resulting in poorer diffusive oxygen exchange (due to an increase in tissue
between the air and blood vessels) and decreased lung volume. In IPF the lungs develop
interstitial fibrosis, areas of inflammation and cysts which may all effect the tissue T1. These
processes are heterogeneously distributed in the lung in a pattern known as honeycombing
and reticulation, with discrete areas of the lung effected by fibrosis presenting next to areas
of normal lung, see Figures 5.1 and 5.2.
Fig. 5.1 Three coronal UTE images from a patient with IPF to demonstrate the heterogeneous
regions of fibrosis characteristics of the condition. Arrows point to regions of elevated signal
which may correspond to regions of fibrosis.
Fig. 5.2 Sagittal CT images from two patients with IPF showing ground glass and reticular
changes non-specific interstitial pneumonia (right) and subpleural honeycombing (left).
Arrows show areas of honey combing and ground glass reticular change respectively.
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As discussed in Chapter 2.3.1, changes to the molecular environment in the body result in
changes in tissue T1. In a normal human lung, around half of the mass of the lung originates
from blood, with the other half originating from tissue. Changes in the lung tissue, such as an
increased collagen content due to fibrosis, will result in changes to the T1 of the tissue in that
area. In addition, the increase of thickened tissue could result in an overall lung T1 change
due to an increase of the fractional contribution of tissue versus blood. Lung perfusion is
also known to change with inflation state, with expiration breath hold resulting in up to
twice the perfusion levels as inspiration [52]. Increased perfusion during expiration leads
to an increase in the fractional blood volume when considering the lung as a whole. As
blood has a higher T1 than tissue, this may be the cause of the elevated T1 which has been
observed in expiration breath hold when compared to inspiration breath hold in both healthy
volunteers [51] and patients with IPF [84]. As discussed in Chapter 2.1.4, oxygenation can
impact T1 of blood and tissue in two ways. By binding to paramagnetic deoxyhaemoglobin or
deoxymyoglobin, oxygen can increase T1 in blood or tissue. However, at hyper-oxygenation
(oxygenation >95%) excess oxygen will dissolve into the blood plasma, which decreases T1
due to its paramagnetism [2].
Therefore, although lung T1 mapping has the potential to detect tissue changes within
the lung, it may also be significantly affected by respiratory state and other confounding
physiological factors such as blood/tissue oxygenation and lung perfusion. This presents a
problem to lung T1 mapping, as it is important to understand the mechanisms behind lung T1
changes and whether changes in T1 are measures of tissue density change or oxygenation
and/or perfusion. However, this also opens up the possibility of lung T1 mapping being able
to provide information on all of these patho-physiological effects if well understood.
When studying T1 in the lung, the whole lung can be compared to controls, or regions of
the lung affected by IPF can be compared to unaffected regions within the same patient, using
CT structural changes as a guide. A MRI study with patients with IPF and healthy controls
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were imaged during 3T inspiration breath hold [85] and the results found pre-contrast lung
T1 was higher in patients with IPF when compared to controls and that fibrotic regions of
the lung had significantly higher T1 when compared to non-fibrotic regions of the same lung
[85], indicating that regions of fibrosis may be able to be identified from MRI alone. A
different study looking at whole lung T1 in patients with IPF on a 1.5T MRI scanner during
both inspiration and expiration showed net lung T1 values lower than had been previously
found by the same group in healthy volunteers [84] [51]. In addition, the study found a
significant relationship between expiratory T1 values and the total lung capacity and lung
residual volume. This indicates that MRI may be useful in identifying IPF and characterising
the condition.
Although patients with IPF would benefit from free breathing T1 mapping acquisition
methods, like in cardiac T1 weighted imaging, lung T1 weighted image contrast changes
with time due to T1 relaxation, making the acquired images difficult to automatically register.
In a typical coronal lung image several tissues with different T1s will be present, such as
diaphragm, liver, lung, bone and fat. The aim of this work is to acquire free breathing lung T1
maps, using image registration to synthetic images to correct respiratory motion. By using
automated image registration for respiratory motion correction, the image acquisition time
remains short, reducing scan time and increasing patient comfort.
As respiratory state of breath hold (inspiration versus expiration) is known to effect
measured lung T1 [51] [84], free breathing lung T1 is also expected to differ from that during
breath hold. In addition, the process of respiration will effect the oxygen saturation and
amount of oxygen (both bound and dissolved into blood plasma) in the blood, which is
expected to effect lung T1. Patients with IPF may have lower levels of oxygen in the blood
and/or higher levels of deoxyhaemoglobin in the blood, in addition to extracellular and tissue
changes due to the pathophysiology of the condition.
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Therefore, it is of interest to characterise the changes in lung T1 due to free breathing
acquisition, as well as confirm whether lung T1 is significantly different in patients with IPF
when compared to subjects without IPF and whether there is a larger regional variation in the
lung of patients with IPF. In addition, free breathing T1 mapping may be a comfortable and
radiation free method of quantifying fibrotic areas of the lungs in patients with IPF.
5.2 Objectives
The objectives of this chapter of work are to:
i. Modify the image registration algorithm for the use in free breathing T1 mapping in
the lung using a Look-Locker sequence.
ii. Demonstrate and evaluate the effectiveness of this method in healthy volunteers and
patients with IPF and assess if lung T1 differs between these two groups.
iii. Investigate whether acquiring images in free breathing affects the measured T1 of the
lung.
iv. Investigate the affect of breathing 100% oxygen on lung T1 during free breathing and
breath hold.
5.3 Method
In order to modify the existing image registration and T1 mapping algorithm developed in
Chapter 3 for use in free breathing, the lung images which occur in the same spatial location
need to be identified. In Chapter 3, the knowledge that respiratory motion due to release
of breath hold tends to occur later in the image acquisition allowed the assumption that the
first images acquired in the series would be best spatially aligned. This assumption held and
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enabled spatially aligned synthetic images to be produced. However, during free breathing,
respiratory motion will be present from the beginning of the sequence and therefore this
assumption can not be used. Instead, a method to determine the respiratory pattern from
the time course of images themselves has been developed, such that images which occur
at the same point of respiration (in 2D space) can be determined without any additional
information.
5.3.1 Model for diaphragm signal changes in free breathing lung Look-
Locker imaging
The basic steps involved in the image registration process are described in Figure 5.4, the
relevant code is given in appendix A with accompanying flow charts of the algorithms used.
Synthetic images are created using three of the acquired images which are spatially aligned.
Spatially aligned images are chosen using a simple model which describes the combined
effect of respiration and inversion recovery on a group of pixels at the diaphragm, as the signal
of a region of interest on an image with respiratory motion is the result of a combination of
inversion recovery behaviour and the motion of tissue in and out of the region of interest,
see Figure 5.3 and appendix A.2.1. A group of pixels at the diaphragm are automatically
selected based on the parameters determined from curve fitting, which will be discussed in
more detail later in this chapter. The synthetic images are then used for pair-wise image
registration with the acquired images, to create a set of registered images, from which a T1
map can be produced.
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Fig. 5.3 Examples of the observed Look-Locker inversion recovery signal over time in a
respiring patient from fixed pixels at the diaphragm, compared to that expected from a single
compartment inversion recovery during breath hold.
The total signal from a fixed ROI in the body is effected by both the inversion recovery
behaviour of the protons in this region of tissue and the changing ratio of the tissues in the
ROI due to respiration, see Figure 5.3. For simplicity, consider a region of interest which
represent two tissue types: tissue A and tissue B, see Figure 5.5.
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Fig. 5.4 Diagram showing the basic steps to the method of automated image registration for
free breathing lung Look-Locker images. In this method S3 acts as a surrogate for S0.
Fig. 5.5 Simplified diagram of a fixed region of pixels at the diaphragm.
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Where k is a constant, nA and nB are the number of pixels corresponding to tissue A and B
respectively, and the densities ρA and ρB are the densities of protons in each tissue per pixel.
If the change in the number of pixels representing each tissue in the ROI changes according
to a sinusoid, where the total number of pixels does not change:
nA = α sin(νt +φ)+κ1,nB =−β sin(νt +φ)+κ2 (5.2)
Where A and B are the two tissues in 5.5, α and β are the coefficient of the sine waves, κ1
and κ2 are constants and ν is the respiratory frequency, and φ is the respiratory phase shift.
Such that
nA +nB = constant (5.3)
Therefore, an increase in nA results in a proportional decrease in nB and vice versa (assuming
that the tissues are incompressible), and ν is the respiratory rate. To account for time-
dependant relaxation changes:
i Equation 5.2 can be substituted back into 5.1 to account for the movement of tissue A
and B due to respiration
ii T1A and T1B become time dependent and are replaced with T ′1A and T
′
1B due to possible
tissue changes due to respiration, for example, oxygenation effects.
iii Two time dependant T ′2 components are included, as T2 may also change due to
respiration resulting in a time-dependency and possible T2 weighting to the images.
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The change in T1 and T2 due to the respiratory cycle is not necessarily known and depends
on the tissue in question. Whole lung T1 has been found to be around 10% longer during
expiration breath hold compared to inspiration breath hold [51] and therefore it may be
that lung T1 varies between these extremes during respiration. However, the difference
between inspiratory and expiratory breath hold volumes is expected to be more than tidal
volume. During free breathing images where acquired images were dichotomised into either
inspiration and expiration states, lung T1 was found not to be significantly different between
inspiration and expiration [7].
Lung T2 has been found to decrease during inspiration due to increased magnetic suscep-
tibility gradients across the lungs due to compression of tissue and increased presence of
paramagnetic oxygen in the air in the alveoli [38] [106]. In freely breathing mouse models
T2 was shown to have a linear relationship with proton density [106] and lung T2∗ was found
to increase in the expiration phase of free breathing acquisition by around 4%. Liver T1 and
T2 may also have a time dependency due to respiration, but will not be affected by the large
tissue susceptibility differences seen in the lung due to air-tissue interfaces.
As respiration rate, ν → 0 (breath hold) S(t)→ equation (5.1). However, equation (5.4)
can be simplified by the assumptions that:
• That tissue A is lung, and therefore ρA′ is time dependent.
• That tissue B is incompressible.
• That the density of the lung tissue is much lower than that of the second tissue and
therefore the signal from the second tissue dominates the overall S(t)
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• That the density of the second tissue (predominantly liver) is not affected significantly
by time-dependent changes in T1 or T2 due to oxygenation or other respiration affects.




















Which can be rewritten:




Where P1 and P2 are constant parameters to be fit to, which correspond to −kρBβ and
kρBκ2 respectively. The intention of these assumptions is to create a simplified model with
minimal free parameters in order to allow a robust curve fitting. Equation (6.4) then has
just five free parameters and can be used to determine the respiratory rate, ν , occurring
within a set of inversion recovery images. νt +φ = 1 and νt +φ =−1 occur at inspiration
and expiration respectively. Therefore, the state of respiration of the first image can be
determined, and the images which minimise sin(νt1+φ)− sin(νti+φ) can be identified and
used to create synthetic images spatially aligned to image 1, see Figure 5.6.
Throughout this thesis, a version of equation 5.7 without a phase shift has been er-
roneously used. The following work has been completed using the equation and 4 free
parameters, and it is expected that further work incorportating the phase shift as an additional
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This simplified model and it’s associated assumptions is set in place only for the purpose
of constructing synthetic images as a registration tool.
Fig. 5.6 Flow diagram to show which image segment is used to determine respiratory rate.
The method aims to find a segment whose signal fits the model well (has a low curve fitting
residual) but is also appreciably effected by respiratory motion (has a large coefficient P1).
The images are segmented into horizontal ROIs of 20 pixels height, resulting in 13
sections as shown in Figure 5.7. Each strip is fitted to equation (6.4). The coefficient P1
is maximum at a region where the effect of respiratory motion on overall signal is most
significant, which is usually at the liver/stomach, see Figure 5.7. The segment used to
determine respiratory rate, ν , is chosen by the algorithm shown in Figure 5.6. The method
aims to choose a segment whose signal fits the model well and therefore has a low curve
fitting residual, but is also appreciably effected by respiratory motion and therefore has a
large coefficient P1.
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Fig. 5.7 Figure illustrating the identification of the diaphragm via the respiratory amplitude
from pixel fitting horizontal segments of pixels to the combined respiratory and inversion
recovery model, see equation (6.4).
Once the respiratory rate, ν , is determined, sin( ν t) can determine the state of respiration
for each image, see Figure 5.6. Three input images for the synthetic image creation are then
selected:
i The first image in the sequence
ii The image where sin(νt1)− sin(νti) is minimised.
iii Of the images which occur at least 1.5 seconds after the first image (when most tissue
will have a largely recovered T1) and which are not already chosen, the image with the
smallest value of sin(νt1)− sin(νti).
The intention here is to choose three well aligned images, but as the third image acts
as a surrogate for the fully recovered signal (S∞), it should not occur at the beginning of a
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sequence. Here there is a trade-off between choosing the best aligned images and choosing
images which well represent the inversion recovery signal curve. An example is shown in
Figure 5.8.
Fig. 5.8 A worked example of how the algorithm chooses images which are well aligned
with image 1, and which occur later in the signal recovery curve. For this set of images,
the images with the closest P1sin(νt) to image 1 (see dashed line) are images 7, 2 and 13.
However image 2 occurs within the threshold of 1.5s and is not selected. Images 7 and 13
are selected to input into the synthetic image creation.
5.3.2 Subjects
9 healthy volunteers (7/9 male, mean age 30.6±4.4 years) with no history of interstitial
lung disease, were recruited as subjects to test 2D Look-Locker T1 mapping during both
inspiration breath hold and free breathing. 7/9 healthy volunteers underwent additional
sequences of expiration breath hold and 4/9 underwent addition free breathing sequences
whilst breathing 100% oxygen at 15L/min for 2 minutes prior to imaging to establish further
whether there is an effect of O2 inspiration upon T1 during free breathing.
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3/9 volunteers underwent additional axial plane 2D Look-Locker imaging during both
inspiration and expiration to evaluate if gravitational effects are evident to lung T1. Free
breathing axial slices were not undertaken, due to the large amount of out of plane mo-
tion observed due to respiration in the axial slice. The same three volunteers underwent
Look-Locker imaging with images acquired over a 10 minute period with 100% oxygen
administered for the first 5 minutes and turned off for the second 5 minutes to assess the
wash in and out of oxygen with time. This was performed in both inspiration breath hold and
free breathing for two volunteers, and only during free breathing for the third volunteer.
11 adult patients with IPF were also recruited from a specialist interstitial lung disease
clinic. Patients were excluded from the study if: they had a resting oxygen saturation below
90%; were pregnant; were on immunosuppressive treatment (not including N-acetylcysteine
or prednisolone at a dose less than or equal to 20mg/day); had stage 4 or 5 chronic kidney
disease; were unable to lie supine for 60 minutes; had severe coronary artery disease or
angina not fully controlled by medication; had significant congestive heart failure; an allergy
to gadolinium contrast; had a significant co-morbidity likely to reduce life expectancy to
less than one year or had significant congestive heart failure. All IPF patients underwent 2D
Look-Locker imaging in inspiration breath hold and free breathing, with the slice positioned
through the descending aorta.
5.3.3 Image acquisition
A whole body, 1.5 T GE HDx scanner (GE Healthcare, Waukesha, WI) and 8-channel
cardiac coil were used for Look-Locker image acquisition. Patients were positioned supine
and 2D images were acquired in a coronal plane through the descending aorta. The Look-
Locker sequences comprises a 180 degree inversion pulse followed by 16 gradient echo
images [22] (see Figure 2.15). Imaging parameters were as follows: Inversion time (TI):
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229ms; TR=3.2ms; α=7; phase x frequency: 128 x 128; slice thickness: 15mm. Breathing
instructions for free breathing acquisition were to breath normally.
5.3.4 Oxygen administration
100% oxygen was administered at a flow rate of 15L/min for two minutes prior to imaging,
unless otherwise specified. A simple face mask with low-flow delivery was used for oxygen
delivery on the free breathing and breath held image acquisitions for 2 minutes. For image
acquisitions while breathing oxygen for 5 minutes to observe the wash-in of oxygen, a
non-rebreather mask was used at a flow rate of 15L/min.
5.3.5 Quantifying the efficacy of registration
Registration efficacy in free breathing lung Look-Locker images was measured using DSC to
measure global lung registration, as described in Chapter 3.3.1.
Fig. 5.9 Example of segmented lungs. Guide lines are given from the upper diaphragm of the
first segmented image.
5.3 Method 141
The DSC was calculated for each set of segmented lung data, see Figure 5.9, pre-
registration and after applying the corresponding registration maps. All images were also
inspected visually as a video looping over time by an MR physicist with 4 years experience,
to ensure that blood vessels and other prominent anatomical lung features were consistently
aligned before calculating the lung T1.
5.3.6 Analysis and statistics
As discussed in section 5.3.1, the acquired images will have a slight T2 weighting due to
the effect of respiration. For this chapter any changes in T2 and T2∗ with time have been
assumed to be negligible compared to the change in signal from inversion recovery, and all
image-processing was performed as described in Chapter 3, using custom functions written in
Matlab 2016b. No images were cropped or segmented. Matlab-based non-rigid registration
toolkit ShIRT [42], which was described in section 3.3.2, was integrated into the custom
Matlab voxel-wise T1 mapping algorithm for both the initial and final registrations. All
computation was performed on a 64 bit Windows 10 workstation with 16GB RAM and 4 X
Intel® Core™ 3.6GHz processors.
Pixel-wise T1 maps were calculated using equations (2.26) and (2.27) and T1 values in the
lung were measured by drawing regions of interest in the entire right and left lung of the T1
maps and calculating the mean lung T1. T1 of the upper and lower lung was also calculated
by placing regions of interest in the upper and lower left lung. Pixel-wise standard deviation
of T1s within each lung was also measured.
Axial T1 maps were segmented into five segments divided evenly (by eye) from anterior
to posterior and mean T1 was calculated for each segment and presented in a scatter plot. For
dynamic T1 maps mean lung T1 was presented on a scatter plot against time.
For lung T1 acquisitions acquired over 5 minutes of breathing 100% O2 and 5 minutes of
breathing air, mean lung T1 from each T1 map was plotted against time for each volunteer.
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Statistical analysis was performed using SPSS 21 (SPSS, Chicago, IL). Data is presented
as mean ± standard deviation. DSC before and after registration were compared using a
paired t-test. T1 values in the same region, but calculated using the two different methods
described, were compared using a paired t-test. Tests for differences between T1 values in
different respiratory states were calculated using a paired t-test. Group T1 differences were
calculated using an independent t-test or an ANOVA, depending on whether two or more
variables were being compared.
5.4 Results
5.4.0.1 Efficacy of registration in Look-Locker images
Image registration significantly increased overall DSC in free breathing datasets (p<0.001 for
all subjects; p=0.001 volunteers only; p=0.016 patients only), see Table 5.1. When inspected
visually as a video looping over time, blood vessels and lung features appeared consistently
aligned post-registration in all image datasets. An example is shown in Figure 5.10.
Table 5.1 Mean lung T1 and DSC values. The standard deviation given is the standard
deviation of T1s within both lungs. † indicates a significant improvement in DSC.







Free breathing 9 0.90±0.06 0.93±0.05† 1145±94 217
Inspiration 9 0.94±0.04 0.94±0.04 1097±53 253
Expiration 7 0.95±0.04 0.95±0.03 1179±93 200
Free breathing with
oxygen
4 0.86±0.04† 0.88±0.03 1189±94 200
Patients with IPF
Free breathing 11 0.90±0.065 0.91±0.04† 1061±59 264
Inspiration 11 0.91±0.04 0.92±0.04 1040±61 297
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Fig. 5.10 Example of a Look-Locker dataset before and after image registration, cropped to
the right lung after registration. An orange line is drawn at the diaphragm on the first image
to demonstrate diaphragm motion.
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DSC did not change significantly after registration in breath hold images (p=0.184 for
all subjects; p=0.306 for volunteers; p=0.212 for patients). Post-registration, free breathing
and breath hold images showed no significant difference in DSC (p=0.486 for all subjects;
p=0.477 volunteers only; p=0.748 patients only).
5.4.0.2 Lung T1 maps in healthy volunteers
Examples of T1 maps in healthy volunteers are shown in Figure 5.11 and mean T1 values
are given in Table 5.1 and Figure 5.12. In healthy volunteers, inspiration breath hold T1 was
significantly lower than free breathing T1 (p=0.031) and expiration T1 (p=0.040). Expiration
T1 and free breathing T1 were not significantly different (p=0.080).
Fig. 5.11 Example T1 maps from acquisitions made during inspiration, free breathing and
expiration for a healthy volunteer.
The standard deviation of T1 values within the lung was not significantly different in
inspiration when compared to free breathing in volunteers (p=0.189).
Although the results in Table 5.1 do not show a lower in oxygen enhanced free breathing
T1, when only the sub-set of patients (n=4) who underwent both free breathing during air and
free breathing during 100% oxygen were considered (n=4), lung T1 was significantly lowered
during oxygen enhanced free breathing (air: T1=1180±30ms; 100%O2: T1=1120±90ms;
p=0.012), see Figure 5.13.
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Fig. 5.12 Lung T1 acquired during free breathing and inspiration breath hold in patients with
IPF (green) and healthy volunteers (blue). P values are shown for differences in mean lung
T1 between patients with IPF and healthy volunteers.
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Fig. 5.13 Examples T1 maps in a healthy volunteer during free breathing air and with oxygen
enhancement.
Inspiration lung T1 was found to have a range from anterior to posterior of 141ms, 87ms
and 309ms in each volunteer. Expiration lung T1 was found to have a range from anterior to
posterior was found to have a range of 91ms, 76ms and 128ms in each volunteer. Therefore,
in each volunteer, less anterior to posterior variation in T1 was seen in expiration breath hold
compared to inspiration breath hold, see Figure 5.15. In both inspiration and expiration the
highest T1 values were found in the posterior slice. An example is shown in Figure 5.15.








Volunteer 1 1040±18 1120±18 p<0.001
Volunteer 2 1030±28 1100±18 p=0.038
Combined 1030±45 1110±30 p<0.001
Free Breathing
Volunteer 1 1090±30 1160±40 p=0.004
Volunteer 2 1020±70 1100±90 p=0.085
Volunteer 3 1180±90 1141±30 p=0.386
Combined 1140±70 1150±80 0.020
Three volunteers underwent Look-Locker T1 mapping over time, where oxygen was
administered for 3-5 minutes and turned off for 3-5 minutes. The mean lung T1 was signifi-
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Fig. 5.14 Standard deviation of lung T1 in free breathing and breath hold, in patients with IPF
and healthy volunteers.
cantly lower when breathing 100% oxygen both during acquisition during breath hold and
acquisition during free breathing, see Figures 5.17, 5.18 and Table 5.2.
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Fig. 5.17 Three volunteers underwent Look-Locker T1 mapping over time, where oxygen was
administered for 3-5 minutes and turned off for 3-5 minutes. Acquisition occurred during
free breathing.
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Fig. 5.18 Two volunteers underwent Look-Locker T1 mapping over time, where oxygen was
administered for 3-5 minutes and turned off for 3-5 minutes. Acquisition occurred during
breath hold.
Maps of ∆T1 were created by subtracting T1 maps acquired during inhalation of 100%
O2 from T1 maps acquired during breathing room air. The maps show a homogeneous
distribution of oxygen enhancement which was expected for healthy volunteers.
5.4.0.3 Lung T1 maps in patients with IPF
Examples of T1 maps in patients with IPF are shown in Figure 5.19. Lung T1 was found
to be significantly lower in patients with IPF when compared to healthy volunteers during
free breathing (p=0.015) and during breath hold (p=0.021). Unlike in healthy volunteers,
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there was no significant difference between inspiration and free breathing lung T1 values in
patients with IPF (p=0.366), see Figure 5.12.
Table 5.3 Mean lung T1 values in the upper and lower lung, † indicates p<0.005.
Respiratory state Upper Lung T1 (ms) Lower Lung T1 (ms) p value
Healthy volunteers
Free breathing 1099±139 1097±131 p=0.803
Inspiration 1109±62 1093±54 p=0.041†
Combined 1103±106 1095±99 p=0.082
Patients with IPF
Free breathing 1073±68 1040±68 p=0.011†
Inspiration 1043±34 1029±41 p=0.182
Combined 1072±52 1044±54 p=0.002†
Fig. 5.19 Example T1 maps from patients with IPF in inspiration and free breathing, with
lung division into upper and lower lung shown on the two example UTE images.
The standard deviation of T1 values within the lung was higher in patients when compared
to healthy volunteers (inspiration: p=0.068; free breathing: p=0.021; both: p<0.001). A
simple way of evaluating lung heterogeneity is whether there is a significant T1 difference
5.5 Discussion 151
in the upper lung compared to the lower lung in each patient, due to the basal prevalence
of fibrosis in IPF. During free breathing there was not a significant difference between
upper and lower lung T1 in healthy volunteers (p=0.803), however there was in patients with
IPF (p=0.011), see Table 5.3. However, during breath hold healthy volunteers did have a
significant difference between the upper and lower lungs (p=0.041) whereas patients did
not have a significant difference between upper and lower lung (p=0.076). When data was
combined, a paired t-test of data from both breath hold and free breathing acquisition showed
patients with IPF had a significantly lower T1 in the lower lung (p=0.002) whereas healthy
volunteers did not (p=0.082), see Figure 5.20.
Fig. 5.20 The absolute value of the T1 difference between upper and lower lung in free
breathing and breath hold acquisitions.
5.5 Discussion
Free breathing lung T1 mapping constituent images were significantly more aligned after
registration, and there was no significant difference in alignment as measured by DSC
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between breath hold images and free breathing images post image registration. The method
described successfully registers free breathing Look-Locker images onto a single spatial
frame to allow pixel-by-pixel T1 mapping of the lung in volunteers and patients with IPF.
Mean T1 values during inspiration in healthy volunteers were 1097±53 ms which is consistent
with the results shown from a normal mean lung T1 values at 1.5T of 1196±152ms [39].
The results in inspiration and expiration are consistent with published literature on the
effect of respiratory state on lung T1 in both healthy volunteers [51] and patients with IPF
[84] [107], with expiration breath hold yielding a significantly higher T1. The effects of
breathing 100% oxygen during imaging are consistent with breath-hold data, which show
a reduction in lung T1, the free breathing data resulted in a reduction of lung T1 by 6%
compared to meta-analysis results of around 10±2.5% [39].
The range of T1 values in the lung of healthy volunteers was found to be smaller during
expiration, with higher T1 in the posterior lung. This is consistent with previous findings
which found a statistically significant T1 variation from anterior to posterior lung in 10 healthy
volunteers in inspiration, with higher T1 found in the posterior lung [51] . This variation is
consistent with an increase in fractional volume of blood towards the posterior lung due to
gravitation effects. This emphasises the importance of consistency in slice choice in 2D lung
T1 mapping, as well as the potential benefits of further work into 3D lung T1 mapping to
improve anatomical specificity in future studies.
The mean lung T1 of healthy volunteers measured with a free breathing approach was
in-between the mean lung T1 calculated during inspiration and expiration, which may suggest
that the predominant mechanism causing lung T1 changes in different respiratory states is the
relative fractional volume of lung components (i.e. tissue, blood, parenchyma, air) leading to
a changed apparent T1, rather than oxygenation affects. In particular, as expiration causes
an increase in pulmonary perfusion of up to twice the perfusion levels in inspiration [52], it
may be that increase of the content of blood in the lungs during expiration results in a larger
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contribution to measured T1 from blood resulting in an increased overall T1. However, it is
also possible that deoxygenation effects due to breath hold are also present but which are to
some extent negated by the increase in fractional blood content. When free breathing with
100% oxygen the overall lung T1 was found to lower, which is consistent with literature, due
to the increased presence of dissolved paramagnetic oxygen in the pulmonary blood and
tissue.
As has been previously observed that the mean lung T1 of patients with IPF is lower
than that found in healthy volunteers. In addition, during free breathing, patients with IPF
were found to have a lower lung T1. It is not possible from this work to identify whether the
changes seen are due to oxygenation, perfusion or lung tissue differences between patients
with IPF and healthy volunteers - as it is known all three variables can affect measured T1.
However, our results show a lower T1 in patients with IPF and a decrease in oxygen dissolved
in the blood would result in a higher T1, and therefore it is unlikely to be a significant factor
in changes in lung T1 in these patients.
Tissue changes in patients with IPF cause heterogeneity in the lung, resulting in both
heterogeneity in the tissue itself as well as heterogeneity in the ability for oxygen to dissolve
into the blood in these areas. This was evaluated by comparing the standard deviation of lung
T1 values within the lung, and regional differences in the upper and lower T1. Our results
showed a higher standard deviation of T1 within the lung in IPF, and an overall significant
difference between the upper and lower lungs in patients with IPF.
Lung T1 was significantly lowered in healthy volunteers when breathing 100% O2 both
during breath hold imaging and during free breathing. This confirms that a free breathing
approach could be used during oxygen enhanced T1 mapping to demonstrate regions where
oxygen is absorbed into the blood within the lung, acting as a measure of combined ventilation
and perfusion [17]. Although T1 significantly decreased when oxygen was administered, the
graphs of T1 changes over time were not able to produce wash-in and wash-out times as seen
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in the work of Arnold et al., [17]. There are two likely causes for the large range of T1 values
seen: i) a conventional Look-Locker imaging sequence was used rather than a sequence with
a shorter acquisition, which limited the rate of T1 map acquisition, therefore not enough data
was acquired to establish a clear pattern; ii) the type of oxygen delivery mask used is know
to significantly affect the interindividual variation of lung T1 when oxygen is administered.
For this work a nontight face mask was used which has been found to yield higher variation
in lung T1 than a closed air-cushion faced mask (a "full closed face mask") [108]. In order
to establish whether the potential outliers seen in Figure 5.17 are due to a physiological
affect this work would need to be repeated with a closed air-cushion faced mask to remove
intersubject variability.
The key limitation of this work is that the phase shift was not included in the respiratory
model. Further work using the model described in equation is expected to improve the
respiratory model and therefore potentially improve image registration further. Nonetheless,
the results in this work show that incorporating a sinusoidal component to curve fitting allows
images of similar respiratory state to be selected and used for synthetic images, resulting in
significant improved image registration. In addition it is that it assumed there was no T2 or
T2∗ weighting in the Look-Locker images during acquisition due to respiration. A previous
study finds a variation in T2 with respiration, with a linear relationship between respiratory
state and time. It would be of interest to future work to explore whether post-processing can
account for and quantify this additional parameter which influences signal in the lungs.
In addition, it is a limitation of this work that scan-scan repeatability of free breathing
acquisition of the Look-Locker sequence has not been compared across breath hold manoeu-
vres (inspiration and expiration) and free breathing. It would be of interest to compare these
methods for scan-scan repeatability in healthy volunteers prior to further work.
Furthermore, neither expiratory lung T1 maps or oxygen enhanced T1 maps were acquired
in patients with IPF. It would be of interest to acquire this data in the future to establish how
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expiratory lung T1 maps compare to free breathing lung T1 maps in terms of differentiating
patients with IPF from healthy subjects, in particular it may be that the increased blood
content in the lungs results in easier identification of fibrotic tissue in the lung due to the
difference in T1 between the two components. In addition, the use of oxygen enhanced free
breathing T1 maps may show regions of poor ventilation and/or perfusion in patients with
IPF.
5.6 Conclusions
Free breathing lung T1 mapping using post-processing image registration to synthetic images
created using a model of respiratory motion modulation of lung tissue signal is feasible and
produces robust registration. Free breathing lung T1 is significantly higher than breath hold
T1 in healthy volunteers, and is not significantly different to breath hold T1 in patients with
IPF. Free breathing lung T1 was found to be significantly lower in patients with IPF compared
to healthy volunteers, and patients with IPF showed a greater degree of lung heterogeneity.
Free breathing lung T1 mapping with and without admission of 100% oxygen may be a fast,
comfortable method of detecting lung structure and functional changes in patients with IPF.
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Fig. 5.15 Axial lung T1 maps in three healthy volunteers were segmented into 5 segments
from anterior (1) to posterior (5) (bottom). Mean T1 from each region was plotted against
time for inspiration and expiration breath hold (top).
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Fig. 5.16 Example maps of T1 change due to oxygen enhancement. The T1 map acquired
prior to administration of 100% O2 was subtracted from a T1 map acquired 2 minutes after
inhalation of O2 in a healthy volunteer, for both breath hold and free breathing acquisitions.

Chapter 6
Image modification of registration
technique for free breathing cardiac T1
mapping to incorporate respiratory
motion
6.1 Introduction
6.1.1 Motivation for free breathing cardiac T1 mapping
As discussed in Chapter 3, for patients with cardiac or pulmonary disease, breath holds can
be difficult or unachievable with around 40% of some cardiac patient cohorts demonstrating
cardiac motion in T1 mapping imaging acquisitions [5]. A free breathing acquisition would
increase the applicability of cardiac T1 mapping to patient cohorts who experience shortness
of breath as well as improve patient comfort. Furthermore, the limitation of sequence duration
to that of a comfortable breath hold limits the precision of the calculated T1 map as it reduces
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the amount of images acquired and therefore increases the uncertainty of calculated T1 during
curve fitting.
However, the free breathing acquisition alternatives discussed in Chapter 2.2.3 result in
an increased acquisition time which may add to patient discomfort and examination cost,
and may decrease patient through-put in a clinical imaging setting. The free breathing T1
mapping method discussed by Weingartner et al., [8] in section 2.2 combined retrospective
and prospective respiratory gating and under-sampling resulting in a 9 minute scan time for
five 2D images. A similar method using a 1D NAV respiratory gating and the SASHA image
acquisition sequence resulted in a 5-10 minute scan time [50] with an average scan time
across 12 adult healthy subjects of 6 minutes [109]. Long scan times when using navigators
may be further increased in patients with irregular respiratory patterns. In these sequences,
the potential to increase T1 precision by increasing the number of acquired images is lost
due to the extended scan-time and inherent inefficiency. These scan times are generally
prohibitive for routine cardiac MRI - for example, for pulmonary hypertension patient
imaging in Sheffield we intent to fit all images into less than 45 minutes.
Free breathing acquisition using post processing image registration to correct respiratory
motion has been performed in inversion recovery imaging for delayed-enhancement imaging
of myocardial infarction [110]. The image registration algorithm required user input to define
the region of the heart, and registration was applied directly to phase-sensitive inversion
recovery images. Similarly, Chow et al [111] used motion correction as a tool for correcting
accidental respiratory or cardiac motion in 2D SASHA T1 mapping images. Chow simul-
taneously acquired additional high contrast images (to allow an easier image registration)
and SASHA images during free breathing. The high contrast images were registered to one
another, after which the high contrast image registration parameters were applied to the
corresponding SASHA images.
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However, although 3D SASHA acquisitions have higher precision than 2D acquisitions,
they are still less precise than 2D MOLLI sequences (assessed using standard deviation of
myocardial T1 values) [50]. Therefore, a free breathing 2D MOLLI cardiac T1 mapping
method that uses image registration to compensate for respiratory motion may result in a more
precise free breathing cardiac T1 mapping method than the existing options. Furthermore,
a free breathing 2D MOLLI cardiac T1 mapping method that uses image registration to
compensate for respiratory motion would reduce scan time and optimise scan efficiency
when compared to free breathing sequences as it would not discard data.
Chapter 3 showed significant improvement in image alignment in MOLLI T1 mapping
images seen with the image registration method proposed, even in patients with considerable
respiratory motion. This chapter demonstrates that the method presented in Chapter 3 can be
modified for use during free breathing. Furthermore, removing the time restriction imposed
by breath hold opens up the possibility for longer sequences, including three dimensional
acquisitions, or for more interleaved inversions which could further improve precision of the
sequence.
The predominant limitation of applying this method to 2D cardiac imaging is that it does
not compensate for out-of-plane motion. The cardiac short axis plane is aligned to each
subject’s cardiac structure, and therefore its position with respect to the coronal, sagittal
and axial planes will vary depending on the individual’s anatomy and thoracic motion.
Respiratory motion is predominately in the superior-inferior direction, with movement of
the heart due to respiration showing an average of 9.1mm of movement in this direction,
compared to 1.0mm and 1.4mm movement in the anterior-posterior and left-right directions
[112]. A diagram of the short axis plane is shown in Figure 6.1 to illustrate its positioning
with respect to the coronal plane. Some out of plane motion is will occur in subjects, with
the amount of out-of-plane motion present depending on their anatomy and lung dynamics.
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Fig. 6.1 A diagram showing the rough position of a short axis plane with respect to the body.
During expiration (right) the cardiac position may move upwards and/or rotate due to the
diaphragm position.
6.1.2 Objectives
The objectives of this chapter of work were to carry out preliminary studies with the aim of:
i Modifying the respiratory model based image registration algorithm described in
Chapter 5 for use in free breathing T1 mapping of the heart.
ii Demonstrate and evaluate the effectiveness of this method in volunteers.
iii Investigate whether acquiring images in free breathing effects the resultant myocardial
T1.
iv Investigate the effect of inhaled oxygen on myocardial T1.
6.2 Method
6.2.1 Model for diaphragm signal changes in free breathing cardiac
MOLLI imaging
The same method as described in Chapter 5 for free breathing lung T1 mapping can be applied
to MOLLI imaging, however cardiac T1 imaging contributes two additional challenges. The
6.2 Method 163
first, as previously discussed, is that out-of-plane motion of the heart results in different
planes of the myocardium may be being imaged at different time points in the sequence and
this remains a challenge that will be addressed and discussed further throughout this chapter.
The second challenge is that cardiac gated MOLLI images from different inversion times (tI)
are time-interleaved. Images following three separate inversions are acquired during MOLLI
imaging, therefore the time, t, during acquisition and the time post-inversion, ti, no longer
have the same value. Time during the acquisition can be written as:
t = tI + ti (6.1)
Where t is the time, tI is the time of the inversion pulse and ti is the time between an
acquisition and the inversion pulse, see Figure 6.2.
Fig. 6.2 Diagram to show the relationship between t, ti and tI where tI(1) is chosen as 0 for
convenience.
A flow diagram showing a summary of the method for automated image registration
of free breathing 2D MOLLI images using synthetic images is shown in Figure 6.3. The
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relevant code and accompanying flow-diagram is shown in appendix A.3.1. Where t is the
time during acquisition, tI is the time between the inversion the acquired image and the first
inversion and ti is the time between image acquisition and the inversion pulse that it follows,
see Figure 6.2.
Fig. 6.3 A method diagram for automated image registration of free breathing 2D MOLLI
cardiac MR images using synthetic images.
Equation 5.2 can be rewritten as:
nA = α sin(ν(tI + ti))+κ1,nB =−β sin(ν(tI + ti))+κ2 (6.2)
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The equation (6.4) can be rewritten as:




Where ν is the respiratory rate, and β and κ2 are constants. Which, following the reasoning
described in Chapter 5 can be approximated as:




With four free parameters to fit to during curve fitting.
tI has three values - the time at which the three different inversion pulses occur. Re-
writing time, t, in this way allows the model to describe the time dependant inversion and
respiratory behaviour separately. As with Chapter 5, the images are segmented into horizontal
strips of 20 pixels and the segment of the image which is chosen to fit to the respiratory
model is described by Figure 6.4. In the case of an image in the short-axis cardiac plane,
see Figure 6.5, the central ROIs contain either: liver and lung; myocardium and lung; or
liver, myocardium and lung. Therefore tissue B represents either liver, myocardium, or both.
Empirically this has not been found to affect image registration and this may be because
both tissues still have a much greater density than the lung tissue and both tissues move
simultaneously. The algorithm aims to choose a segment whose signal fits the model well
and therefore has a low curve fitting residual, but is also appreciably effected by respiratory
motion and therefore has a large coefficient P1, which is likely to be at the diaphragm or the
superior myocardium.
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Fig. 6.4 A schematic diagram showing a case where P1sin(νt1) results in poorer alignment
with images 10 and 11 than P1sin(νt2). In this case, using the second image (t2) as the
first input image would result in a better aligned set of input images (i.e. P1sin(νt2)−
P1sin(νt11)< P1sin(νt1)−P1sin(νt11)).
Fig. 6.5 A cardiac short axis plane image segmented into 13 horizontal ROIs.
Curve fitting to equation (6.4) is used to identify three images in the same respiratory
spatial state. At least one of these chosen images must occur at t > 1.5s so that it can act as a
surrogate for a fully recovered image (S∞) . However, in some instances there are not two
images which are well aligned to the first image. To compensate for this, an additional step
is added, where both the first and second image (ti=1 and ti=2 ) are evaluated as candidates
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for the first image to be input into the synthetic image model, and the three images with the
lowest residual found during curve fitting are chosen. An example where using the second
image as the first input image into the synthetic image model would result in a better aligned
set of images to input into the model is shown in Figure 6.4.
Once the model for respiration has identified two images which occur in the same
respiratory state as the first image, synthetic images can be created using exactly the same
method as described in Chapter 3 for cardiac MOLLI images. Each acquired image is then
co-registered to its corresponding synthetic image, as shown in Figure 5.4. The synthetic
images will have similar image contrast to the acquired images but are now in an aligned
spatial frame.
6.2.1.1 Image and analysis
MOLLI imaging parameters are as described in Chapter 3, with a matrix size of 128 x 128.
Registration efficacy in free breathing cardiac MOLLI was measured using DSC in the left
ventricle myocardium, as described in Chapter 3. The mean DSC is calculated from the
DSC of each segmented image to the first or second image in the series, depending on which
image was input into the synthetic image model. In addition, T1 values were evaluated in two
ways: 1) by drawing an appropriate region of interest on each acquired image, calculating
the mean signal for each image, and fitting these to an inversion recovery curve to calculate a
mean T1 value; 2) ROIs were drawn on registered T1 maps to calculate the mean T1. This
was to evaluate whether T1 values measured on acquired images are consistent with those
calculated from registered T1 maps, to address the possibility that the registration algorithm
itself was corrupting T1 values.
In addition, regions of interest were also drawn onto a region of body fat in each T1 map,
as fat has a relatively sparse capillary bed, and therefore should be less effected by perfusion
and oxygenation related T1 changes resulting from respiration [113].
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6.2.2 Subjects
10 healthy volunteers (8/10 male, mean age 29±7 years) were recruited as subjects to test
the method. Each volunteer underwent 2D MOLLI both breath hold and free breathing
with post-processing motion correction via registration. 4/10 volunteers also underwent 2D
MOLLI breath hold acquisition imaging during inhalation of 100% oxygen after a delay of 2
minutes. 3/10 volunteers also underwent 2D MOLLI breath hold imaging during inhalation
of 100% oxygen over a period of 6-9 minutes.
6.2.3 Oxygen administration
100% oxygen was administered at a flow rate of 15L/min for two minutes prior to imaging,
unless otherwise specified. A simple face mask with low-flow delivery was used for oxygen
delivery on the free breathing and breath held image acquisitions for 2 minutes. For image
acquisitions while breathing oxygen for 6-9 minutes to observe the wash-in of oxygen, a
non-re-breather mask was used at a flow rate of 15L/min.
6.3 Results
6.3.0.1 Efficacy of registration in free breathing MOLLI images
DSC significantly increased, (p<0.001) see Figure 6.7 and Table 6.1. Image registration
improved in all patients, with an unregistered DSC range of 0.55-0.75 and a registered DSC
range of 0.60-0.78. An example of registered free breathing images can be seen in Figure
6.8.
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Fig. 6.6 Mean DSC from all images, calculated with respect to the first image, before and
after image registration in free breathing healthy volunteers, DSC is significantly increased
post registration p<0.001.
Examples of free breathing T1 maps without image registration and with image registra-
tion are shown in Figure 6.6. The figure demonstrates the kinds of erroneous T1 values you
may see due to motion in MOLLI images.
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Fig. 6.7 T1 maps before and after image registration to illustrate the improvement in T1 maps
after image registration are shown. A) Unregistered T1 map from a free breathing healthy
volunteer. Blue and black arrows indicate regions of error in the myocardium. Whereas the
erroneous value in the pixel shown by the blue arrow may be easily identified, the area shown
by the black arrow may be misidentified as elevated myocardial T1. B) The registered version
of the T1 map shown in A. Black arrow shows area of erroneous T1 in A now corrected. C)
Unregistered T1 map from a free breathing healthy volunteer. Green arrows show areas of
erroneous T1 values in the myocardium. D) The registered version of the T1 map shown in C.
Green arrow shows area of erroneous T1 in A now corrected.
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Fig. 6.8 Example cardiac MOLLI images before and after image registration, a blue line is
added for reference and aligns with the bottom of the myocardium in the first image for each
dataset.
Table 6.1 DSC (mean from all time points) before and after image registration.
Unregistered DSC Registered DSC paired t-test
Free breathing 0.64±0.07 0.72±0.04 p<0.001
Breath hold 0.77±0.04 - -
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6.3.0.2 Effect of respiration on overall myocardial T1
In breath hold, myocardial septal T1 was significantly lower than in free breathing (p=0.002), although LV
blood T1 was higher in free breathing it was not significantly so, see Table 6.3, Figure 6.9.
Table 6.2 Consistency of myocardial T1 when measured directly from images and from
registered T1 maps.
T1 from images (ms) T1 from T1 maps (ms) p-value
Breath hold 930±45 940±50ms p=0.142
Free breathing 1100±100ms 1000±90ms p=0.534
Fig. 6.9 An example of a T1 map acquired during inspiration breath hold and acquired during
free breathing with image registration using a respiratory model in a healthy volunteer.
There are no significant differences between myocardial septal T1 values measured from
registered T1 maps compared to myocardial septal T1 values measured from mean signal
calculated from individual regions of interest drawn on MOLLI images, see Table 6.2.
Table 6.3 Effect of respiration on overall myocardial T1






Breath hold 910±120 1400±100 1400±75 200±32
Free breathing 990±160 1500±140 1500±134 200±25
Paired t-test p=0.02** p=0.156 p=0.212 p=0.846
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6.3.0.3 Effect of respiration of 100% O2 on overall myocardial T1
Myocardial and LV blood pool was significantly lower post inhalation of 100% O2 during
free breathing acquisitions, but there were no significant differences in the myocardium or
blood pool during breath held acquisition.
Table 6.4 Effect of respiration of 100% O2 for 2 minutes prior to acquisition of images on
overall myocardial T1. T1 data was analysed from 8 of the volunteers, 4 of whom underwent
T1 acquisition before and after inhalation of 100% O2 for 2 minutes with free breathing
acquisitions and 4 of whom underwent T1 acquisition before and after inhalation of 100%
O2 for 2 minutes with breath hold acquisitions.
Myocardial septal T1 RV blood T1 LV blood T1
Breath hold
Breathing air 987±100 1260±100 1440±200
100% O2 980±70 1190±140 1430±140
p-value 0.831 0.101 0.757*
Free breathing
Breathing air 1030±70 1260±260 1470±60
100% O2 940±30 1210±60 1600±40
p-value 0.035* 0.281 0.044*
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Fig. 6.10 T1 over time for subjects breathing 100% oxygen during breath hold MOLLI
imaging in the myocardium and ventricular blood pools.
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A series of time resolved T1 maps were acquired during breath hold and inhalation of
100% O2 in three volunteers, see Figure 6.10, and Table 6.5. The mean myocardial T1
during breathing 100%O2 was 962±80 ms and the mean myocardial T1 after the oxygen
was switched off was 1000±70ms (p=0.156). The mean RV blood pool T1 was significantly
lower when the 100% O2 was switched on (p=0.009).
Table 6.5 Effect of respiration of 100% O2 on overall myocardial T1 from three volunteers
with breath hold acquisitions. N is the number of datasets included, where multiple T1 maps
were acquired for each volunteer, as shown in Figure 6.10. T1 was grouped into T1 measured
before breathing % O2 and during breathing 100% O2. The values shown are mean values




RV blood T1 LV blood T1
Breathing air 3 1000±130 1500±240 1500±240
100% O2 ON 13 960±80 1300±150 1500±190
100% O2 OFF 16 1000±70 1500±170 1600±200
p-value 0.156 0.009** 0.226
6.4 Discussion
Myocardial alignment was significantly increased and resulted in myocardial T1 values
consistent with those determined from the mean signal from ROIs drawn on each image.
This indicates the registration did not lead to erroneous T1 values from the myocardium.
Myocardial T1 was found to be significantly higher during free breathing, and blood T1 values
were also found to be higher - but not significantly so.
During respiration, it is likely that the imaging plane will include images from slices
which are anatomically positioned further towards the apex or base of the heart than other
images, and therefore respiration will move the cardiac system in and out of the plane. In
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subjects where the myocardium may demonstrate a heterogeneous T1 this will affect the
precision of overall T1 and therefore remains a substantial problem. This problem could
be overcome by adopting the method for use in 3D imaging [50] [8] where the adjacent
slices are acquired. Additionally, post-acquisition registration may be well suited to 3D
T1 mapping as it would remove the time consuming navigation or breath hold procedures
otherwise required.
Although the method described in this chapter is susceptible to a lack of precision due
to out of plane motion described above, this motion is unlikely to cause systematic errors
resulting in an apparent elevated or lowered T1 across a group of subjects, because the
potential imprecision introduced due to the respiratory motion, the effects of which will
be randomly distributed across the group (i.e. the breathing state of constituent images is
essentially random). Therefore, it is unlikely that this explains the systematic differences seen
in T1 due to free breathing and breath hold acquisition. However, if the effect is due to motion
rather than physiological effects, it is still relevant to the field to know that post-acquisition
respiratory correction could lead to an apparent T1 change which could be misleading or
result in inaccuracies in studies where significant proportions of the study population have
undergone post-acquisition motion correction.
Our study found significantly higher T1 during free breathing acquisition when compared
to inspiration breath hold. It is not clear what the mechanism of increasing T1 during res-
piration is, however, it is known that myocardial perfusion and oxygenation change with
breathing manoeuvres [114]. One study shows a trend of shorter breath holds decreasing
myocardial oxygenation with very long breath holds having shown to result in decreased
oxygenation in the LV blood pool and significantly increased myocardial oxygenation -
the study suggests this may be due to increased blood flow compensating for desaturation
[114]. Therefore, it may be due to a increase in paramagnetic deoxymyoglobin and deoxy-
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haemoglobin in the perfused myocardium during breath hold that decreases the T1 during
breath-hold.
As discussed in Chapter 5, a key limitation of this work is that the phase shift was not
included in the respiratory model. Further work using the model described in equation is ex-
pected to improve the respiratory model and therefore potentially improve image registration
further. Nonetheless, these results show that incorporating a sinusoidal component to curve
fitting allows images of similar respiratory state to be selected and used for synthetic images,
resulting in significant improved image registration.
It is a limitation of this work that scan-scan repeatability of free breathing acquisition
of the MOLLI sequence has not been compared to that of a breath hold MOLLI sequence,
which shows excellent scan-scan repeatability in healthy volunteers [91]. It would be of
interest to compare both methods for scan-scan repeatability in healthy volunteers prior to
further work.
When breathing 100% oxygen for 2 minutes prior to MOLLI imaging during free
breathing, the LV blood and myocardial T1 values significantly decreased. This is consistent
with dissolved oxygen in the highly oxygenated LV blood lowering the blood T1, due to the
increase of oxygen delivery [2]. The breath hold T1 values in the blood pool and myocardium
were not significantly lower after inhalation of 100% oxygen. However, when breathing
100% oxygen followed by breath hold MOLLI imaging over a time period of 6-9 minutes,
there was a significant overall lowering of T1 seen in the RV blood pool. This indicates
that the response to inhalation of 100% O2 may be dependant on the breathing manoeuvre
undertaken during imaging.
Breathing 100%O2 during free breathing myocardial T1 mapping has been shown to
significantly decrease myocardial T1 in healthy volunteers. This may mean that oxygen
enhanced myocardial T1 mapping can be used to visualise myocardial oxygenation - however
more work with greater numbers of volunteers would be required to establish this. In addition,
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it has been shown that the use of a full closed air cushioned oxygen face mask for oxygen
enhanced lung imaging results in higher oxygen transfer in the lung [108] and therefore
repetitions of these experiments with a full closed oxygen mask may similarly result in higher
oxygen transfer in the blood and myocardium.
6.5 Conclusions
Despite the limitations discussed, the method has been shown to significantly improve image
registration in the short-axis plane, and indicates that there may be changes in measured
myocardial T1 due to respiration during T1 mapping image acquisition. This indicates that
respiratory state needs to be considered when evaluating T1 values and that if a subject
does not maintain breath hold it may artificially elevate their resultant myocardial T1. The
study also shows a significant decrease in free breathing T1 after breathing 100% oxygen
for 2 minutes. This emphasises that oxygenation, and any associated perfusion changes to
compensate for oxygenation changes, can significantly affect myocardial T1 and therefore, in
patients with conditions associated with decreased oxygenation, there may be an associated
change in measured myocardial T1 which is not due to pathological tissue changes, but is due
to blood oxygenation and/or perfusion changes. Indeed, it is worth noting that in Chapter 4
a significant negative correlation was found in patients with pulmonary hypertension with
svO2 and the myocardial T1 in the LV free wall and RV insertion points.
In addition, this chapter demonstrates preliminary evaluation of a novel free breathing
cardiac T1 mapping technique which does not extend image acquisition time, and which could
be extended to 3D acquisition to overcome the shortcomings discussed. Oxygen enhanced
myocardial T1 mapping post processing method may also be able to show oxygenation
changes in the myocardium.
Chapter 7
Conclusions
The work in this thesis concerns the development and application of motion correction for
cardiac and lung T1 mapping sequences using synthetic-image based image registration
methods. The thesis proposes two key methods: the first for correcting accidental motion
in cardiac MOLLI images; the second for correcting motion due to respiration during free
breathing acquisition of both cardiac MOLLI images and lung look locker images.
The development of a method to correct accidental motion in MOLLI images is presented
in Chapter 3, and verified against an alternative, established motion correction method. The
presented method was found to be equally as effective as the method by Xue et al [5] against
which it was verified, but significantly more computationally efficient. Chapter 3 established
that a shortened acquisition sequence such as shMOLLI alone does not reduce all respiratory
motion in a pulmonary hypertension cohort of patients. Chapter 3 also found that in a cohort
of patients with suspected pulmonary hypertension, neither measured T1 nor the pixel wise
standard deviation of T1 values was significantly affected by image resolution.
This developmental work allowed a large cohort of pulmonary hypertension patients
to undergo MOLLI imaging with post-processing image registration to correct accidental
motion due to difficulties maintaining breath hold in this patient population. The application
of this method to a pulmonary hypertension cohort of 490 patients and 25 healthy volunteers
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was presented in Chapter 4. To the authors knowledge, Chapter 4 is the largest study
of cardiac T1 mapping in pulmonary hypertension, and the only study to consider the
diagnostic and prognostic significance of T1 mapping in pulmonary hypertension to date.
Myocardial T1 in the right ventricular insertion points was significantly higher in patients
with pulmonary hypertension than in patients without pulmonary hypertension or healthy
volunteers. Although there are distinctive myocardial T1 changes with the condition, they
were not found to provide diagnostic value or additive prognostic value.
Chapter 5 and Chapter 6 modify the method described in Chapter 3 for free breathing
image acquisition, with the intention of removing uncomfortable breath holds from MOLLI
and Look-Locker imaging sequences without extending the time the patient is on the MRI
scanner. The method was found to be successful in both cases, however, it was also found
that the act of free breathing may result in significant changes to the measured T1 in the
lungs and in the myocardium. This may mean that unintended breathing during a breath-hold
MOLLI or Look-Locker sequence may result in T1 changes due to respiration.
Chapter 5 uses the image registration to correct respiratory motion in a free breathing
Look-Locker acquisition in small cohort of 9 healthy volunteers and 10 patients with IPF.
This work found significant differences in the free breathing lung T1 in patients with IPF
compared to healthy volunteers, with patients with IPF having a lower overall lung T1 during
free breathing and greater lung heterogeneity. These changes were significant in both breath
hold and free breathing acquisition. A subset of 3 healthy volunteers also underwent T1
mapping whilst breathing 100% O2, which found that lung T1 significantly reduced after
administration of 100% O2 in both breath held and free breathing acquisition.
Chapter 6 uses image registration to correct respiratory motion in a free breathing
MOLLI acquisition in a small cohort of 10 healthy volunteers. The registration method
significantly improved image registration in the short-axis plane and indicates that there
may be changes in measured myocardial T1 due to respiration during T1 mapping image
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acquisition. The chapter also shows that a significant decrease in breath hold and free
breathing myocardial T1 after administration of 100% O2 for 2 minutes prior to imaging,
which indicates that blood oxygenation affects measured myocardial T1, although future
work with larger subject numbers is required to fully establish this association. Chapter 6
describes cardiac T1 mapping in 2D which is affected by out-of-plane motion, and it would
be of interest in future work to look at 3D cardiac T1 mapping with image registration to
correct motion. This would overcome the issues concerning out-of-plane motion and confirm
whether breathing manoeuvres affect myocardial T1.
7.1 Future work
Chapter 4 presented the largest study of cardiac T1 mapping in pulmonary hypertension,
and the only study to consider the diagnostic and prognostic significance of T1 mapping in
pulmonary hypertension to date. The study found significantly elevated myocardial T1 in
the RV insertion points compared to both control groups - however the study did not find
diagnostic or prognostic significance to native myocardial T1. The discussion in Chapter 4
highlights that normalising myocardial T1 values using blood T1 values in order to remove
effects due to hematocrit, oxygenation or perfusion changes in the myocardium may be a
useful technique in this patient population, and this is strengthened by the data in Chapter 6
which shows that oxygenation can affect myocardial T1. In particular, it would therefore be
of interest to look at whether normalising myocardial T1 data with each patients blood T1
shows greater differences between patients with pulmonary hypertension and patients without
pulmonary hypertension. In addition, it would be of interest in future work to establish: the
scan-scan repeatability in patients with pulmonary hypertension; whether native myocardial
T1 elevation changes with time in patients with pulmonary hypertension and whether any T1
changes over time have prognostic significance.
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This thesis has described the development and application of methods for free breathing
cardiac and lung T1 mapping using post-processing image registration. These methods have
the potential to provide a clinically applicable free breathing T1 mapping for patients with
cardiac and respiratory disease, however, there remains several areas of developmental work
required to establish the methods are robust, repeatable and to correctly interpret their results.
For the free breathing lung T1 mapping method developed in Chapter 5 a phase term
would need to be incorporated into the respiratory model as discussed in Chapter 5 before
any future work. I would like to acknowledge the examiners for this thesis for highlighting
this error. It is expected that a phase term will improve the accuracy of the respiratory model
which will further improve the success of the image registration based motion correction. It
would also be a priority to understand the scan-scan repeatability in healthy volunteers during
free breathing and breath hold. In addition, it would be of interest to extend the oxygen
enhanced lung T1 mapping methods undertaken in Chapter 5 to patients with IPF, as ∆T1
between T1 maps acquired whilst breathing room air compared to breathing 100% O2 may be
able to visualise regions of poor ventilation and/or perfusion in patients with IPF. If data were
acquired alongside CT images it would also be possible to explore whether any oxygenation
deficits are associated with regions of fibrosis. Furthermore, if the increased lung T1 in
expiration (compared to inspiration) is due to increased lung perfusion, co-registration of
inspiration and expiration lung T1 maps using synthetic images may allow a contrast-free
visualisation of lung perfusion. This could be explored by comparison with contrast enhanced
lung perfusion scans.
Redeveloping the method discussed in Chapter 6 to compensate for out-of-plane motion
would overcome the key limitation of this method. One way of achieving this may be to use a
3D MOLLI acquisition during free breathing with image registration in all three dimensions.
It may also be beneficial to calculate inspiration and expiration T1 maps from a free breathing
acquisition, using only the images which occur in inspiratory and expiratory states (and are
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therefore within the same plane). The differences between inspiration (and expiration) T1
maps in breath hold and during free breathing acquisition will show how much of the T1
changes are breathing manoeuvre dependent (i.e. dependent on the oxygenation and perfusion
effects of breath holding rather than the changes to the fractional components of tissue within
the lung). This could be implemented by interleaving the only the inspiratory and expiratory
components of several MOLLI scans acquired during free breathing. In addition, it would be
a priority to do scan-scan repeatability testing comparisons between free breathing and breath
held MOLLI acquisitions. It would also be interesting to explore whether myocardial T1
changes due to oxygen enhancement would enable oxygenation mapping of the myocardium.
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The following appendix shows the relevant code for this thesis, with accompanying flow
charts describing the algorithm for each section of code.
A.1 Matlab code for Chapter3
Each step of the algorithm in Figure A.1 is described in the following section, with an
accompanying flow chart describing each section of code further.
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Fig. A.1 Flow chart to show the relevant sections of code and their ordering for Chapter 3.
A.1.1 Reorder images
The purpose of this section of code is to reorder the MOLLI images according to their time
post-inversion (T I). The steps of the algorithm, as well as input and output information, are
outlined in Figure A.2.
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Fig. A.2 Flow chart to demonstrate following code. The code reorders and centrally crops
the images.








9 IMc(:,:,i)=imcrop(IM(:,:,i), [64 64 128 128]);
10 end
A.1.2 Code to determine the image of lowest overall signal
The purpose of this section of code is to determine the MOLLI image with the lowest overall
signal, to later provide information on curve steepness during the creation of synthetic images.
The steps of the algorithm, as well as input and output information, are outlined in Figure
A.3.
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A.1.3 Code for initial registration
The purpose of this section of code is to determine whether the input images for synthetic
image creation require initial registration, and to register them if so. The steps of the
algorithm, as well as input and output information, are outlined in Figure A.4.
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Fig. A.4 Flow chart to demonstrate following code which determines whether or not images
need to undergo an initial registration.
1 function imgs=reg_approx(imgs, null_I, time_trig, time_real)
2 [¬,¬, z] = size(imgs);










13 A = image_object(imgs(:,:,I));
14 B = image_object(imgs(:,:,i));
200 Appendix





A.1.4 Code to restore signal polarity pixel-wise
The purpose of this section of code is to restore signal polarity to a set of inversion recovery
images. The steps of the algorithm, as well as input and output information, are outlined in
Figure A.5.
Fig. A.5 Flow chart to demonstrate following code. The code restores signal polarity for a
set of inversion recovery images.
1 [pixelx, pixely, series_size]=size(im);
2 for i=1:pixelx







9 opts = optimset('Display','off');
10 x = lsqcurvefit(@myfun, [IM(i,j,series_size), ...
IM(i,j,series_size)*2, 0.8], trig_time', squeeze(IM(i,j,:)), ...
[], [], opts);
11 y = x(1) - x(2) * exp ( -trig_time / x(3));
12 xyvalues{k,1}=x;
13 xyvalues{k,2}=y;
14 residu2(k)=sum( (squeeze(IM(i,j,:)) -y').^2 ./ y' );
15 end








A.1.5 Code to create synthetic images
The purpose of this section of code is to create synthetic images via curve fitting to a
simplified inversion recovery model, from the three chosen input images. The steps of the
algorithm, as well as input and output information, are outlined in Figure A.6.
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Fig. A.6 Flow chart to demonstrate following code. The code creates synthetic images for a
set of inversion recovery images.
1 [pixelx, pixely, series_size]=size(IM);
2 for i=1:pixelx
3 for j=1:pixely
4 y_real = double([IM(i,j,1), IM(i,j,I), IM(i,j,I2)]);
5 t_real=[trig_time(1), trig_time(I), trig_time(I2)];
6 ymax = IM(i,j,I2);
7 global ymax;
8 opts = optimset('Display','off');
9 X=lsqcurvefit(@myfun_synth, 1, t_real, y_real, [], [], opts); % ...
fit to just signal for 1,4 and 11





15 function f = myfun_synth (x, xdata)




A.1.6 Code for image registration
The purpose of this section of code is perform pair-wise final image registration between the
acquired images and the synthetic images. The steps of the algorithm, as well as input and
output information, are outlined in Figure A.7.
Fig. A.7 Flow chart to demonstrate following code. The code creates registers acquired
images to synthetic images using toolkit ShIRT.
1 function [reg_imgs, map]= final_reg(imgs, synth_imgs)
2
3 IRLab;




8 A = image_object(synth_imgs(:,:,i));
9 B = image_object(imgs(:,:,i));
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A.1.7 Code for T1 map creation
The purpose of this section of code is perform the T1 mapping on the registered images. The
steps of the algorithm, as well as input and output information, are outlined in Figure A.8.
Fig. A.8 Flow chart to demonstrate following code. The code creates the final registered T1
maps.
1






8 opts = optimset('Display','off');
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9 x= lsqcurvefit(@myfun,[regtemp(series_size), ...
regtemp(series_size)*2, 1], ...
10 trig_time(1,:), regtemp(1,:), [], [], opts); % x(1) is A, x(2) is ...
B, x(3) is T1*
11 y = x(1) - x(2) * exp ( -trig_time / x(3));
12 T1_matrix(i,j) = x(3) * (x(2)/x(1) - 1); % x(1) is A, x(2) is B ...
and x(3) is C/T1*]










A.2 Matlab code for Chapter 5
Each step of the algorithm in Figure A.9 is described either in the previous section (for steps
which are in common with the previous chapter), or in the following section (for new or
altered steps) with an accompanying flow chart describing each section of code further.
A.2.1 Code to determine aligned images for synthetic image creation
The purpose of this section of code is to determine three aligned images to use for creating
synthetic images. These images are determined using a combined inversion recovery and
respiratory model. Regions of interest are fit to the combined model to determine respiratory
rate and therefore, images which occur in the same respiratory state.
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Fig. A.9 Flow chart to show the relevant sections of code and their ordering for Chapter 5.
Sections that are different to that described in Chapter 3 are highlighted in red.
The steps of the algorithm, as well as input and output information, are outlined in Figure
A.10.
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Fig. A.10 Flow chart to demonstrate following code. The code determines aligned images
for synthetic image creation.
1 function [I1, I2, model]=lung_t1analysis(im, t)




















21 ymax = max(meansig1);
22
23 guess= [ ymax/4, 1.75, ymax ,0.2];
24 opts = optimset('Display','off');
25 xA = lsqcurvefit(@myfun7, guess, t, meansig1A, [], [], opts);
26 xB = lsqcurvefit(@myfun7, guess, t, meansig1B, [], [], opts);
27
28 A=[1 4 7];
29 B=[2 5 8];
30 C=[ 3 6 9 10 11];
31 global invtime
32
33 yA(A) = ...
(xA(1)*sin(xA(2)*(t(A)+invtime(1)))+xA(3)).*(1-2*exp(-t(A)/xA(4))) ...
;
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34 yA(B) = ...
(xA(1)*sin(xA(2)*(t(B)+invtime(2)))+xA(3)).*(1-2*exp(-t(B)/xA(4))) ...
;




37 yB(A) = ...
(xB(1)*sin(xB(2)*(t(A)+invtime(1)))+xB(3)).*(1-2*exp(-t(A)/xB(4))) ...
;
38 yB(B) = ...
(xB(1)*sin(xB(2)*(t(B)+invtime(2)))+xB(3)).*(1-2*exp(-t(B)/xB(4))) ...
;




41 residuA(k,:)=sum( ( squeeze(yA(1,:)) - meansig1A(:)' ).^2 ./ ...
meansig1A(:)');













































85 f = (x(1)*sin(x(2)*xdata+x(5))+x(3)).*(1-2*exp(-xdata/x(4))) ;
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86 end
A.3 Matlab code for Chapter 6
Each step of the algorithm in Figure A.11 is described either in the previous sections (for
steps which are in common with the previous chapters), or in the following section (for new
or altered steps) with an accompanying flow chart describing each section of code further.
Fig. A.11 Flow chart to show the relevant sections of code and their ordering for Chapter 6.
Sections that are different to that described in Chapter 5 or Chapter 3 are highlighted in red.
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A.3.1 Code to determine aligned images for synthetic image creation
The purpose of this section of code is to determine three aligned images to use for creating
synthetic images for cardiac images with images interleaved from multiple inversions. These
images are determined using a combined inversion recovery and respiratory model. Regions
of interest are fit to the combined model to determine respiratory rate and therefore, images
which occur in the same respiratory state.
The steps of the algorithm, as well as input and output information, are outlined in Figure
A.12.
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Fig. A.12 Flow chart to demonstrate following code. The code determines aligned images
for synthetic image creation.
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1
2 function [I1, I2, model]=cardiac_t1analysis(im, t)






















25 ymax = max(meansig1);
26
27 guess= [ ymax/4, 1.75, ymax ,0.2, 0];
28 opts = optimset('Display','off');
29 xA = lsqcurvefit(@myfun1, guess, t, meansig1A, [], [], opts);
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30 xB = lsqcurvefit(@myfun1, guess, t, meansig1B, [], [], opts);
31
32 A=[1 4 7];
33 B=[2 5 8];
34 C=[ 3 6 9 10 11];
35 global invtime
36
37 yA(A) = ...
(xA(1)*sin(xA(2)*(t(A)+invtime(1))+xA(5))+xA(3)).*(1-2*exp(-t(A)/xA(4))) ...
;
38 yA(B) = ...
(xA(1)*sin(xA(2)*(t(B)+invtime(2))+xA(5))+xA(3)).*(1-2*exp(-t(B)/xA(4))) ...
;




41 yB(A) = ...
(xB(1)*sin(xB(2)*(t(A)+invtime(1))+xB(5))+xB(3)).*(1-2*exp(-t(A)/xB(4))) ...
;
42 yB(B) = ...
(xB(1)*sin(xB(2)*(t(B)+invtime(2))+xB(5))+xB(3)).*(1-2*exp(-t(B)/xB(4))) ...
;




45 residuA(k,:)=sum( ( squeeze(yA(1,:)) - meansig1A(:)' ).^2 ./ ...
meansig1A(:)');
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